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ABSTRACT

Variation in cryotolerance exists between embryos from different animal
breed, species and management conditions. Reduced tolerance to chilling and
cryotolerance of oocytes and embryos has been associated with greater
cytoplasmic lipids (Kim et al., 2001; Seidel, 2006). Previous studies in the cow
have demonstrated nutrition-induced modification of follicular components.
Trans-10, cis-12 conjugated linoleic acid (CLA) was identified as a potent
inhibitor of milk fat synthesis in lactating cows (Baumgard et al., 2000) and
inclusion of CLA in bovine embryo culture medium improved post-thaw embryo
survival (Pereira et al., 2007). Dietary supplementation of cows with CLA could
alter oocyte fatty acid metabolism, oocyte lipid composition and embryo
cryotolerance, and responses may be different between Bos indicus and Bos
taurus breeds of cattle. Therefore, a series of experiments were conducted to
evaluate effects of dietary CLA supplementation of cows on (1) milk fat
depression in lactating Holstein cows, (2) follicle and oocyte production and lipid
content of oocytes from Brahman and Holstein cows, (3) mRNA expression of
genes involved in lipid metabolism in oocytes from Brahman and Holstein cows
and (4) cryosurvival of in vitro-produced embryos from CLA-supplemented
oocyte donor cows.
Milk fat was depressed by 10.1% in lactating Holstein cows fed CLA.
Follicle, oocyte and embryo production of cows were not influenced by CLA
supplementation. Dietary supplementation of cows with CLA before oocyte
collection did not influence cryotolerance of in vitro-produced embryos or
xii

expression of genes in oocytes involved in lipid metabolism. Lipid content of
oocytes was not influenced by CLA supplementation. The ovarian response to
dietary CLA was similar among Brahman, Holstein and crossbred beef cows.
The highly regulated mechanisms involved in fatty acid uptake by ovarian
components may help explain the lack of ovarian response to dietary CLA in the
current study.
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CHAPTER I
INTRODUCTION

The successful cryopreservation of embryos is vital for embryo transfer to
make genetic improvement while being economically viable in a particular
species. Embryo cryopreservation has become an important and rather routine
practice in bovine embryo transfer. There are many reasons bovine embryos are
cryopreserved for short or long-term storage in liquid nitrogen. Embryos are
cryopreserved rather than immediately transferred into recipient females when
greater-than-expected embryos are produced or recipient females are
unavailable. Producers may want to cryopreserve embryos and transfer at a
later date so offspring are born at a desired season due to weather, economic or
marketing constraints. Cryopreserved embryos are often marketed by cattle
producers, similar to selling cryopreserved semen of genetically superior bulls.
Shipment of cryopreserved embryos across great distances is very efficient and
economical and presents less risk of disease transmission compared with live
animal transport. Embryo cryopreservation is also important in germplasm
preservation programs.
The International Embryo Transfer Society (IETS) Data Retrieval
Committee produces an annual report detailing embryo collection and transfer
activities worldwide. In 2012, over 1.1 million embryos were collected or
produced globally with embryos transferred to over one million cattle. In North
America, 72% of the 355,866 in vivo embryos collected in 2012 were
cryopreserved, while 57% of the 235,344 in vivo-produced embryos transferred
1

in 2012 were cryopreserved and thawed embryos. The trend of more embryos
transferred after cryopreservation compared with fresh-transferred embryos has
occurred annually for more than a decade in the cattle embryo transfer industry.
Cryopreservation of in vivo-produced embryos has become widely
adapted and successful in cattle embryo transfer. Pregnancy rates after transfer
of in vivo-produced, frozen-thawed embryos are reportedly 80 to 90% of the
pregnancy rates achieved after transfer of fresh embryos (Hasler, 2001).
However, variation in cryotolerance exists between in vivo-produced embryos
from different species, breeds and management conditions.
Reduced tolerance to chilling and cryotolerance of oocytes and embryos
has been associated with greater cytoplasmic lipids (Kim et al., 2001; Abe et al.,
2002; Seidel, 2006). Nagashima et al. (1994) provided clear evidence for
reducing cytoplasmic lipids by improving cryopreservation of porcine embryos
after physical delipidation. Cooling and cryopreservation of lipid-rich porcine
oocytes causes lipid droplets to coalesce and increase in size, which alters the
structural organization within the cytoplasm of the oocyte (Edidin and Petit.,
1977). The movement and structural alteration of lipid droplets during cooling
may irreversibly damage bovine embryos by decreasing cytoplasmic organization
of organelles (Mohr and Trounson, 1981).
The concentration and type of fat included in ruminant diets may influence
the composition of oocytes and embryos, and therefore, their cryotolerance.
Fatty acid composition of follicular fluid in dairy cows is sensitive to dietary supply
of polyunsaturated fatty acids (PUFA) when feeding soybean oil (Batista et al.,
2

2010) and flaxseed oil (Zachut et al., 2010). In vivo-produced embryos from
Nellore heifers fed PUFA had reduced cryotolerance (Guardieiro et al., 2014).
Another interesting area of study has identified specific conjugated linoleic
acids (CLA) isomers that inhibit milk fat synthesis in dairy cows (Loor and
Herbein, 1998; Chouinard et al., 1999a; Chouinard et al., 1999b). The trans-10,
cis-12 CLA isomer was identified as a potent inhibitor of milk fat synthesis in
lactating cows (Baumgard et al., 2000; Baumgard et al., 2001; Peterson et al.,
2002). Addition of trans-10, cis-12 CLA into culture media reduced lipid
accumulation and improved cryotolerance of in vitro-produced bovine embryos
(Pereira et al., 2007). Although the trans-10, cis-12 CLA isomer appears to
influence both milk fat synthesis and embryo lipid accumulation in vitro, it is
unknown whether oocyte and embryo lipid composition could be altered in vivo
by feeding trans-10, cis-12 CLA. Research is warranted to elucidate possible
relationships between dietary CLA supplementation of cows and oocyte and
embryo composition, with potential implications for embryo cryopreservation.
Although cryopreservation of in vivo-produced bovine embryos is
common, in vitro-produced embryos are more sensitive to chilling and
cryopreservation than in vivo-produced embryos (Leibo and Loskutoff, 1993;
Pollard and Leibo, 1993; Farin et al., 1999). Only 13% of the 40,546 in vitroproduced embryos transferred in North America in 2012 were cryopreserved
embryos (IETS, 2012). In Brazil, the global leader of bovine in vitro embryo
production, 303,168 fresh in vitro-produced embryos were transferred, while only
28,314 cryopreserved and thawed embryos were transferred (8.5%) in 2012.
3

Embryo transfer practitioners are reluctant to cryopreserve in vitro-produced
bovine embryos at a rate similar to in vivo embryos because in vitro bovine
embryos have not produced consistent satisfactory pregnancy rates after
transfer. Research has closed the gap in cryosurvival between in vivo and in
vitro bovine embryos, yet there remains opportunity for improvement before the
widespread adoption of in vitro embryo cryopreservation in cattle.
Successful cryopreservation of embryos from Bos indicus cattle is variable
(Visintin et al., 2002). Cytoplasmic lipid content is greater in Bos indicus oocytes
compared with Bos taurus oocytes (Ballard, 2006), likely contributing to reduced
cryotolerance in embryos from Bos indicus cattle. Bos indicus cattle also have
greater milk fat compared with other breeds of cattle.
Additional research is necessary to elucidate mechanisms contributing to
variation in cryotolerance associated with individual animal, breed, species,
nutrition and season of the year (Seidel, 2006). Previous studies in the cow have
demonstrated nutrition-induced modification of follicular components. Dietary
supplementation of cows with CLA could alter oocyte fatty acid metabolism,
oocyte lipid composition and embryo cryotolerance. The response to CLA
supplementation may be different between Bos indicus and Bos taurus breeds of
cattle. Better understanding of mechanisms contributing to variation in
cryotolerance of embryos will likely continue to improve success of embryo
cryopreservation. Research models that evaluate variation in lipid composition of
oocytes and embryos have the potential to impact biological disciplines beyond
cryopreservation.
4

CHAPTER II
REVIEW OF LITERATURE

Cryotolerance of Embryos
Cryotolerance and cryosurvival are terms used in the literature that
describes the ability of cells to survive a particular cryopreservation process. The
most accurate test for the survival of embryos to cryopreservation is the birth of
healthy offspring resulting from transfer of frozen and thawed embryos. The next
best measure of embryo survival is a confirmed pregnancy in recipients after
transfer of frozen- thawed embryos. However, applying statistical methods to
observed differences in live offspring or pregnancy rates is very challenging. To
show a statistical difference (P ≤ 0.05) based on a power of 0.90 and pregnancy
rates of 60% and 70% for control and treatment groups using a two-tailed test
requires 496 embryo transfers in each treatment group (Chapman and Seidel,
2007; Hasler, 2010). A change in pregnancy rate of 10% in commercial embryo
transfer would be financially significant, but it is very difficult and expensive to
design practical studies to evaluate these differences (Hasler, 2010). Pregnancy
rate differences of much less (e.g., 5% points) would be financially important, but
would require an even greater number of embryo transfers than specifications
listed above.
Researchers have developed techniques for the evaluation of cryosurvival
of embryos that require fewer resources. Although many of these techniques are
less robust than comparing pregnancy rates or live offspring, they allow for some
inference into cryosurvival in experimental settings. One such method is a post5

thaw analysis followed by an in vitro survival assay. In vitro survival assays have
been used to evaluate post-thaw survival in a number of published studies
involving different in vitro culture conditions or cryopreservation techniques for
bovine (Pugh et al., 1998; Enright et al., 2000; Abe et al., 2002; Lopatářová et al.,
2002; Rizos, 2003; Pereira et al., 2007; Pereira et al., 2008; Al Darwich et al.,
2010; Ruiz et al., 2013) and porcine embryos (Men et al., 2006). Generally,
these researchers evaluated survival or re-expansion based on a defined set of
criteria at the time of thawing and again at 12 h or 24 h intervals through 24 h to
72 h of in vitro culture. The number of embryos hatching was also reported in a
number of the aforementioned studies. Most evaluated cryosurvival in moderate
to low numbers of embryos (n ≤ 50) per treatment group.
A number of research groups have transferred d-7 to d-8 in vitro-produced
embryos and recovered them on d 14 to d 16 to evaluate embryonic survival,
development and/or gene expression. After transferring d-7 embryos, d-14 to
d-16 embryos were recovered and embryonic development was evaluated
between in vivo- and in vitro-produced embryos (Bertolini et al., 2002; AnguloCampos, 2010), in vitro and somatic cell nuclear transfer embryos (Alexopoulos
and French, 2009) and in vitro culture conditions (Block et al., 2007; Clemente et
al., 2009). Day-14 bovine embryos are spherical, ovoid or elongated
(Alexopoulos and French, 2009; Clemente et al., 2009) and this stage
immediately precedes important embryonic events, such as maternal recognition
of pregnancy and the formation of extra-embryonic membranes and the embryo
proper (Bertolini et al., 2002).
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Embryo development was evaluated by comparative morphology and the
presence of an embryonic disk (Bertolini et al., 2002; Alexopoulos and French,
2009). A more detailed assessment of d-16 embryos was reported using
histological evaluation (Alexopoulos and French, 2009). Recovery rates at d 14
to d 16 after embryo transfer on d 7 ranged from 20% to 70% (Bertolini et al.,
2002; Block et al., 2007; Alexopoulos and French, 2009). Clemente et al. (2009)
evaluated development after in vitro culture with progesterone by transferring d-7
embryos (20 embryos per recipient) and recovering d-14 embryos from
reproductive tracts after recipient heifers were slaughtered. Clemente et al.
(2009) noted large variation in conceptus size on d 14, even within recipients,
and recovery rate of d-14 embryos was 31% (1425 embryos transferred).
The period from d 8 to d 16 is also the time of greatest embryonic loss in
cattle (Diskin and Sreenan, 1980; Roche et al., 1981). Embryonic loss during
this period ranged from 40% to 60% in studies involving artificial insemination
(Diskin and Sreenan, 1980; Roche et al., 1981; Dunne et al., 2000) and transfer
of in vitro-produced embryos (Farin and Farin, 1995; Peterson and Lee, 2003;
Farin et al., 2004). Embryonic loss after natural mating or AI from d 24 to term is
only 5% to 8% in beef cows (Sreenan and Diskin, 1986). Transfer of d-7
embryos and recovery at d 14 may be a useful assay to evaluate early embryonic
survival and development of cryopreserved embryos. The number of embryos
recovered at d 14 and their morphology may allow some comparison of
cryosurvival between experimental treatments.
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Factors Contributing to Variation in Cryotolerance of Embryos
Modification of cryopreservation procedures has historically been the most
common approach to improve success of cryopreservation of certain cell types
(Leibo, 1981). Optimizing procedures (e.g., cryoprotectant type and
concentration, cooling rate, warming rate) usually results in improvements, but
they are often limited. Therefore, an alternative approach is to modify the cells
themselves to improve their cryotolerance (Seidel, 2006). The remainder of this
review will focus on biological, rather than procedural, factors which contribute to
variation in cryotolerance of embryos.
Cryopreservation procedures exert considerable physical stress on cells; a
major stress is osmotic due to movement of water and cryoprotectants across
cell membranes, sometimes resulting in significant changes in volume (Leibo,
1981). Therefore, cells with relatively flexible membranes that are highly
permeable to water and cryoprotectants may undergo less membrane damage
than cells with more rigid membranes (Seidel, 2006).
Membrane Composition
Cell membranes properties are mediated by membrane composition. Cell
membranes are composed mainly of phospholipids, cholesterol, other lipids and
proteins. Except for proteins, the concentrations of these components in cell
membranes of oocytes and embryos can potentially be altered by nutrition of the
donor animal and/or composition of culture media (Seidel, 2006). Cell
membranes that maintain a relatively fluid state allow for more effective diffusion
of water and cryoprotectants. Some cell membranes change from fluid to a gel
8

state at decreased temperatures (Zeron et al., 2001), reducing membrane
permeability and increasing cell damage upon warming. Membrane phase
transition is also dependent on the composition of the cell membrane (Zeron et
al., 2001). Therefore, research designed to better understand factors influencing
cell membrane composition will likely lead to practices that improve membrane
characteristics and decreased damage during cryopreservation.
Intracytoplasmic Lipid Composition
In addition to cell membrane properties, high concentrations of
cytoplasmic lipid droplets have been associated with decreased cryotolerance.
Triglyceride is the major lipid component of bovine and porcine oocytes (Homa et
al., 1986; McEvoy et al., 2000; Kim et al., 2001) and is used as an energy source
for embryo maturation both in vitro (Kim et al., 2001; Sturmey and Leese, 2003)
and in vivo. Nagashima et al. (1994) provided clear evidence for reducing
cytoplasmic lipids by improving cryopreservation of porcine embryos after
physical delipidation. The sensitivity of porcine embryos to chilling may result in
irreversible changes in membrane structure when porcine embryos are cooled
below a critical temperature (Nagashima et al., 1994). Cooling causes lateral
phase separation of membrane lipids in artificial and bacterial membranes (Petit
and Edidin, 1974) and ram spermatozoa (Holt and North, 1986). Additionally,
lipid droplets in porcine oocytes generally have close spatial relationship with
smooth endoplasmic reticulum (Hyttel and Niemann, 1990) and are believed to
be involved in modifying the physical properties and functions of mammalian cell
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membranes (Stubbs and Smith, 1984). Therefore, modification of cytoplasmic
lipids may influence membrane composition, which can influence cryotolerance.
Another theory is that the actual presence of lipid droplets may directly
influence embryo survival during chilling (Nagashima et al., (1994). Cooling and
cryopreservation of porcine oocytes causes lipid droplets to coalese and increase
in size, which alters the structural organization within the cytoplasm (Edidin and
Petit., 1977). The movement and structural alteration of lipid droplets during
cooling may irreversibly damage bovine embryos by decreasing cytoplasmic
organization of organelles (Mohr and Trounson, 1981).
Triglyceride is metabolized by mitochondria through β-oxidation and the
TCA cycle within the mitochondria matrix. Nonphysiological in vitro culture
conditions (specifically those containing serum) are reported to decrease
concentration of mitochondria and alter their ability to metabolize lipids by βoxidation (Crosier et al., 2001b; Abe et al., 2002). Therefore, studies have
focused on increasing lipid metabolism in vitro in an effort to mimic metabolic
conditions in vivo. Additionally, embryo lipid metabolism may differ between
donor animal or between breeds, leading to variation in both embryo lipid content
and cryotolerance.
The quantity of unsaturated fatty acids rather than gross lipid content may
be more critical to chilling sensitivity and cryopreservation of oocytes and
embryos from domestic livestock species (McEvoy et al., 2000). Analysis of fatty
acid composition of bovine (Zeron et al., 1999a; McEvoy et al., 2000; Kim et al.,
2001) and porcine oocytes (Homa et al., 1986) showed palmitic (16:0), oleic
10

(18:1) and stearic (18:0) acids were the three most abundant fatty acids, listed in
order. However, Sata et al. (1999) reported that myristic acid (14:0) was the
most abundant fatty acid in bovine embryos, and indicated that fatty acid
composition may differ by species or between age or breed of cow.
Stage of Development
The origin of oocyte lipids and the timing of lipid deposition are not fully
understood. It appears that oocytes acquire and/or deposit lipids between the
time of primordial follicle activation and the antral stage (Fair et al., 1997). It is
not clear whether lipids pass into oocytes via junctions between the oocyte and
cumulus cells or if they are taken directly from follicular fluid. A variety of
pathways are likely involved in oocyte lipid metabolism and deposition during
follicle development (Algriany et al., 2007).
Follicle formation in ruminants begins during fetal development and
primordial follicle activation occurs over a long period of time, allowing groups of
follicles to be activated and leave the resting pool while other follicles remain
inactive (Hirshfield, 1991; Fortune et al., 2000; Fortune, 2003). Early growth of
primordial follicles begins slow, the time needed to double the number of
granulosa cells in early developmental stages takes ~7 d in the rat (Hirshfield,
1989) and 189 h in the rabbit (Mariana and De Pol, 1986). The rate of oocyte
growth and granulosa cell proliferation increases with increasing follicle size
(Hirshfield, 1991). It likely takes longer for a follicle to grow from 4 cells to 32
cells than it takes to grow from 32 cells to 2500 cells in the rat (Hirshfield, 1991).
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The time necessary for a follicle and developing oocyte to advance from
primordial stage to the antral follicle stage is likely highly variable because of the
many factors that influence this process (Hirshfield, 1991). Although it is difficult
estimate, the course of follicular growth takes a long time relative to the
reproductive cycle of the animal; several weeks in rodents, and perhaps several
months in larger animals (Hirshfield, 1991; Fortune, 2003).
Lipid content of porcine embryos gradually declines during development in
vivo, which may explain why expanded and hatched blastocyst stage embryos
have a higher tolerance to cooling compared with morulae and early blastocysts
(Nagashima et al., 1988). Bovine embryos follow a similar pattern, as lipid
droplets diminish as the bovine embryo develops from early cleavage stages to
the blastocyst stage (Mohr and Trounson, 1981; Pryor et al., 2008a). This
demonstrates that lipids are utilized by the developing embryo, likely as a source
of energy. The presence of relatively high concentrations of intracellular lipids in
immature oocytes of most mammals likely contributes to limited success with
oocyte cryopreservation.
In the mouse, in vivo-matured ovulated oocytes had significantly greater
lipid concentrations and distinct droplet distribution patterns compared with
immature oocytes (Yang, 2010). Higher lipid content in mature oocytes of the
mouse could be due to uptake from follicular fluid or from the oviduct, de novo
lipid synthesis or relocalisation of diffuse lipid stores into larger droplets (Yang,
2010). Dynamic reorganization of lipid droplets occurs along with oocyte
maturation, likely in response to the LH surge (Yang, 2010).
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Additionally, membranes of human zygotes and oocytes at different
developmental stages have different membrane lipid phase transitions,
suggesting a variation in their composition (Ghetler et al., 2005). Finally, oocytes
from abbatoir-derived heifer ovaries (breed not specified) produced blastocysts
with greater lipid content than those from mature cow-derived ovaries (BarcelóFimbres and Seidel, 2008).
Species
Porcine oocytes and embryos are darker than those of ovine and bovine,
indicating greater lipid content (Sturmey and Leese, 2003). Uneven intracellular
ice crystal formation was noted when porcine embryos were cooled (Nagashima
et al., 1988). Porcine oocytes contain greater lipid stores than bovine oocytes,
which may help explain the limited success with cryopreservation of porcine
oocytes and embryos (McEvoy et al., 2000). A great deal of research has been
devoted to reducing intracellular lipids of porcine oocytes and embryos in an
effort to improve success of cryopreservation. Triglyceride concentrations of
porcine oocytes are greater than bovine and ovine (McEvoy et al., 2000),
however, relative fatty acid compositions seem rather similar between these
species.
Cattle Breed
Cryopreservation of embryos from Jersey donors resulted in reduced
pregnancy rates compared with those from Holstein donors (Steel and Hasler,
2004), and this observation is correlated with greater fat content in milk from
Jersey cows. Cytoplasmic lipid content is greater in Bos indicus oocytes
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compared with Bos taurus oocytes (Ballard, 2006), likely contributing to reduced
cryotolerance of in vivo-produced and in vitro-produced embryos of Bos indicus
cattle. More Holstein Friesian embryos were classified as dark (measure as light,
medium, or dark with stereomicroscope at 40x) compared with Belgian Blue
embryos (Leroy, 2004). Holstein embryos contained greater intracellular lipids
than Nelore embryos (Vistin, 2002); however, experimental numbers were
relatively small (n = 20 per breed) and description of donor animal management
and number of donors used was minimal. The previous study evaluated
semi-thin sections of embryos stained with toluidine blue using light microscopy
and ultrathin sections of embryos stained with uranyl acetate evaluated with
transmission electron microscopy (Visintin, 2002). Embryos from Bos indicus
and Jersey donors produce pregnancy rates similar to other breeds when
collected and transferred fresh; however, successful embryo cryopreservation
with these breeds is variable. In addition to greater embryo lipid content, Bos
indicus and Jersey cattle generally have high milk fat content compared with
other breeds of dairy and beef cattle.
Season
Seasonal effects on reproductive performance of cattle have been
attributed to variation in temperature, humidity, photoperiod and nutrition
(Thatcher, 1974). Many mechanisms contributing to sub-optimal reproductive
efficiency during heat stress have been elucidated. Elevated ambient
temperatures causing heat stress in cattle decreased the duration and intensity
of estrus (Gwazdauskas et al., 1981), impaired follicular development and altered
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dominance of first wave and pre-ovulatory dominant follicles (Wolfenson et al.,
1995), increased the number of abnormal bovine embryos (Putney et al., 1989)
and decrease the quality and developmental competence of bovine oocytes
(Rocha et al., 1998). The physical properties of lipids in biological membranes
and changes in lipid composition of membranes may help explain decreased
fertility during heat stress (Quinn, 1985). Ambient temperature regulates
transition from the lipid crystalline to the gel phase, known as lipid phase
transition (Crowe et al., 1989), and injury to bovine oocytes occurs near the lipid
phase transition (Arav et al., 1999).
Oocytes collected from Holstein cows during summer months had greater
nonhomogeneous dark regions, possibly due to changes in lipid composition and
content with season (Zeron et al., 2001). Increasing concentrations of
unsaturated fatty acids in biological membranes is associated with increased
membrane fluidity (Crowe et al., 1989) and the phosopholipids of bovine oocyte
membranes contained over twice the concentration of polyunsaturated fatty acids
in winter compared with summer (Zeron et al., 2001). In addition, the Tm value
(midpoint lipid phase transition) for bovine oocytes decreased from 19.5°C in
summer to 13.5°C in winter (Zeron et al., 2001), which is likely explained by
changes in relative and/or absolute concentrations of fatty acids in membranes
and their corresponding chain lengths and number and position of double bonds.
Together, these data indicate ambient temperature and/or season, directly or
indirectly influences the composition of cell membranes of oocytes, which likely
influences their cryotolerance.
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Donor Nutrition
Important interactions between nutrition and reproduction have been given
a great deal of attention in Scientific Literature. Recent research has focused on
nutritional mechanisms influencing oocyte developmental competence and
embryo quality. However, minimal data exists regarding nutrition potentially
influencing embryo composition and cryopreservation. A possible source of
variation in embryo cryopreservation may be dietary fat supplementation of donor
animals.
Fats are included in ruminant diets primarily to provide energy, as fat is
caloric dense (NRC, 1996). Positive effects on reproductive processes in fat
supplemented beef cattle have been attributed to altering unsaturated fatty acid
status rather than changes in energy status (Hess et al., 2008). Considerable
research has focused on improving fertility of cattle through dietary fatty acid
supplementation. Strategies for improving fertility in dairy cows, such as dietary
fatty acid supplementation, was previously reviewed by Thatcher (2006).
Reproductive responses after feeding supplements high in
polyunsaturated fatty acids (PUFA) has been investigated in both dairy and beef
cows. The composition of bovine follicular fluid is sensitive to changes in dietary
supply of PUFA (Batista et al., 2010). However, feeding PUFA failed to influence
oocyte quality in lactating Holstein cows, suggesting that benefits of PUFA are a
result of other biological mechanism (Bilby et al., 2006). Similarly, PUFA
supplementation of beef heifers increased concentrations of PUFA of both
plasma and uterine fluid, yet did not influence superovulation response, embryo
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recovery rate, embryo quality or gene expression related to early embryo
development (Childs et al., 2008). These results concurred with those of Bilby et
al. (2006), who concluded that the potential positive effects of dietary PUFA on
reproductive performance in dairy cattle were not a result of altering the early
developing embryo.
Fouladi-Nashta et al. (2007) reported inclusion of calcium salts of palm oil
(rich in PUFA) in the diet of lactating dairy cows did not influence oocyte quality
or cleavage rate; however, cows fed a diet with high calcium salts of palm oil
(800 g/d) had superior blastocyst production in vitro compared with cows fed a
diet low in calcium salts of palm oil (200 g/d). Also, lactating Holstein cows
supplemented with PUFA accelerated early embryonic development in vivo
(Thangavelu et al., 2007). A contrasting report by Wakefield et al. (2008) in the
mouse demonstrated that high dietary PUFA reduced normal embryo
development; authors suggested that this could be associated with altered
mitochondrial function. Feeding dairy cows a source of n-3 fatty acids (whole flax
seed) compared with calcium salts of palm fatty acids decreased embryo quality
yet did not influence pregnancy success after embryo transfer (Petit et al. 2008).
Thatcher et al. (2006) indicated that inclusion of PUFA in ruminant diets during
late gestation and early postpartum may accelerate uterine recovery and
restoration of the reproductive system to support embryo development.
Furthermore, PUFA supplementation (fish oil enriched calcium salts) altered fatty
acid composition of the endometrium in a manner that would reduce secretion of
PGF2α (Bilby et al., 2006b).
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Inconsistency in response in ruminants are likely a result of supply of
specific unsaturated FA for absorption in the small intestine (Santos et al.,
2008b), which is influenced by the efficacy of methods used to protect the
supplement from biohydrogenation in the rumen. Additionally, the effects of fat
supplementation on bovine oocyte quality depend on body condition of cows
(Adamiak et al., 2005; Adamiak et al., 2006). Dietary fat induced alterations in
fatty acid composition of bovine cumulus-oocyte complexes (COC) were
influenced by carbohydrate source (high starch compared with high fiber) fed to
cows (Adamiak et al., 2006). Further discrepancies between experiments could
be due to the presence or lack of a negative control treatment (no fat diet), the
use of transvaginal ultrasound-guided oocyte aspiration (TUGA) and in vitrofertilization compared with collection of in vivo matured d-7 embryos, differences
in energy required by donor animals (i.e., lactation in dairy cattle compared with
beef cattle or ewes) or the timing of dietary treatments relative to oocyte/embryo
recovery.
Although the effects of dietary fat supplementation on oocyte
developmental competence and embryo quality appear negligible, the
concentration and type of fat included in ruminant diets may influence the
composition of oocytes and embryos, and therefore, their cryotolerance. Zeron
et al. (2002a) reported that ewes supplemented with calcium salts of fish oil (high
PUFA) increased the number of high quality oocytes compared with controlsupplemented ewes (74% and 57%, respectively). Fish oil supplementation of
ewes increased the proportion of long-chain unsaturated fatty acids in plasma
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and cumulus cells and increased chilling resistance of ewe oocytes (Zeron et al.,
2002a). However, changes in fatty acid composition of oocytes in the previously
mentioned research were relatively small (not statistically different from controls),
indicating that uptake of PUFA by bovine oocytes is likely selective or highly
regulated in the cow (Bilby et al., 2006) and/or that tools used to evaluate lipid
composition were not robust enough for microscopic samples, such as oocytes
and embryos.
Cryotolerance of in vivo-produced embryos decreased when Nellore heifer
diets were supplemented with calcium salts of palm oil, a rumen-protected fat
high in PUFA (Guardieiro, 2010; Guardieiro et al., 2014). Pregnancy rate after
transfer of cryopreserved bovine embryos was not influence by fat source fed to
Holstein cows (whole flax seed high in n-3 fatty acids compared with calcium
salts of palm fatty acids), suggesting that these supplements likely did not
significantly alter embryo lipid composition and therefore, cryotolerance of
embryos was similar (Petit et al., 2008). However, the number of embryos
transferred was relatively small (n = 60/treatment) and neither embryo
cryotolerance nor embryo lipid composition were measured in the study by Petit
et al. (2008).
Collectively, these studies indicate that both membrane and intracellular
lipid composition of oocytes and embryos can be altered by diet of the donor
animal. However, this area remains understudied, likely due to the complexity of
these experiments. Furthermore, composition of developmentally competent
embryos, produced either in vivo or in vitro, may differ from the composition of
19

embryos that are most cryotolerant. Therefore, nutritional and management
recommendations for donor animals may differ when embryos collected are
cryopreserved rather than transferred fresh.
Culture Environment
Culture of embryos in vitro results in fundamental differences compared
with in vivo-produced embryos (Lonergan et al., 2003). In vitro-produced porcine
embryos differed morphologically and contained greater cytoplasmic lipid
droplets compared with those produced in vivo (Kikuchi, 2002). Ovine embryos
cultured in medium containing blood serum resulted in lambs with heavier birth
weights compared with embryos produced in medium containing serum albumin
(Thompson et al., 1995). It has been reported several times that bovine embryos
cultured in serum-containing media have altered ultrastructural morphology (Abe
et al., 1999; Crosier et al., 2000, 2001a), more intracellular lipid droplets (Abd El
Razek, 2000; Abe et al., 2002) and decreased cryotolerance (Abe et al., 2002;
Rizos, 2003) compared with embryos cultured in serum-free media. Lipid
composition of embryos is also influenced by the presence of serum in the
medium (Sata et al., 1999; Abd El Razek, 2000).
Three mechanisms have been suggested to interfere with lipid metabolism
of in vitro-produced bovine embryos: serum may increase lipid synthesis in the
embryo (Abd El Razek, 2000), lipoproteins present in serum could be internalized
by the cells (Ferguson and Leese, 1999; Sata et al., 1999) or lipid accumulation
results because nonphysiological culture conditions containing serum decrease
the concentration of mitochondria and alter their ability to metabolism lipids by
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β-oxidation (Dorland et al., 1994; Crosier et al., 2001b; Abe et al., 2002). Crosier
et al. (2001b) concluded that embryonic development of in vitro-produced bovine
embryos may be negatively influenced as a result of both increasing lipids and
decreasing mitochondria concentrations. Although removing serum from culture
media decreases cytoplasmic lipid accumulation compared with controls, in vivomatured bovine embryos still contain less cytoplasmic lipids than in vitroproduced bovine embryos cultured in serum-free medium (Rizos, 2003; De La
Torre-Sanchez et al., 2006a).
Modification of Oocytes and Embryos to Improve Cryotolerance
To improve cryopreservation of certain cell types you must either modify
cryopreservation procedures or modify the cells themselves to make them better
suited to survive cryopreservation (Seidel, 2006). The first method is the
historical basis for cryopreservation methods used today, however, further
modification of current methods often result in limited improvement. Therefore,
recent research has focused on methods that modify cells in an effort to improve
their compatibility with cryopreservation procedures. These methods include
physical modification by centrifugation with or without physical delipidation,
altering the composition of culture medium and modifying donor nutrition.
Physical Modification
Nagashima et al. (1994) was the first to use centrifugation and
micromanipulation to delipidate porcine embryos, providing clear evidence that
the low tolerance of porcine embryos to chilling is associated with their high lipid
content and that chilling sensitivity can be reduced by decreasing lipid content in
21

the embryo. Similarly, physical delipidation improved survival rate after freezing
of porcine oocytes (Hara et al., 2005) and embryos (Ushijima et al., 2004) and in
vitro-produced bovine embryos (Ushijima et al., 1999; Diez et al., 2001).
Additionally, removal of cytoplasmic lipids from oocytes of domestic cat did not
impair development after cryopreservation (Karja et al., 2006). Preliminary
results indicate centrifugation and treatment of in vitro-produced bovine embryos
with cytochalasin B (microfilament inhibitor) before cryopreservation, combined
with laser-assisted hatching post-thaw improves cryotolerance (Pryor et al.,
2008b). However, centrifugation of immature bovine oocytes produced in vitro
with or without lipid removal (Murakami et al., 1998) and centrifugation of mature
bovine oocytes produced in vitro (Otoi et al., 1997) did not influence cryosurvival.
Nagashima et al. (1994) concluded the development of a noninvasive method to
remove lipids may improve cryopreservation of porcine embryos and warrants
further attention.
Cell membranes with greater concentrations of cholesterol are more fluid
at lower temperatures, and therefore improve tolerance to chilling (Horvath and
Seidel, 2006). The addition of cholesterol to sperm improved cryotolerance of
bovine (Purdy and Graham, 2004), equine (Moore et al., 2005) and porcine
(Moraes et al., 2010) sperm. Cholesterol-enhanced bovine oocytes had
moderate improvement in development to the 8-cell stage compared with
controls (55% vs. 41%; P < 0.05) after they were thawed and fertilized in vitro
(Horvath and Seidel, 2006). These studies all used methyl-β-cyclodextrin, a
hydrophilic molecule with a hydrophobic center, to transfer cholesterol to cell
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membranes. Zeron et al. (2002b) modified bovine oocytes by incorporating
liposomes containing egg-phosphatidylcholine into cell membranes. This
treatment altered membrane phase transition and reduced chilling injuring, likely
due to alterations in cell membrane composition.
Modification of Culture Systems
Modification of in vitro embryo culture systems has received a great deal
of research attention in an effort to improve the efficiency and success of these
systems. Although serum was historically an important component of bovine in
vitro culture systems, it has been associated with abnormal pregnancies and
offspring and increased embryo lipid accumulation (Young et al., 1998; Hasler,
2000; Farin et al., 2001; Thompson et al., 2007) and has largely been
discontinued in bovine culture medium (Hasler, 2010). Removing serum from
culture decreases cytoplasmic lipid accumulation, yet bovine embryos produced
in serum-free medium contain greater cytoplasmic lipids compared with in vivoproduced embryos (Rizos, 2003; De La Torre-Sanchez et al., 2006a). Therefore,
studies have been conducted to bridge this gap, which will likely improve
cryopreservation of in vitro-produced embryos.
Dorbrinsky et al. (2000) treated porcine embryos with cytochalasin B
before vitrification in an effort to limit cytoskeletal damage. Cytochalasin B
treatment improved blastocyst developmental competence after cryopreservation
and normal piglets were produced after embryo transfer (Dobrinsky et al., 2000).
However, cytochalasin B treatment before vitrification did not improve post-thaw
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viability of bovine oocytes (Mezzalira et al., 2002) or caprine parthenogenic
blastocysts (Nims et al., 2004).
Experiments to improve the composition of bovine embryos by altering cell
metabolism in vitro indicated that inclusion of phenazine euthosulfate (PES) into
embryo culture medium decreased embryo lipid content (Barceló-Fimbres and
Seidel, 2005; De La Torre-Sanchez et al., 2006a). Phenazine ethosulfate is an
electron acceptor that oxidizes NADPH to NADP, which is necessary for
conversion of glucose-6-phosphate into 6-phospholguconate. Thus, PES
increases flux of glucose through glycolysis and the pentose phosphate pathway
(De La Torre-Sanchez et al., 2006a; De La Torre-Sanchez et al., 2006b),
decreases lipid accumulation in bovine embryos produced in vitro (De La TorreSanchez et al., 2006a; De La Torre-Sanchez et al., 2006b; Barceló-Fimbres and
Seidel, 2007a; Sudano et al., 2010), and improved cryotolerance of bovine
embryos (Barceló-Fimbres and Seidel, 2007a).
Inclusion of PES into embryo culture medium did not prevent apoptosis
after embryo cryopreservation (measured using the TUNEL Assay). The TUNEL
assay is a method used to detect DNA fragmentation resulting from apoptotic
signals by labeling the terminal end of nucleic acids (Gavrieli et al., 1992;
Negoescu et al., 1996). Furthermore, PES supplementation reduced in vitro
blastocyst development and reduced post-thaw hatching rates (Ruiz et al., 2013).
Barceló-Fimbres et al. (2009) recently reported that embryos cultured in the
presence of PES did not influence pregnancy rates between d 35 and d 98 of
pregnancy, and had no detectable effect on postnatal fetal development.
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Treatment of porcine embryos with the lipolytic agent forskolin during invitro maturation increased intracellular lipolytic activity and improved cryosurvival,
likely due to reduction in intracellular lipid content (Men et al., 2006). Briefly,
forskolin activates adenylate cyclase (Seamon et al., 1981), resulting in activation
of lipase through the cAMP/protein kinase pathway (Strayfors and Belfrage,
1983; Honnor et al., 1985), which ultimately stimulates lipolysis through
phosphorylation. Current literature is inconsistent regarding effects forskolin as a
lipolytic agent in bovine embryos. The addition of 10 µM and 40 µM forskolin
failed to decrease intracellular lipids of in vitro-produced bovine embryos in one
trial (Pryor et al., 2008a), yet successfully decreased lipid content in another trial
(Barceló-Fimbres and Seidel, 2008). Both of these authors measured
intracellular lipids using a similar Nile Red staining procedure. Addition of 10 µM
forskolin increased survival and blastocyst hatching rates after slow-cool
cryopreservation of in vitro-produced Bos indicus embryos (Pryor et al., 2010;
Sanches et al., 2010). However, inclusion of 10 µM forskolin in culture had no
effect on bovine embryo development or cryosurvival (Ruiz et al., 2013).
Inclusion of trans-10, cis-12 congugated linoleic acid (CLA) in bovine
embryo culture medium improved post-thaw embryo survival compared with
controls, without influencing bovine blastocyst production (Pereira et al., 2007;
Pereira et al., 2008; Ruiz et al., 2013). This improvement in cryosurvival may be
due to reduced accumulation of lipids in trans-10, cis-12 CLA cultured embryos,
evaluated by Nomarski differential interference contrast microscopy.
Additionally, results may be explained by increased membrane fluidity due to
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incorporation of trans-10, cis-12 CLA into membranes of bovine embryos
(Pereira et al., 2007). In contrast, post-thaw in vitro survival of bovine embryos
was not improved after co-culture with 100 µM trans-10, cis-12 CLA (Al Darwich
et al., 2010). The primary difference between the previous two studies is the
cryopreservation method used. Embryo survival may not have been improved in
the study by Al Darwich et al. (2010) because embryos were cryopreserved using
vitrification, while Pereira et al. (2007) cryopreserved embryos using a slowcooled method. However, Pereira et al. (2008) reported bovine embryos cultured
with trans-10, cis-12 CLA had improved survival after biopsy and vitrification.
Multiple mechanisms are likely involved in trans-10, cis-12 CLA improving
cryotolerance of embryos, requiring further research. With particular interest is
the influence of trans-10, cis-12 CLA on oocyte lipid metabolism and embryo lipid
composition.
In vitro embryos cultured with L-carnitine, a rate-limiting enzyme of
β-oxidation, improved embryo development and increased metabolic activity via
increased β-oxidation resulting in reduced embryo lipid concentration measured
by fluorescence (Sutton-McDowall et al., 2011). Embryos cultured with
L-carnitine did not improve embryo development but increased post-thaw
reexpansion and hatching rates compared with control cultured embryos (Ruiz et
al., 2013). Linoleic acid (18:2 n-6) supplementation during bovine in vitro oocyte
maturation reduced maturation rate and subsequent embryo development to the
blastocyst stage in a dose dependent manner (Marei et al., 2010). However, the
supplement used in by Marei et al. (2010) did not include trans-10 cis-12 and
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linoleic acid inclusion rates were much greater than most trials involving fatty acid
supplementation of bovine culture medium.
Although significant research has focused on improving the cyrotolerance
of in vitro-produced bovine embryos, a gap remains between the cryosurvival of
in vivo and in vitro bovine embryos. Researchers will continue to modify in vitro
culture systems toward conditions similar to those found in vivo. Commercial
production of bovine embryos in vitro has the potential to significantly impact both
genetic advancement and economic development, especially if further
improvement in cryopreservation of these embryos is achieved.
Modification of Donor Nutrition
Supplementation of stallion diets with a nutriceutical containing
docosahexaenoic acid (DHA) improved motion characteristics of cool-stored
stallion semen and improve cryotolerance (Brinsko et al., 2005). Addition of
dietary fish oil to boar diets increased the content of DHA in spermatozoa but did
not improve cryotolerance (Maldjian et al., 2005). Supplementation of ewe diets
with PUFA altered phospholipid fatty acid composition of follicular components
and improved oocyte quality and resistance to chilling (Zeron et al., 2002a;
Wonnacott et al., 2010). Oocytes from ewes fed PUFA had a lower temperature
of lipid phase transition, leading to superior membrane integrity after chilling
compared with control oocytes (Zeron et al., 2002a). Additionally, in vitroproduced embryos from Nellore heifers were more sensitive to cryopreservation
when diets included rumen-protected PUFA (Guardieiro, 2010; Guardieiro et al.,
2014).
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Although long chain unsaturated fatty acids comprise a relatively small
portion of the phospholipid portion of oocytes, slight increases in concentrations
of these fatty acids could drastically improve membrane fluidity. These studies
demonstrate potential means for modification of bovine oocyte or embryo
composition and membrane fluidity in vivo, which could have implications for
embryo cryotolerance.
Conjugated Linoleic Acid Supplementation
Another interesting area of study has identified specific conjugated linoleic
acids (CLA) that inhibit milk fat synthesis in lactating dairy cows (Loor and
Herbein, 1998; Chouinard et al., 1999a; Chouinard et al., 1999b). The trans-10,
cis-12 CLA isomer was identified as a potent inhibitor of milk fat synthesis in
lactating cows (Baumgard et al., 2000; Baumgard et al., 2001; Peterson et al.,
2002). The trans-10, cis-12 and cis-9, trans-11 CLA isomers result from natural
biohydrogenation of dietary unsaturated fatty acids by rumen bacteria (Bauman
et al., 1999; von Soosten et al., 2013). De Veth et al. (2004) analyzed
relationships between abomasal infusion of trans-10, cis-12 CLA and milk fat
across seven published studies. Significant milk fat depression (20 to 40%)
occurs at a very minimal doses of abomasal infusion (2 to 6 g/d), while doses of
trans-10 cis-12 greater than 10 g/d result in little or no further reduction in milk fat
synthesis (de Veth et al., 2004). Transfer efficiency of abomasally infused trans10, cis-12 into milk was relatively consistent with mean transfer efficiency of 22%
across seven abomasal infusion studies in Holstein cows compared by de Veth
et al. (2004).
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Mechanisms Involved in CLA-Induced Milk Fat Depression in Dairy Cows
The trans-10, cis-12 CLA isomer is reported to exert specific effects on
adipocytes that reduce the uptake of fatty acids without increasing lipolysis
(Pariza et al., 2001). Trans-10, cis-12 CLA has inhibited both gene expression
and Δ9-desaturase activity in the mammary gland (Lee et al., 1998; Bretillon et
al., 1999; Park et al., 2000; Baumgard et al., 2002). De Veth et al. (2004)
indicated that alterations in the desaturase ratio are not essential to significantly
reduce milk fat secretions, and the mechanism by which trans-10, cis-12 inhibits
milk fat synthesis involves the coordinated regulation of lipogenic enzymes.
Mammary tissue from cows abomassally infused with trans-10, cis-12 CLA had
decreased mRNA abundance for lipogenic genes involved in lipid uptake and
transport, de novo synthesis, desaturation and triglyceride synthesis (Baumgard
et al., 2002). Peterson et al. (2004) indicated that the signal by which trans-10,
cis-12 CLA regulates milk fat depression involves the sterol response elementbinding protein regulatory pathway (SREBP-1) and a reduction in transcriptional
activation of lipogenic genes.
Partially Rumen-Protected CLA Supplementation
A partially rumen-protected CLA supplement was developed (Lutrell®,
BASF) containing CLA isomers known to suppress milk fat. This product
suppressed milk fat when fed to lactating sheep (Lock et al., 2006; Lock et al.,
2008) and cows (Perfield et al., 2004; Castañeda-Gutiérrez et al., 2007a;
Pappritz et al., 2011). Milk fat yield was significantly decreased by 14.1% in
cows fed a rumen-protected CLA containing 7.1 g/d of each cis-9, trans-11 and
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trans-10, cis-12 CLA (Castañeda-Gutiérrez et al., 2007a). Pappritz et al. (2011)
reported milk fat depression was 14.8% in cows fed a lipid encapsulated CLA
(Lutrell® Pure) containing 8 g per hd/d trans-10, cis-12 CLA.
The efficacy of a rumen-protected trans-10, cis-12 CLA supplement is
measured by the degree of milk fat depression (Perfield et al., 2004). The
transfer efficiency of CLA from a supplement into milk fat is influenced by efficacy
of the protection from rumen metabolism as well as postruminal availability (Wu
et al., 2010). Transfer efficiencies of CLA from rumen-protected supplements are
generally much lower than the ~20% transfer efficiencies found in abomasal
infusion studies (Chouinard et al., 1999a; Chouinard et al., 1999b; Baumgard et
al., 2000; Baumgard et al., 2001; Peterson et al., 2002).
Comparing the transfer of trans-10, cis-12 CLA from rumen-protected
supplements with that from abomasal infusion (average 22%) provides an
estimate of rumen biohydrogenation and a measure of the efficacy of rumen
protection (de Veth et al., 2005). The efficiency of transfer to milk across 14
treatments supplementing Ca salts of CLA averaged 3.9% with a median value of
3.3% (de Veth et al., 2005). When compared with 100% protection with
abomasal infusion, these values represent 83% to 85% of CLA metabolized in
the rumen and 15% to 17% protected from rumen biohydrogenation (de Veth et
al., 2005). The transfer efficiency of trans-10, cis-12 CLA into milk fat across
eight published studies supplementing cows with Ca salts of CLA ranged from
1.9% to 7.4%, equating to 9% to 34% protection from rumen biohydrogenation
(de Veth et al., 2005). Transfer efficiency of trans-10, cis-12 CLA into milk fat or
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cows was similar for formaldehyde-protected (de Veth et al., 2005), amideprotected and lipid-encapsulated CLA (Perfield et al., 2004); when compared with
transfer efficiencies of abomasal infusion studies, these methods provided 32%
to 36% protection of trans-10, cis-12 from rumen biohydrogenation.
Pappritz et al. (2011) used duodenal fistulated cows to evaluated rumen
metabolism and postruminal bioavailability of a lipid-encapsulated CLA
supplement manufactured by BASF (Lutrell®, BASF Ludwigshafen, Germany).
Only 0.4 g of the daily consumed 8 g of trans-10, cis-12 CLA reached the
duodenum, while transfer efficiency of the isomer into milk was 3%; this suggests
a low (5%) ruminal protection rate (Pappritz et al., 2011). Of the 0.4 g of CLA
reaching the duodenum, 48% was transferred to milk (Pappritz et al., 2011).
Assuming similar biohydrogenation conditions to the Pappritz et al. (2011) study,
von Soosten et al. (2013) reported that 0.24 g to 1.04 g of trans-10, cis-12 were
available for absorption in the small intestine after cows were fed a lipid
encapsulated supplement containing 6 g of trans-10, cis-12 CLA. The majority of
the CLA in rumen-protected supplements are either metabolized in the rumen or
unavailable for post-rumenal absorption. However, as evidenced by significant
milk fat depression in cows fed rumen-protected CLA supplements, CLA isomers
can alter lipid metabolism in biological tissues after very minimal postruminal
absorption and transfer into these tissues.
Increases in milk yield of 3% to 10% has been reported when cows were
fed supplements containing trans-10, cis-12 CLA (Bernal-Santos et al., 2003;
Mackle et al., 2003; de Veth et al., 2006; Castañeda-Gutiérrez et al., 2007a).
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Similarly, milk yield was 13% greater in lactating ewes fed CLA compared with
control-supplemented ewes (Sinclair et al., 2010). In studies where milk energy
output and cow energy balance are similar between supplemental treatment
groups, energy spared by milk fat depression is likely repartitioned for milk
production (Bernal-Santos et al., 2003; de Veth et al., 2006; Castañeda-Gutiérrez
et al., 2007a; Sinclair et al., 2010). However, milk production was not influenced
by CLA supplementation in a study by Castañeda-Gutiérrez et al. (2007a).
Factors such as the inclusion rate of CLA isomers, method used to protect the
supplement from rumen biohydrogenation, length of dietary treatment and
season may influence the effect of CLA supplementation on milk production.
Deposition of CLA into Animal Tissues and Products
Any CLA isomers that are not metabolized in the rumen are available for
absorption in the duodenum and transferred into products of the cow (von
Soosten et al., 2013). Tissue-specific in-vivo synthesis of cis-9, trans-11 CLA by
Δ9-desaturase has also been reported (Bauman et al., 1999). Trans-10, cis-12
CLA increased in milk fat of cows fed a rumen-protected CLA containing 7.1g/d
of each cis-9, trans-11 and trans-10, cis-12 CLA, while no other changes in the
fatty acid profile of milk were detected (Castañeda-Gutiérrez et al., 2007a). In
many of the CLA abomasal infusion studies, trans-10, cis-12 CLA
supplementation significantly decreases the relative percentage of short chain
saturated fatty acids (<C16) in milk and increases long chain fatty acids (>C16),
many of which are unsaturated. If dietary CLA could alter fatty acid composition
of developing oocytes in a manner similar to CLA-induced alterations in milk,
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changes in membrane composition could improve membrane fluidity of oocytes
and embryos.
The trans-9, cis-12 isomer was detected in bovine fat deposits
(retroperitoneal, omental, mesenteric and subcutaneous) but composition of fat
was not influenced by CLA supplementation (von Soosten et al., 2013). The
trans-10, cis-11 isomer was transferred into fat deposits after supplementation
with the isomer, but only in minimal amounts (von Soosten et al., 2013). Transfer
efficiency of trans-10, cis-11 into fat deposits was negligible in lactating dairy
cows fed a rumen-protected CLA at a rate of 6 g of trans-10, cis-11 per hd/d (von
Soosten et al., 2013). Trans-10, cis-12 and cis-9, trans-11 CLA isomers were
increased in perirenal fat of lactating ewes after CLA supplementation (Sinclair et
al., 2010). Wynn et al. (2006) also observed increased trans-10, cis-12 and cis9, trans-11 CLA in perirenal, omental and mesenteric fat deposits of ewe lambs.
Supplementation with CLA increased trans-10, cis-12 and cis-9, trans 11 in
Longisimus dorsi of lactating ewes (Sinclair et al., 2010) but transfer of CLA into
meat of dairy cows did not occur in a study by von Soosten et al. (2013).
Endometrial tissue of cows supplemented with CLA had increased
proportions of C16:1 and tended to have increase C18:1 trans 6 to 9, but cis-9,
trans-11 CLA was not increased in endometrial tissue of CLA-supplemented
cows and trans-10, cis-12 was undetected in endometrial tissue of both treatment
and control-supplemented cows (Castañeda-Gutiérrez et al., 2007a). Harris et
al. (2001) reported incorporation of cis-9 trans-11 and trans-10, cis-12 CLA into
uterine tissue of pregnant rats fed CLA at 1.1% of the diet. Significantly greater
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doses of CLA were fed in the mouse study by Harris et al. (2001) compared with
most CLA studies reported in ruminants. Additionally, a significant portion of the
lipid-encapsulated supplement was likely biohydrogenated in the rumen in the
study by Castañeda-Gutiérrez et al. (2007a), making less CLA available for
absorption and deposition into tissues.
Fatty acid composition of follicular fluid appears to be sensitive to dietary
lipid supplementation. Follicular fluid linolenic acid (C18:3) and C20:2 were
greater and cis-9, trans-11 CLA and C22:2 tended (P ≤ 0.09) to increase in cows
fed a rumen-protected CLA containing 7.1g/d of each cis-9, trans-11 and trans10, cis-12 CLA compared with control-supplemented cows (Castañeda-Gutiérrez
et al., 2007a). However, proportions of saturated, monounsaturated or
polyunsaturated fatty acids in follicular fluid were not influenced by CLA
supplementation (Castañeda-Gutiérrez et al., 2007a).
Zeron et al. (2002a) reported an increase in C18:2n-6 and C22:6n-3 in the
phospholipid portion of follicular fluid of PUFA (fish oil) supplemented ewes.
Fatty acid composition of follicular fluid is sensitive to changes in dietary supply
of PUFA using soybean oil (Batista et al., 2010). Heifers fed fish oil had grater
proportions of EPA and DHA in follicular fluid (Childs et al., 2008). Feeding dairy
cows an encapsulated fat rich in C18:3n-3 (flaxseed oil) change the fatty acid
composition of milk, plasma, follicular fluid, cumulus-oocyte complexes (COC)
and granulosa cells and (Zachut et al., 2010). The composition of fatty acids in
follicular fluid and plasma are similar (Zachut et al., 2010) and composition was
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comparable to values reported by Castañeda-Gutiérrez et al. (2007a) and Zachut
et al. (2008).
The fatty acid composition of granulosa cells and COC are quite different
than that found in plasma and follicular fluid of cows (Zachut et al., 2010). Trans10, cis-12 CLA was increased in both oocytes and cumulus cells after maturation
with 100 uM of the CLA (Lapa et al., 2011). Uptake of fatty acids by the follicle
and oocyte is likely highly selective in the cow as a protective mechanism to
ensure fatty acid composition of oocytes remains safe or optimum (Bilby et al.,
2006; Santos et al., 2008a; Fouladi-Nashta et al., 2009; Sturmey et al., 2009).
The highly regulated process of fatty acid uptake leads to relatively small, if any
change in fatty acid composition of oocytes to different dietary treatments. Lapa
et al. (2011) reported minimal changes in fatty acid concentration of bovine
oocytes after maturation with trans-10, cis-12 CLA, concluding that oocytes
accumulated very small amounts of trans-10, cis-12 in a selective manner but
maintained relatively consistent fatty acid concentration to ensure cellular
integrity.
Fouladi-Nashta et al. (2009) reported fatty acid composition of plasma and
milk reflected composition of fatty acids supplemented to cows, but fatty acids in
granulosa cells were not altered by dietary fatty acid supplementation. It was
concluded that the bovine ovary has mechanisms to buffer the oocyte against
major fluctuations in plasma n-3 and n-6 fatty acids, resulting in very small
alterations on oocyte developmental potential (Fouladi-Nashta et al., 2009).
Greater concentrations of free fatty acids in bovine folliucular fluid resulted in
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significant fatty acid accumulation in cumulus cells, but only marginal changes in
oocyte fatty acid composition (Aardema et al., 2012). Aardema et al. (2012)
concluded that cumulus cells protect bovine oocytes against elevated follicular
fluid fatty acid concentrations by accumulation of these fatty acids. These results
indicate that cumulus cells may indeed be the buffer mechanism in the cow that
protect the oocyte from changes in the follicular environment brought on by a
variety of conditions such as stress, diet, season or stage of production.
Differences in fatty acid composition between follicular fluid, granulosa
cells and COC suggest a selective uptake of specific fatty acids in different
ovarian compartments of ruminant livestock species (Zeron et al., 2002a;
Adamiak et al., 2006; Zachut et al., 2010). Although there appears to be a
selective uptake mechanism of fatty acids in bovine ovarian tissues, reported
data suggests that specific dietary supplementation can alter the fatty acid profile
of ovarian components in cattle (Zachut et al., 2010).
Castañeda-Gutiérrez et al. (2007a) indicated that the incorporation of CLA
isomers into milk fat and tissues of animals may be influenced by the plasma lipid
fraction in which they are transported. Specific isomers appear to have
preferential incorporation into specific lipid fractions, which differs among tissues
and species. In a study by (Kramer et al., 1998) involving CLA-supplemented
pigs, trans-10, cis-12 CLA was primarily incorporated into the triglyceride fraction
of liver and heart, while cis-9, trans-11 CLA was incorporated into phospholipids.
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Reproduction Responses to CLA Supplementation
Studies have examined CLA-induced milk fat depression as an approach
to lessen negative energy balance during early lactation in dairy cows. There
appears be a positive effect of CLA supplementation on reproduction in lactating
dairy cows, although the specific mechanism of action is not well established.
Supplementation with ≤ 10 g/d of each trans-10, cis-12 and cis-9, trans-11 CLA
appears to benefit reproduction in lactating dairy cows even with no change in
energy balance (Bernal-Santos et al., 2003; Castañeda-Gutiérrez et al., 2005).
Castañeda-Gutiérrez et al. (2007a) reported increased plasma concentrations of
IGF-I in lactating cows fed a rumen-protected CLA containing 7.1g/d each of cis9, trans-11 and trans-10, cis-12 CLA. Additionally, CLA-supplemented cows
tended (P = 0.08) to have greater concentration of progesterone during the early
luteal phase, d 6 to d 8 of the estrous cycle (Castañeda-Gutiérrez et al., 2007a).
Beneficial reproductive effects in dairy cows continued after supplementation
concluded in studies by Bernal-Santos et al. (2003) and Castañeda-Gutiérrez et
al. (2005). Castañeda-Gutiérrez et al. (2007a) concluded that CLA
supplementation may improve bovine embryo viability by supporting
development of the ovarian follicle.
De Veth et al. (2009) used semi-parametric and paremetric models to
conduct an integrated analysis of five controlled studies involving CLA
supplementation and reproduction in early lactating dairy cows. In this study,
models concluded that supplementation with trans-10, cis-12 CLA was positively
associated with the probability of pregnancy success and a decrease in the
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number of days to pregnancy detection as dietary dose increased (de Veth et al.,
2009). Pregnancy success increased as CLA dose increased up to an optimal
dose of 10.1 g of trans-10, cis-12 CLA. Models predicted the probability of
pregnancy increased by 26% and the median time to pregnancy detection was
decreased by 34 d when cows were fed the optimal daily dose of 10.1 g
(pregnancy) and 10.5 g (d to pregnancy detection) of trans-10, cis-12 CLA
compared with control-supplemented cows (de Veth et al., 2009).
Supplementation of cows with 100 g of lipid-encapsulated CLA per hd/d
increased the number of follicles present and oocytes collected per session, and
improved cleavage and d-8 embryo production in vitro (Höffmann et al., 2008).
Inclusion of 100 µM of trans-10, cis-12 CLA into bovine maturation media
increased the rate of high quality embryos on d 8 in vitro, but did not influence
oocyte maturation or embryo cleavage or blastocyst production (Lapa et al.,
2011). Maturation of bovine oocytes with 100 µM of trans-10, cis-12 CLA
suppressed arachidonic acid (C20:4n-6) concentrations in oocytes (Lapa et al.,
2011).
Supplementation with trans-10, cis-12 CLA appears to alter fatty acid
composition of a variety of tissues and animal products. Additionally, CLA alters
embryos in vitro in a manner that decreased lipid content and improved
cryosurvival. However, there are currently no reports evaluating the
cryotolerance of embryos from cows fed CLA supplements. Research may be
warranted to elucidate possible relationships between CLA supplementation and
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ovarian lipid metabolism as it relates to oocyte and embryo lipid composition and
cryotolerance of embryos.
Evaluation and Quantification of Lipids in Oocytes and Embryos
Several methods have been developed to evaluate the lipid content of
embryos and oocytes. The first detailed lipid analysis of immature mammalian
oocytes was conducted with porcine oocytes using gas-liquid chromatography
(Homa et al., 1986). Thin-layer gas chromatography has been used to quantify
the fatty acid composition of oocytes and embryos in domestic livestock species;
however, these techniques require pooling 100 to 1,000 oocytes or embryos
(Coull et al., 1998; Sata et al., 1999; McEvoy et al., 2000; Kim et al., 2001; Zeron
et al., 2001). These researchers quantified the fatty acid composition of the total
lipid portion of samples and/or the fatty acid composition within phospholipids.
Kim et al. (2001) used a kit-based assay to determine composition of lipids in
immature and in vitro-matured bovine oocytes and embryos; however, a pool of
100 oocytes or embryos was used to evaluate lipid content. Concentration of
triglyceride, the major lipid component of embryos, has been measured using 1
to 3 embryos with an enzymatic approach in combination with microfluorescence
techniques (Ferguson and Leese, 1999; Sturmey and Leese, 2003).
Ultrastructural morphometry of in vitro and in vivo embryos was compared
using light microscopy after staining ultra-thin or semi-thin histological sections of
bovine (Crosier et al., 2000, 2001a; Abe et al., 2002) and porcine (Kikuchi, 2002)
embryos. These studies facilitated evaluation of the morphological composition
of lipid droplets, cell organelles, and their relative spatial relationships. Sturmey
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et al. (2006) used a fluorescence resonance energy transfer (FRET) technique to
study the co-localization of mitochondria and lipid droplets in porcine embryos.
This method labels organelles with fluorescent probes (Mitotracker Green and
Nile Red) whose spectral profiles overlap. Results indicated that mitochondria
and lipid droplets lie within the FRET-distance (6 to 10 nm) of each other in
porcine oocytes. The number and size of lipid granules was evaluated in
embryos cultured in different medium by staining with Sudan Black-B (Abe et al.,
2002; De La Torre-Sanchez et al., 2006a).
Nile Red is a lipid specific fluorescent dye that can be used to evaluate the
lipid content in single mammalian oocytes; peak fluorescence observed
corresponds to neutral lipids, which are mainly triglycerides (Genicot et al.,
2005). In a hydrophobid lipid environment, lipids stained with Nile Red fluoresce
yellow to orange with (580-596, 590 nm peak fluorescence) (Genicot et al.,
2005). Fluorescence intensity after staining with Nile Red was used to evaluate
differences in cytoplasmic lipids of oocytes and embryos differing in donor breed
(Bos indicus vs. Bos taurus) (Ballard, 2006), species (Genicot et al., 2005), in
vitro culture conditions (Barceló-Fimbres and Seidel, 2008), or visual color (dark
vs. light) (Leroy et al., 2005). A strong linear relationship (r2 = 0.910) was found
between number of small lipid droplets (<2 µm) and fluorescence intensity after
staining with Nile Red. Fluorescent intensity is the preferred method as it is a
faster, more objective quantification of lipid content (Barceló-Fimbres and Seidel,
2007b). This technique allows rapid, highly repeatable evaluation of lipid content
for relative comparison of individual oocytes from different donors, culture
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conditions, or other treatments. However, this method does not permit qualitative
analysis for the composition of lipids, such as identification of fatty acids or
different lipid fractions, nor does it allow absolute quantitative analysis.
Glycerol production was quantified as a measure of intracellular lipolytic
activity in porcine oocytes (Men et al., 2006). Under physiological conditions,
lipase catalyzes the hydrolysis of triacylglycerols into glycerol and fatty acids.
This method is widely used to measure lipolytic activity in a broad range of cells
in lipid research. Measuring glycerol production is a relatively straightforward
technique that can measure lipolytic activity within embryos without the need to
quantify lipid concentrations.
Direct lipid analyses of individual, intact embryos and oocytes was
recently reported using a matrix-assisted laser desorption/ionization mass
spectrometry (MALDI-MS) method (Ferreira et al., 2010). MALDI-MS spectra
were acquired in the positive ion using a mass spectrometer equipped with a
200-Hz solid-state laser in the m/z range of 700-950. Human, bovine, sheep and
fish oocytes, as well as bovine and insect embryos were analyzed. This method
allows the detection of intact lipids of individual oocytes without solvent extraction
or pooling of samples. Results indicate MALDI-MS is an accurate and highly
reproducible method for lipid analysis in embryos and oocytes, with high sample
throughput (Ferreira et al., 2010). This method provides the ability to compare
gamete lipid profiles across a multitude of different treatments and conditions.
Most importantly, few samples are needed and oocytes can be evaluated on an
individual basis.
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A slightly different mass spectrometry technique known as desorption
electrospray ionization (DESI-MS) has been used to evaluate embryo lipids in
oocytes and embryos from cows (Ferreira et al., 2011, 2012b; González-Serrano
et al., 2013a; González-Serrano et al., 2013b) and mice (Ferreira et al., 2012a).
This is an ambient ionization used for MS analysis of lipids directly from
biological samples with no sample preparation. DESI-MS allows direct analysis
of individual intact embryos and provides detailed free fatty acid and complex
lipid profiling (Ferreira et al., 2011, 2012b). Ferreira et al. (2011) concluded that
DESI-MS is likely to become a routine analytical tool for lipid analysis of
mammalian embryos and will contribute to the development of culture systems
that produce embryos with improved cryotolerance.
Another approach has been to evaluate membrane properties and their
influence on fertility and cryopreservation. Membrane phase transition, the
transition of membrane lipids from the crystalline to the gel phase (Crowe et al.,
1989), was evaluated in the bovine oocytes and spermatozoa (Zeron et al., 2001;
Zeron et al., 2002b) and human oocytes (Ghetler et al., 2005) using a Fourier
transform infrared (FTIR) analyzer connected to a FTIR microscope. This
method measures the vibration frequency of methylene (CH2) groups, which are
the primary component of the hydrocarbon chain of lipid molecules (Ghetler et
al., 2005). Chilling injury to oocytes occurs near the lipid phase transition (Arav
et al., 1999), with maximum injury at a midpoint (Tm) lipid phase transition of
16°C (Zeron et al., 1999b). Changes in membrane phase transition are related
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to membrane composition, which ultimately influences membrane permeability
and likely alters cryotolerance of the embryo.
Expression of Metabolic Genes in Oocytes and Embryos
Energy demands within most mammalian cells are regulated through βoxidation of fatty acids in the mitochondria. A host of genes are involved in
transcriptional control of β-oxidation. Oocytes and early embryos must closely
regulate the expression of metabolic genes to prepare for changes in demand for
energy from lipids during oocyte maturation and early embryonic development.
However, relatively little is known about oocyte control of fatty acid metabolism
during important final stages of maturation (Algriany et al., 2007). Exogenous
fatty acids are likely the preferred source of long-chain fatty acids and energy
source during oocyte maturation (Algriany et al., 2007). Alterations in the
expression of different lipid metabolic genes are likely initiated by direct contact
with fatty acids, altering chromatin structure and transcription through histone
deacetylase activity (Pégorier et al., 2004). Diet induced milk fat depression in
dairy cows resulted in the coordinated down regulation of mRNA expression for
genes involved in mammary lipid synthesis (Piperova et al., 2000; Peterson et
al., 2003). Al Darwich et al. (2010) reported that PUFA were involved in the
control of adipogenesis and events that alter gene expression of multiple
enzymes involved in lipid metabolism of bovine embryos.
ACCβ and CPT1
The enzyme AMP-activated protein kinase (AMPK), which is activated by
low ATP/AMP, increases fatty acid oxidation in skeletal muscle (Bergeron et al.,
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1999; Ihlemann et al., 1999; Russell et al., 1999) and inhibits acetyl-CoA
carboxylase (ACCβ) (Carling et al., 1994; Winder et al., 2000). Mitochondrial
ACCβ regulates fatty acid oxidation through carnitin palmitoyl transferases
(CPT1), a group of enzymes involved in mitochondrial energy homeostasis. The
CPT1 enzyme catalyzes a rate-limiting step in the transfer of long-chain fatty
acyl-CoA from the cytosol to mitochondria for oxidation (Abu-Elheiga et al., 2000;
Kerner and Hoppel, 2000). There are multiply mechanisms by which CPT1
regulates β-oxidation in different mammalian cell. Mechanisms include changes
in activity and rate of transcription of CPT and/or its inhibitor malanyl-CoA, the
end product of ACCβ (Abu-Elheiga et al., 2000). Expression of CPT1 was upregulated in liver and adipose by dietary PUFA supplementation in rats (Ikeda et
al., 1998). During oocyte maturation, CPT1 mRNA increases indicating an
increase in β oxidation during this stage (Algriany et al., 2007).
PPARα
Peroxisome proliferator-activated receptor alpha (PPARα) is a member of
the PPAR family of ligand-dependent transcription factors (Rosen et al., 1999).
Expression of PPARα is greater in tissues that have high rates of fatty acid
oxidation, and is the primary subtype that facilitates lipid-induced activation of
fatty acid oxidation associated genes (Braissant et al., 1996). Dietary
unsaturated fatty acids have been reported to alter gene expression through
PPAR, leading to altered metabolism, growth and cell differentiation in different
tissues of rats (Ide, 2000; Jump, 2004). Polyunsaturated fatty acids were
described as a natural ligand or activator of PPAR, although PUFA mediated
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genes involved in lipid metabolism through both PPAR dependent and PPAR
independent pathways (Ren et al., 1997).
FADS2
The FADS2 gene is a member of the fatty acid desaturase (FADS) gene
family. Enzymes resulting from FADS2 regulate unsaturation of fatty acids
through the addition of double bonds. Bovine embryos cultured with 100 µM of
trans-10, cis-12 CLA had reduced FADS2 transcript level compared with control
cultured embryos (Al Darwich et al., 2010). This result likely modified the
saturated/unsaturated fatty acid balance in bovine embryos and could influence
membrane fluidity (Al Darwich et al., 2010). However, post-thaw survival of in
vitro-produced bovine embryos was not improved after co-culture with 100 µM of
trans-10, cis-12 CLA (Al Darwich et al., 2010).
SREBP1
Sterol response element-binding protein-1 (SREB1) is a transcription
factor that, when activated, stimulates lipogenic gene transcription (Peterson et
al., 2004). Fatty acid synthesis was suppressed through inhibition of SREBP in
the liver of mice supplemented with PUFA (Kim et al., 1999). Trans-10, cis-12
CLA suppressed SREBP1 maturation in adipose and liver of rats in a dose
dependent post-translational manner (Xu et al., 1999), inducing a decrease in
fatty acid synthesis. Treatment of bovine mammary gland cells with 75 µM/L of
trans-10, cis-12 CLA did not alter SREBP-1 mRNA expression, but abundance of
the activated nuclear fragment of the SREB-1 protein was reduced by CLA
treatment (Peterson et al., 2004). Peterson et al. (2004) concluded that trans-10,
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cis-12 CLA reduces lipid synthesis in the bovine mammary gland by inhibition of
the proteolytic activation of SREBP-1 and reduction in transcription of lipogenic
genes (ACC, FAS, SCD). Day-7 to d-8 bovine embryos contained SREBP1
mRNA and expression was down-regulated by PUFA inclusion into culture media
(Al Darwich et al., 2010).
Alteration in gene expression at the transcriptional level cannot be
definitively equated to changes in functional pathways as transcripts must be
translated and post-translational modifications may be necessary in order for
proteins to be functional. Functional biochemical assays such as proteomic
analysis are necessary to accurately validate changes in mRNA expression;
however, these techniques require large quantities of oocytes, which can be
difficult to obtain in many large animal experimental models.
In vitro culture of bovine embryos altered mRNA expression of genes
coding for fatty acid utilization and synthesis, which likely help explain lower
developmental competence of in vitro compared with in vivo embryos (Algriany et
al., 2007). Furthermore, altered gene expressing and resulting modification in
lipid metabolism likely changes the composition of oocytes and embryos,
resulting in differences in embryo cryotolerance. Trans-10, cis-12 CLA appears
to influence mRNA expression of genes involved in lipid metabolism in the bovine
mammary gland, as well as in bovine embryos after culture with CLA.
Supplementation of cows with CLA may alter lipid composition of oocytes via
modification of oocyte gene expression. To our knowledge there are no current
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reports evaluating mRNA expression of genes involved in lipid metabolism in
oocytes and embryos collected from cows fed CLA.
Summary
Better understanding of biological mechanisms contributing to variation in
cryotolerance of embryos will likely continue to improve success of embryo
cryopreservation. Research designed to better understand factors influencing
the composition of oocytes may lead to practices that produce embryos better
suited to survive cryopreservation. This research may be especially important for
those breeds and/or species that have limited success with cryopreservation.
Additionally, there is a lack of understanding of the mechanisms contributing to
variation in cryotolerance of gametes between and within individuals of a
particular species. Development of models that evaluate variation in lipid
metabolism and lipid composition of oocytes and embryos have the potential to
impact biological disciplines beyond cryopreservation.
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CHAPTER III
MILK FAT, MILK PRODUCTION, FIRST SERVICE PREGNANCY RATE
AND OOCYTE LIPID CONTENT IN LACTATING HOLSTEIN COWS FED
TRANS-10, CIS-12 AND CIS-9, TRANS-11 CONJUGATED LINOLEIC ACIDS

Introduction
Dietary supplements containing CLA reduced milk fat synthesis when fed
to lactating cows (Loor and Herbein, 1998; Chouinard et al., 1999a; Chouinard et
al., 1999b). The trans-10, cis-12 CLA isomer was identified as a potent inhibitor
of milk fat synthesis in lactating cows (Baumgard et al., 2000; Baumgard et al.,
2001; Peterson et al., 2002). A rumen-protected CLA supplement has been
developed (Lutrell®, BASF) containing CLA isomers known to suppress milk fat.
Lipid encapsulated CLA suppressed milk fat when fed to lactating sheep and
goats (Lock et al., 2006; Lock et al., 2008) and cows (Perfield et al., 2004;
Castañeda-Gutiérrez et al., 2007b; Pappritz et al., 2011). In addition,
supplementation with ≤10 g/d each of trans-10, cis-12 and cis-9, trans-11 CLA
appears to benefit reproduction in lactating Holstein cows even without significant
changes in energy balance (Bernal-Santos et al., 2003; Castañeda-Gutiérrez et
al., 2005).
Tolerance to chilling and cryotolerance of oocytes and embryos has been
correlated to their lipid content (Kim et al., 2001; Abe et al., 2002; Seidel, 2006),
that is, more and larger cytoplasmic lipid droplets reduce cryotolerance.
Nagashima et al. (1994) improved post-thaw survival of porcine embryos after
centrifugation and removal of lipids at the 1-cell stage. Inclusion of trans-10, cis12 CLA (the same isomer which induces milk fat depression in dairy cows) in
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bovine embryo culture media decreased lipid accumulation and improved postthaw embryo survival (Pereira et al., 2007; Pereira et al., 2008; Ruiz et al., 2013).
Intracellular lipid content of embryos can be qualitatively quantified and
compared between treatments using Nile Red and florescence microscopy. Nile
Red is a lipid specific fluorescent dye that can be used to evaluate the lipid
content in single mammalian oocytes. Peak fluorescence observed correspond
to neutral lipids, which are mainly triglycerides (Genicot et al., 2005).
Fluorescence intensity after staining with Nile Red was used to evaluate
differences in cytoplasmic lipids of oocytes and embryos differing in donor breed
(Bos indicus vs. Bos taurus, Ballard, 2006; Holstein Fresian vs. Belgian Blue
(Leroy, 2004) domestic livestock species (Genicot et al., 2005), bovine in vitro
culture conditions (Barceló-Fimbres and Seidel, 2008), or visual color (dark vs.
light) (Leroy et al., 2005).
Additional research is necessary to elucidate mechanisms contributing to
variation in cryotolerance associated with individual animal, breed, species and
nutrition (Seidel, 2006). Better understanding of mechanisms contributing to
variation in cryotolerance of embryos will continue to improve success of embryo
cryopreservation. If dietary CLA could alter ovarian lipid metabolism in a manner
similar to CLA-induced effects on the bovine mammary gland, it may alter oocyte
lipid composition, which could influence subsequent embryo cryotolerance.
Therefore, objectives of this study were (1) to verify previously reported milk fat
depression and reproductive responses in Holstein cows fed rumen-protected
CLA and (2) to evaluate CLA supplementation on follicle and oocyte production
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and lipid content of oocytes using Nile Red stain. This trial is intended to
generate proof-of-principal data necessary to undertake a series of experiments
investigating the effects of CLA supplementation on bovine oocyte composition
and embryo cryotolerance.
Materials and Methods
Animals and Experimental Diets
Experimental procedures in this study were approved by the Louisiana
State University Animal Care and Use Committee, and were conducted at the
Louisiana State University Agricultural Center Dairy Research Farm (Baton
Rouge, LA) from September through December, 2010. Primiparous (n = 15) and
multiparious (n = 24) Holstein females in late gestation were randomly allotted to
experimental diets after stratification by previous (cows) or expected (heifers)
milk production, lactation number and expected date of parturition. During
gestation cows were housed in groups according to expected calving date in sodbased pens and group fed a corn silage-based total mixed ration (TMR). After
calving, cows were housed in partially shaded free-stall pens with fans and
sprinklers and were allowed access to bermudagrass-based (Cynodon dactylon)
paddocks (0.6 ha).
Cows received a corn silage-based TMR (Table 3.1) enriched with either a
lipid-encapsulated supplement containing trans-10, cis-12 and cis-9, trans-11
conjugated linoleic acids (CLA, Lutrell®, BASF, Lampertheim, Germany) or a
rumen-protected calcium salts of palm oil (Ca salts, Megalac®, Church and
Dwight Co., Inc., Ewing, NJ). Diets were formulated to meet or exceed

50

Table 3.1 Experimental diets for primiparous and multiparous Holstein cows1
Ingredient

Kg/DM2

% DM

Corn silage

7.1

31.2

Alfalfa hay

2.8

12.2

Ground corn

3.6

15.8

Corn distillers with sol.

2.4

10.4

Soybean hulls

2.3

10.0

Soybean meal

1.6

7.1

Bakery waste

1.4

6.2

Molasses

0.3

1.1

Megalac/Lutrell3

0.1

0.4

Mineral premix

1.3

5.6

1

Each included at 100 g per hd/d in respective treatments.
Dry matter.
3
Diets fed as a total mixed ration in two daily offerings.
2

NRC (2001) recommendations for early-lactation Holstein cows that weighed
600 kg and produced 35 kg of 3.5% fat corrected milk (FCM). Supplements were
included at 100 g per hd/d to respective treatment diets from parturition through
98 ± 7 days in milk (DIM). Calculated CLA inclusion was 10 g per hd/d each of
trans-10, cis-12 and cis-9, trans-11 CLA. The fatty acid composition of the
supplements is detailed in Table 3.2. The diets included corn silage, alfalfa hay,
ground corn, corn distillers with solubles, soybean hulls, soybean meal,
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Table 3.2 Percentage of fatty acids from total fatty acids in supplement1
Fatty acid isomer

CLA

Ca salts

12:0

-

0.2

14:0

-

1.6

16:0

1.3

50.8

18:0

61

4.1

18:1 cis

10.1

35.7

18:2

1.3

7.0

cis-9, trans-11

12.6

-

trans-10, cis-12

12.6

-

18:3

-

0.2

Other

1.1

0.4

1

Composition according to manufacturer formulation.
CLA (Lutrell) and Megalac are rumen-protected supplements with fat contents of
79.5% (Lutrell) and 84.5% (Megalac).
2

bakery waste, molasses and a mineral premix. Diets were mixed in a verticalmixing feed wagon and offered twice daily to allow 5 to 10% refusal (as-fed
basis). Refusal from each treatment diet (pen) were collected and weighed daily.
Dry matter (DM) of silage was monitored weekly to maintain the correct forageto-concentrate ratio.
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Milk production was assessed at each of two daily milkings (3 AM and 3
PM) by electronic meters and a mean weakly milk yield was calculated for
analysis. Milk composition (fat, protein and SCC) was analyzed weekly from
consecutive AM and PM milk samples. Weekly body weight (BW) was recorded
after milking and before afternoon feeding.
Synchronization for Oocyte Collection and Timed Artificial Insemination
Oocytes were collected using transvaginal ultrasound-guided oocyte
aspiration (TUGA) at 63 ± 7 and 77 ± 7 DIM. An outline of the synchronization
procedures is presented in Figure 3.1. A dominant follicle removal (DFR)
procedure was performed on each female to synchronize the follicular wave at 59
± 7 DIM. Three injections (im) of FSH (Folltropin®-V, Bioniche Animal Health,
Athens, GA) were administered at 12-h intervals beginning 36 h after the DFR. A
descending-dose FSH schedule was used with injections of 4.5, 4.0 and 3.5 ml
(20 mg/ml) equating to 90, 80 and 70 mg of FSH for each of the three injections,
respectively. Cumulus-oocyte complexes (COC) were collected 36 h after the
final FSH injection (4 d after DFR) at 63 ± 7 DIM. These procedures were
repeated on each animal beginning with DFR 10 d following the first TUGA
session. The interval between TUGA sessions was 14 d and the second TUGA
session was conducted at 77 ± 7 DIM. If cows had an ovarian cyst at the initial
DFR or any DFR or TUGA session they were excluded from the remaining
oocyte collections and from analysis of pregnancy rate after AI (artificial
insemination).
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Figure 3.1 Synchronization schedule and procedures for transvaginal ultrasound-guided oocyte aspiration (TUGA). DFR
is dominant follicle removal; FSH is Folltropin®-V, porcine follicle stimulating hormone, administered im.
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Cows were synchronized for fixed-time AI (FTAI) using a modified
OvSynch protocol in conjunction with the TUGA sessions (Figure 3.2). Cows
were administered prostaglandin F2α (Lutalyse®, 5ml, 25 mg, im) at the time of
both the first and second TUGA sessions. An injection of GnRH (Cysterellin, 2
ml, 100 µg, im) was administered 10 d following the second PGF2α and a third
injection of PGF2α 7 d following GnRH. A final injection of GnRH was
administered ~56 h after the third PGF2α injection. All cows were inseminated at
97 ± 7 DIM by the same experienced technician with Holstein semen of good
fertility at 16 to 20 h following GnRH. Pregnancy status was assessed at
34 ± 5 d after AI by transrectal ultrasound or return estrus was recorded. Cows
that had an ovarian cyst at any DFR or TUGA session were not included in
pregnancy status analysis.
Oocyte Collection
Equipment and materials used for TUGA are presented in Appendix A.
Cows were restrained in a manual squeeze chute and given local anesthesia via
a caudal epidural injection of 5 ml of lidocaine (2%, Reproduction Resources,
Walworth, WI). Follicles were visualized using a SonoSite® MicroMaxx® 8.5
MHz curved array transducer encased in a hard plastic probe equipped with a
needle guide. Disposable needles (18 ga x 7.6 cm, Air-Tite Products Co., Inc.,
Virginia Beach, VA) were connected to polyethylene tubing (Becton Dickinson
and Co., Sparks, MD) using metal hardware. The opposite end of the tubing was
threaded into a urethral catheter connector (Cook Urological, Bloomington,IN)

55

Figure 3.2 Synchronization schedule for fixed-time artificial insemination (FTAI). DFR is dominant follicle removal, PG is
prostaglandin F2α (Lutalyse®, 5 ml, 25 mg, im), G is GnRH (Cysterellin®, 2 ml, 100 µg, im)
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fitted to the plastic lid of filter (EmCon®, Reproduction Resources), which is
equipped with a 75 micron stainless steel mesh. A regulated vacuum pump
(Watanabe Tecnologia Aplicada, Brazil) was connected to the filter creating a
constant vacuum with aspiration rate of 15 to 20 ml/min when the foot pedal
switch was engaged.
Follicular contents from follicles approximately ≥4 mm were collected into
the filter containing 10 ml collection medium. The number of follicles targeted
and CL present were recorded for each cow, in each TUGA session. Oocyte
collection medium (OCM) was Dulbecco’s phosphate-buffered saline (PBS) with
calcium and magnesium containing 1% calf serum and heparin (10 IU/ml).
Immediately following collection, filters were taken to the laboratory at the LSU
AgCenter Dairy Research Farm to search for COC. Aspirate from each cow was
transferred to a gridded dish containing OCM and searched for COC with a
dissecting microscope. Recovered COC were graded according a four point
scale (Table 3.3), similar to the procedures reported by Leibfried and First
(1979).
Grade I, and II COC were washed in fresh OCM and cumulus cells were
removed by high speed vortex 3 to 4 min in a 15 ml conical tube containing 1 ml
of HEPES Talp medium (buffered culture medium, Appendix L) with 1 mg/ml of
hyaluronidase. Completely denuded oocytes were washed in fresh OCM and
divided for further processing. Half the oocytes were placed in 1.5 ml
microtubules in a small drop (1 to 2 µl) of 50% methanol in PBS and stored at 80°C for later mass spectrometry analysis. The remaining oocytes were placed
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in a single well of a 4-well plate (Thermo Scientific, Rochester, NY) containing
fixative medium for Nile Red analysis. All oocytes were held at 4°C until all cows
were collected and transported on ice to the LSU Reproductive Biology Center
for storage or further analysis.

Table 3.3 Classification protocol for evaluating bovine oocyte components 1

Component
Investment
(Cumulus Cell
Status)

Ooplasm

Numerical
score

Description

1

Complete, cumulus oophorus present; more
than three layers thick; compact

2

Partial, cumulus present; either not completely
surrounding the oocyte or <3 layers thick;
compact

3

Expanded, cumulus present; cellular
investment shows expansion; cumulus cells
appear in scattered clumps in matrix

4

Nude, cellular investment not present; oocyte
only enclosed by zona pellucida

1

Even granulation giving oocyte a dusty
appearance; ooplasm fills the zona pellucida
evenly

2

Granules clumping or unevenly distributed in
ooplasm, may be withdrawn to center of oocyte
leaving clear periphery or coalescing into black
bodies in ooplasm; ooplasm fills zona pellucida

3

Ooplasm shrunk away from zona pellucida not
evenly filling the zona; ooplasm degenerate,
vacuolated, fragmenting or just left in remnants;
empty zona pellucida

1

Modifed from Leibfried and First (1979).
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Nile Red Stain
Denuded oocytes were incubated in 4-well petri dishes containing
gluteraldehyde/formaldehyde fixative medium (Appendix B) overnight (18 ± 2 h)
at 4°C. Fixed oocytes were washed 4 times with PBS before Nile Red staining.
Oocytes were rinsed 3 times in Nile Red working solution before staining in a
single well of a 4-well plate containing Nile Red (1 µg/ml) working solution
(Appendix C). Oocytes were incubated in Nile Red working solution at room
temperature (~24°C) inside a sealed cardboard box (to ensure complete
darkness) for 24 h. After incubation, oocytes were washed 3 times in PBS and
suspended in 10 µl droplets of ProLong® Gold antifade reagent (Invitrogen
Corporation, Carlsbad, CA) on a 25 x 55 mm glass slide. Slides were prepared
with three droplets per slide containing 5 to 15 stained oocytes per droplet.
Cover slips were carefully placed over the droplet of ProLong® Gold, lightly
pressed down on all four corners and sealed with nail polish. Oocytes from each
donor cow remained separated throughout fixing, staining and slide preparation.
Oocytes stained with Nile Red were evaluated with a Nikon Labophot
microscope equipped with epifluorscent illumination and a FITC dichroic filter
cube with long pass filter (excitation: 400-500 nm and emission: 515 nm).
Images of each oocyte were captured with fluorescence microscopy at 20X
objective (0.4 NA) using a QImaging Micropublisher 3.3 camera with QCapture
Pro software and stored on a PC for analysis. After established, camera settings
remained identical to capture each image. Prepared thin-layer slides of oyster
ovarian tissue stained with hemotoxylin-eosin were used as control slides.
These slides were used to account for possible variation in camera and
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microscope settings or florescent bulb intensity between days. ImageJ software
(imagej.nih.gov/ij/index.html) was used to evaluate mean florescence intensity of
Nile Red stained oocytes in each image. Five samples from similar areas of
each oocyte were measured to calculate mean florescence intensity. A total of
57 oocytes collected from cows fed CLA (n = 13 cows) and 54 oocytes from cows
fed Ca salts (n = 12 cows) were used for Nile Red staining.
Statistical Analyses
The experimental unit in this study was pen as animals were fed on a pen
(not individual) basis. Cow BW, mean weekly milk yield, milk composition data
(fat, protein, ECM and FCM) were analyzed using the GLM procedure of SAS
(SAS Institute Inc., Cary, NC). The model included treatment (CLA and Ca salts)
parity (primiparous and multiparous) and higher order interactions. Follicle and
COC responses (number of follicles targeted, total COC and Quality COC
recovered) were analyzed with the Mixed procedure of SAS. Main effects
included dietary treatment, parity, collection and higher order interaction.
Nile Red intensity was analyzed with the GLM procedure of SAS. The
model included supplemental treatment, collection and higher order interactions.
If higher order interactions were not significant (P > 0.07) they were excluded
from the model. When effects were significant (P ≤ 0.05), least squares means
(LSM) were compared using LSD (pdiff) of SAS. Recovery rate of COC and
pregnancy rate between dietary treatments were analyzed using Chi Square with
the frequency procedure of SAS.
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Results
Body Weight and Dry Matter Intake
Multiparous cows weighed more (644, 632, 641, 646 and 659 ± 12 kg, P ≤
0.001) at each weigh period than primiparous cows (548, 551, 556, 564, 569 ±
14 kg), respectively. Body weight of cows was not influenced (P ≥ 0.77) by
dietary treatment and was 607, 600, 608, 614 and 623 ± 12 kg at 12, 32, 55, 74
and 94 ± 7 DIM, respectively. There was no difference (P = 0.50) in DMI
between cows supplemented CLA (19.8 ± 0.3 kg) or Ca salts (19.5 ± 0.3 kg).
Milk Production and Composition
Mean weekly milk yield during the first 13 weeks of lactation was greater
(P = 0.0002) for cows fed CLA (38.2 ± 0.4 kg) compared with cows fed Ca salts
(35.4 ± 0.4 kg) (Figure 3.3). Milk yield and milk composition data are detailed in
Table 3.4. Multiparous cows produced more milk (P < 0.0001) than primiparous
cows (42.3 and 31.2 ± 0.5, respectively).
Multiparous cows had greater milk fat yield (P < 0.0001) and percent milk
fat (P = 0.042) than primiparous cows (1.56 ± 0.02 vs. 1.14 ± 0.03 kg; 3.69 ± 0.04
vs. 3.52 ± 0.07%, respectively). Milk fat yield (P = 0.0007) and percent milk fat
(P < 0.0001) were reduced (Figure 3.4) in cows fed CLA compared with cows fed
Ca salts (1.28 ± 0.03 vs. 1.42 ± 0.03 kg; 3.28 ± 0.05 vs. 3.93 ± 0.06%,
respectively). There was a treatment by parity interaction with milk fat yield
(P < 0.025); supplementation with CLA depressed milk fat yield in multiparous
cows, but milk fat was not depressed in primiparous cows (Figure 3.5).
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Figure 3.3 Mean weekly milk production of Holstein cows fed CLA or Ca salts. Means differ when signified with ^ (P <
0.07) and * (P < 0.05). Mean weakly milk production across all weeks was greater (P = 0.0002) for cows fed CLA
compared with cows fed Ca salts (38.2 vs. 35.4 ± 0.4 kg, respectively).
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Table 3.4 Milk production and milk composition of cows fed CLA or Ca salts
Dietary Supplement1
Item

CLA

Ca salts

SE

P value

Mean weekly milk yield, kg

38.2

35.4

0.4

< 0.0001

Milk fat yield, kg

1.28

1.42

0.03

0.0007

Milk fat, %

3.28

3.93

0.05

< 0.0001

Protein yield, kg

1.05

1.00

0.02

0.08

Milk protein, %

2.73

2.78

0.04

0.37

Energy corrected milk2, kg

37.1

38.2

0.6

0.20

3.5% fat corrected milk3, kg

37.4

39.3

0.7

0.05

1

Partially rumen-protected supplements fed at 100g per hd/d. CLA cows
consumed 8.6g per hd/d each of trans-10, cis-12 and cis-9, trans-11 CLA.
2
Energy corrected milk (ECM) expresses the amount of energy in milk based on
milk weight, fat and protein standardized to 3.5% fat and 3.2% protein. The
formula used for ECM calculations (Dairy Records Management Systems DHI
Glossary, 2013) was: (0.327 X milk kg) + (12.95 X fat kg) + (7.65 X protein kg).
3
Fat corrected milk adjusts the pounds of milk produced to a standard fat (usually
3.5%) to calculate milk energy produced/excreted. The formula taken from the
Dairy Records Management Systems DHI Glossary (2013) is: (milk kg X 0.432) +
(fat kg X 16.216).

Protein yield was greater (P < 0.0001) in multiparous cows (1.16 ± 0.02
kg) compared with primiparous cow (0.90 ± 0.03 kg). Protein yield (P = 0.08) and
percent protein (P = 0.37) in milk were not influenced by fatty acid
supplementation (Table 3.4). Energy corrected milk (ECM) was greater
(P < 0.0001) in multiparous compared with primiparous cows (43.1 ± 0.6 vs. 32.2
± 0.8 kg, respectively), but was not influenced (P = 0.20) by dietary
supplementation (Table 3.4).
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Figure 3.4 Percent milk fat of Holstein cows fed CLA or Ca salts. Means differ when signified with * (P < 0.05). Percent
milk across all weeks was greater (P < 0.0001) for cows fed Ca salts compared with cows fed CLA (3.93 vs. 3.52 ± 0.05
%, respectively).
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Figure 3.5 Milk fat yield of multiparous and primiparous Holstein cows fed CLA or
Ca salts. A dietary treatment by parity interaction (P < 0.025) was identified.
Different superscripts indicate mean differences (P < 0.05).

Mulitparous cows had greater (P < 0.0001) 3.5% fat corrected milk (FCM)
than primiparous cows (43.9 ± 0.6 vs. 32.8 ± 0.8 kg, respectively). Cows fed Ca
salts had greater 3.5% FCM (P = 0.05; 39.3 ± 0.7 kg) than cows fed CLA (37.4 ±
0.7 kg).
Follicle, Oocyte and Pregnancy Responses
A total of 516 oocytes were collected from 32 Holstein cows after a total of
62 TUGA sessions (n = 269 CLA, n = 247 Ca salts). Follicle and oocyte
responses of Holstein cows are presented in Table 3.5. No interactions were
detected for collection (P ≥ 0.52), treatment by collection (P ≥ 0.14), treatment by
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Table 3.5 Follicle and oocyte responses of Holstein cows fed CLA or Ca salts
Dietary supplement1
Item

CLA

Ca salts

SE

P value

Follicles targeted

17.0

15.7

1.6

0.54

COC recovered

8.2

7.6

1.0

0.69

Quality COC recovered2

6.0

5.7

0.8

0.74

Recovery rate3 (%)

47.9

48.3

3.0

0.88

No collection, treatment by collection or treatment by parity interactions were
detected so mean response per cow per collection was reported.
1
Holstein cows were supplemented with either a supplement containing trans-10,
cis-12 and cis-9, trans-11 conjugated linoleic acids (CLA, Lutrell) or Ca salts of
palm oil supplement (Ca salts, Megalac) at 150 g per hd/d, respectively.
2
Qualtiy Grade I and Grade II oocytes according to a four-point scale.
3
Number COC recovered/number follicles targeted.

parity (P ≥ 0.36) or collection by parity (P ≥ 0.74) for the number of follicles
targeted, COC and Quality COC recovered. Multiparous cows had greater
follicles targeted per TUGA session (P = 0.02) than primiparous cows (19.2 ± 1.6
vs. 13.4 ± 2.0 follicles, respectively) (Table 3.6). Accordingly, multiparous cows
produced more COC (P = 0.009) and quality (Grade I and II) COC (P = 0.03) per
TUGA session compared with primiparous cows (9.9 ± 0.8 vs. 5.9 ± 1.3 COC; 7.2
± 0.6 vs. 4.3 ± 1.0 Quality COC, respectively). Dietary treatment did not
influence the number of follicles targeted (P = 0.54), COC recovered (P = 0.69)
or Quality COC recovered (P = 0.74) per TUGA session (Table 3.5). Rate of
COC recovery (48.1%) was similar (P = 0.88) between dietary treatments.
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Table 3.6 Follicle and oocyte responses of multiparous and primiparous
Holstein cows
Parity
Multiparous

Primiparous

SE

P value

Follicles targeted

19.2

13.4

1.5

0.02

COC recovered

9.9

5.9

1.0

0.01

Quality COC recovered2

7.2

4.4

0.8

0.03

Item

No treatment or treatment by parity interactions were detected so mean response
per cow per collection across dietary treatment groups (CLA and Ca Salts) was
analyzed.
2
Qualtiy Grade I and Grade II oocytes according to a four-point scale.

First service pregnancy rate was similar (P = 0.30) for cows supplemented
CLA (n = 8/16, 50.0%) and those supplemented with Ca salts (n = 5/17, 29.4%),
respectfully (Figure 3.6).
Nile Red Stain
Intensity of control slides did not differ across day of image collection (P =
0.68). A total of 111 oocytes (n = 57 CLA, n = 54 Ca salts) from 25 cows (n = 13
CLA, n = 12 Ca salts) were stained and evaluated. There were no collection (P =
0.34) or treatment by collection (P = 0.51) interactions for Nile Red intensity.
Mean Nile Red intensity was not influenced (P = 0.88) by dietary treatment
(Figure 3.7). Representative images of Nile Red stained oocytes are available in
Appendix D.
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Figure 3.6 First service artificial insemination pregnancy rate of Holstein cows fed
CLA or Ca salts. 1Number of cows confirmed pregnant via ultrasound at 34 ± 5 d
after AI over the number of cows inseminated.
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Figure 3.7 Mean Nile Red intensity of oocytes collected from Holstein cows fed
CLA (n=57 oocytes, n =13 cows) or Ca salts (n=54 oocytes, n=12 cows).
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Discussion
Mean animal feed refusal in this study was 13.5% (as fed) per d.
Therefore, actual intake of the CLA supplement was calculated at 86 g/hd per d
(100 g/hd per d offered). This equates to 8.6 g each of trans-10, cis-12 and cis9, trans-11 CLA. Mean weekly milk yield for cows fed CLA was 7.9% greater
than cows fed Ca salts in this study. This is similar to reported increases in milk
yield of 3 to 10% in cows fed supplements containing trans-10, cis-12 CLA
(Bernal-Santos et al., 2003; Mackle et al., 2003; de Veth et al., 2006; CastañedaGutiérrez et al., 2007b). Similarly, milk yield was 13% greater in lactating ewes
fed CLA compared with control fed ewes (Sinclair et al., 2010).
In studies where milk energy output and cow energy balance are similar
between supplemental treatment groups, energy spared by milk fat depression is
likely repartitioned for milk production (Bernal-Santos et al., 2003; de Veth et al.,
2006; Castañeda-Gutiérrez et al., 2007b; Sinclair et al., 2010). However, milk
production in Holstein cows was not influenced by CLA-supplementation in a
study by Castañeda-Gutiérrez et al. (2007a). Milk production was also not
influenced in dozens of studies involving very short-term abomasal infusion of
CLA that significantly decreased milk fat. Factors such as the dose of CLA
isomers, method used to protect the supplement from rumen biohydrogenation,
length of dietary treatment, stage of lactation during treatment and season may
influence milk production responses to CLA supplementation.
Milk fat yield was decreased by 9.9% in cows fed CLA compared with Ca
salts in the current study. Milk fat percentage decreased from 3.93% in Ca salts
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fed cows to 3.28% in CLA-fed cows. Sippel et al. (2009) reviewed CLA-induced
milk fat depression using different doses of trans-10, cis-12 CLA in seven trials
(Giesy et al., 2002; Perfield et al., 2002; Piperova et al., 2004; Selberg et al.,
2004; de Veth et al., 2005; de Veth et al., 2006; Sippel et al., 2009). Sippel et al.
(2009) plotted depression in daily milk fat yield over CLA dosage to develop a
prediction equation for expected milk fat depression after dietary
supplementation of CLA. Using that equation in the present study, dietary
addition of 8.6 g trans-10, cis-12 CLA per hd/d resulted in an expected milk fat
depression of 14.8%. This is slightly greater, but within reasonable range of the
9.9% milk fat depression in the current study.
Milk fat yield was significantly decreased by 14.1% in cows fed a rumenprotected CLA containing 7.1 g/d each of cis-9, trans-11 and trans-10, cis-12
CLA (Castañeda-Gutiérrez et al., 2007a). Pappritz et al. (2011) reported milk fat
depression was 14.8% in cows fed a lipid encapsulated CLA (Lutrell®) at nearly
the same inclusion rate (8.0 g of trans-10, cis-12 CLA) as the present study.
The efficacy of a rumen-protected trans-10, cis-12 CLA supplement is
measured by the degree of milk fat depression (Perfield et al., 2004). The
transfer efficiency of CLA from a supplement into milk fat is influenced by efficacy
of the protection from rumen metabolism as well as postruminal availability (Wu
and Papas, 1997). Transfer efficiencies of CLA from rumen-protected
supplements are generally much lower than the ~20% transfer efficiencies found
in abomasal infusion studies (Chouinard et al., 1999a; Chouinard et al., 1999b;
Baumgard et al., 2000; Baumgard et al., 2001; Peterson et al., 2002). The
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majority of the CLA in rumen-protected supplements are either metabolized in
the rumen or unavailable for postruminal absorption. However, as evidenced by
significant milk fat depression in cows fed rumen-protected supplements, CLA
isomers can alter biological tissues after very minimal absorption and transfer
into these tissues.
Comparing the transfer of trans-10, cis-12 CLA from rumen-protected
supplements with that from abomasal infusion (average 22%) provided an
estimate of rumen biohydrogenation and, therefore, a measure of the efficacy of
rumen protection (de Veth et al., 2005). The CLA in the current study was
coated with hydrogenated vegetable fat consisting of palmitic and stearic acid
linked to glycerin. Pappritz et al. (2011) used duodenal fistulated cows to
evaluated rumen metabolism and postruminal bioavailability of a lipidencapsulated CLA supplement manufactured by BASF (Lutrell®, BASF
Ludwigshafen, Germany). This supplement is the same encapsulation and CLA
formulation used in the current study, and one of the inclusion rates in the
Pappiritz et al. (2011) study was 100 g of CLA per hd/d. Only 0.4 g of the daily
consumed 8 g trans-10, cis-12 CLA reached the duodenum, while transfer
efficiency of the isomer into milk was 3%; this suggests a low (5%) ruminal
protection rate (Pappritz et al., 2011). Of the 0.4 g reaching the duodenum, 48%
was transferred to milk (Pappritz et al., 2011).
Assuming similar biohydrogenation conditions to the Pappritz et al. (2011)
study, von Soosten et al. (2013) reported that 0.24 g to 1.04 g of trans-10, cis-12
were available for absorption in the small intestine after cows were fed a lipid
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encapsulated supplement containing 6 g of trans-10, cis-12 CLA. Although the
current study used a similar approach to lipid encapsulate supplements, rumen
protection may not have been as efficient in the current study compared with
previously reported studies; resulting in less incorporation of trans-10, cis-12 into
milk and less pronounced milk fat depression. Possible variation in individual
animal DMI may also account for the less pronounced milk fat depression in the
current study, as individual dietary intake of cows was not accessed.
A treatment by parity interaction was found with milk fat yield in the current
study (Figure 5). Supplementation with CLA significantly decreased milk fat yield
in multiparous cows, but milk fat yield of primiparous cows did not differ between
CLA and Ca salts supplemented groups. Although very few studies involving
milk fat depression have included primiparous cows, no report of this interaction
could be found in the literature. Milk fat is often greater in multiparous compared
with primiparous cows. Because individual intake was not assessed, DMI of
primiparous cows may have been less than multiparous cows, resulting in less
intake of CLA and little to no effect on milk fat depression. Additionally, low
experimental numbers of primiparous cows may have influenced results.
However, first lactation cows may indeed respond differently to CLA
supplementation, with this finding needing further examination.
Cows fed Ca salts had significantly greater 3.5% FCM compared with
CLA-supplemented cows, but ECM was not significantly altered by dietary
supplementation. Fat corrected milk uses a standard formula to adjust milk yield
to a standard fat test, usually adjusted to 3.5% FCM (DRMS DHI Glossary,
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2013). Energy corrected milk calculates the amount of energy in milk based on
milk weight, fat and protein standardized to 3.5% fat and 3.2% protein. These
two measures are used to evaluate the total milk energy excreted in milk, and
directly relates to profitability as dairy operations are compensated for both the
quantity and quality (fat %) of their milk. In the current study, CLA-supplemented
cows repartitioned a portion of the energy spared by milk fat depression into
increased milk production. However, it appears that additional energy was
retained and may have been repartitioned into other tissues or systems.
Multiparous cows had more follicles, COC recovered and Quality COC
recovered per TUGA session compared with primiparous cows in this study. In
contrast, Bilby et al. (2006) reported more visible follicles aspirated in
primiparous compared with multiparous Holstein cows in a study feeding various
dietary unsaturated fatty acids. However, only 4.6 ± 0.4 follicles were aspirated
and 3.7 ± 0.3 oocytes recovered per cow in the Florida study using nonstimulated lactating Holstein cows collected every 3 d during summer months
(Bilby et al. 2006). Differences in age, growing conditions, body condition and
genetics of primiparous cows as well as season of experiment may have
contributed to differences in parity effects for follicle and oocyte responses
between studies.
Dietary treatment did not influence the number of follicles targeted, COC
recovered or Quality COC recovered per TUGA session in the current study.
Lactating Holsteins fed Lutrell (100 g/d) produced more follicles per collection
compared with those produced from non-supplemented animals (Höffmann et al.,
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2008). The previous report is an abstract that does not explain details regarding
isoenergenic formulation of control and CLA fed cows. In the current study,
energy spared by milk fat depression and not repartitioned into milk production of
CLA fed cows does not appear to support the quantity of follicles nor the quantity
and quality of COC produced by the ovary. Developmental potential of oocytes
was not evaluated in the current study.
First service pregnancy rate was not influenced by dietary treatment in the
current trial, as experimental numbers were too limited to establish a statistical
difference. Supplementation with ≤10 g/d of each trans-10, cis-12 and cis-9,
trans-11 CLA appears to benefit reproduction in lactating Holstein cows even
without significant changes in energy balance (Bernal-Santos et al., 2003;
Castañeda-Gutiérrez et al., 2005). Castañeda-Gutiérrez et al. (2007b) reported
increased plasma concentrations of IGF-I in lactating cows fed a rumenprotected CLA containing 7.1g/d each of cis-9, trans-11 and trans-10, cis-12
CLA. Additionally, CLA-supplemented cows tended (P = 0.08) to have greater
concentrations of progesterone during the early luteal phase (d 6 to 8 of the
estrous cycle; (Castañeda-Gutiérrez et al., 2007b). Beneficial reproductive
effects were reported after supplementation of cows was terminated in studies by
Bernal-Santos et al. (2003) and Castañeda-Gutiérrez et al. (2005). CastañedaGutiérrez et al. (2007b) concluded that CLA supplementation may improve
embryo viability via improvement in the follicular environment. Supplementation
of cows with 100 g of lipid-encapsulated CLA per hd/d improved cleavage rates
and d-8 blastocyst rates in vitro (Höffmann et al., 2008).
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Using semi-parametric and parametric models, de Veth et al. (2009)
conducted an integrated analysis of five controlled studies involving CLA
supplementation and reproduction in early lactating dairy cows. In this paper,
prediction models concluded that supplementation with trans-10, cis-12 CLA was
positively associated with the probability of pregnancy success and a decrease in
the time to pregnancy as dietary dose increased (de Veth et al., 2009). Models
predicted the probability of pregnancy increased by 26% and the median time to
pregnancy was decreased by 34 d when cows are fed the optimal daily dose of
10.1 g (pregnancy) and 10.5 g (d to pregnancy) trans-10, cis-12 CLA compared
with control-supplemented cows (de Veth et al., 2009).
Nile Red intensity was not influenced by dietary treatment in the current
study. This indicates that concentration of intracytoplasmic neutral lipids was not
significantly different in oocytes collected from cows fed CLA or Ca salts in this
study. Nile Red staining allows evaluation of lipid content for relative comparison
of individual oocytes from different donors or culture conditions. However, this
method does not permit qualitative composition of lipids, such as identification of
fatty acids or different lipid fractions, nor does it allow absolute quantitative
analysis. Embryos co-cultured with trans-10, cis-12 CLA in vitro contained less
lipids and post-thaw viability was improved compared with control cultured
embryos (Pereira et al., 2007). However, there are currently no reports using
Nile Red to evaluate lipid content of oocytes from cows fed CLA known to
suppress milk fat. More dynamic quantitative lipid analysis techniques may have
been beneficial to evaluate possible differences between dietary treatments.
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Cows in different physiological stages may differ in the way they respond to CLA
supplementation, particularly at the ovarian level.
Summary
Milk fat was depressed by 10.1% and milk production increased 7.3% in
cows fed CLA compared with Ca salts. Supplementation with CLA did not
influence follicle or oocyte production or the number of quality oocytes produced.
Nile red intensity did not differ by dietary treatment, indicating no difference in
lipid content of oocytes. However, further research is warranted to evaluate the
influence of CLA supplementation on ovarian lipid metabolism and to elucidate
mechanisms that may influence reproductive performance and embryo
composition and cryosurvival. Better understanding of mechanisms contributing
to variation in cryotolerance of embryos will continue to improve success of
embryo cryopreservation.
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CHAPTER IV
EXPRESSION OF GENES INVOLVED IN LIPID METABOLISM IN OOCYTES
FROM HOLSTEIN AND BRAHMAN COWS FED TRANS-10, CIS-12 AND
CIS-9, TRANS-11 CONJUGATED LINOLEIC ACIDS

Introduction
Variation in cryotolerance exists between embryos from different breed,
species and management conditions. Reduced tolerance to chilling and
cryotolerance of oocytes and embryos has been associated with greater
cytoplasmic lipids (Kim et al., 2001; Abe et al., 2002; Seidel, 2006). Nagashima
et al. (1994) previously reported improved post-thaw survival of porcine embryos
after centrifugation and removal of lipids at the 1-cell stage.
The concentration and type of fat included in ruminant diets may influence
the composition of oocytes and embryos, and therefore, their cryotolerance.
Feeding ewes diets high in polyunsaturated fatty acids (PUFA) altered fatty acid
composition of follicular components (Wonnacott et al., 2010) and improved
membrane integrity after chilling (Zeron et al., 2002a). Fatty acid composition of
follicular fluid in dairy cows is sensitive to dietary supply of polyunsaturated fatty
acids (PUFA) using soybean oil (Batista et al., 2010) and flaxseed oil (Zachut et
al., 2010). In vivo-produced embryos from Nellore heifers were more sensitive to
cryopreservation when diets included rumen-protected PUFA (Guardieiro, 2010;
Guardieiro et al., 2014).
Another interesting area of study has identified specific conjugated linoleic
acids (CLA) that inhibit milk fat synthesis in dairy cows (Loor and Herbein, 1998;
Chouinard et al., 1999a; Chouinard et al., 1999b). The trans-10, cis-12 CLA
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isomer was identified as a potent inhibitor of milk fat synthesis in lactating cows
(Baumgard et al., 2000; Baumgard et al., 2001; Peterson et al., 2002).
Additionally, inclusion of trans-10, cis-12 CLA in bovine embryo culture medium
improved post-thaw embryo survival without influencing overall blastocyst
production (Pereira et al., 2007; Pereira et al., 2008; Ruiz et al., 2013).
The trans-10, cis-12 CLA isomer is reported to exert specific effects on
adipocytes that reduce the uptake of fatty acids without increasing lipolysis
(Pariza et al., 2001). Trans-10, cis-12 CLA altered expression of genes involved
fatty acid oxidation and synthesis in the bovine mammary gland (Lee et al., 1998;
Bretillon et al., 1999; Park et al., 2000; Baumgard et al., 2002) and in in vitro
bovine embryos cultured with trans-10, cis-12 CLA (Al Darwich et al., 2010).
Additionally, In vitro culture of embryos altered mRNA expression of genes
coding for fatty acid utilization and synthesis; results likely help explain lower
developmental competence of in vitro compared with in vivo embryos (Algriany et
al., 2007). Altered gene expression and resulting modification in oocyte lipid
metabolism likely alters the composition of oocytes, resulting in potential
differences in the cryotolerance of embryos.
Carnitin palmitoyl transferase-1 (CPT-1) is an enzyme involved in
mitochondrial energy homeostasis that catalyzes a rate-limiting step in the
transfer of long-chain fatty acyl-CoA from the cytosol to mitochondria for
oxidation (Abu-Elheiga et al., 2000; Kerner and Hoppel, 2000). During oocyte
maturation, CPT1 mRNA increases indicating an increase in β-oxidation during
this stage (Algriany et al., 2007). The FADS2 gene is a member of the fatty acid
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desaturase (FADS) gene family. Enzymes resulting from FADS2 regulate
unsaturation of fatty acids through the addition of double bonds. In vitro embryos
cultured with 100 µM trans-10, cis-12 CLA had reduced FADS2 transcript level
compared with control cultured embryos (Al Darwich et al., 2010). Peroxisome
proliferator-activated receptor alpha (PPARα) is a member of the PPAR family of
ligand-dependent transcription factors (Rosen et al., 1999) and expression of
PPARα is upregulated in tissues with high rates of fatty acid oxidation. Dietary
unsaturated fatty acids have been reported to alter gene expression through
PPAR, leading to altered metabolism, growth and cell differentiation in different
tissues of rats (Ide, 2000; Jump, 2004).
Successful cryopreservation of embryos from Bos indicus cattle is variable
(Visintin et al., 2002). Cytoplasmic lipid content is greater in Bos indicus oocytes
compared with Bos taurus oocytes (Ballard, 2006), likely contributing to reduced
cryotolerance in embryos from Bos indicus cattle. Cryopreservation of embryos
from Jersey donors resulted in reduced pregnancy rates compared with those
from Holstein donors (Steel and Hasler, 2004). In addition to greater embryo
lipid content, Bos indicus and Jersey cattle have greater milk fat content
compared with other breeds of cattle.
Intracellular lipid content of embryos can be qualitatively compared
between treatments using Nile Red and florescence microscopy. Peak
fluorescence observed correspond to neutral lipids, which are mainly triglycerides
(Genicot et al., 2005). Fluorescence intensity after staining with Nile Red was
used to evaluate differences in cytoplasmic lipids of oocytes and embryos
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differing in donor breed (Bos indicus vs. Bos taurus, Ballard, 2006; Holstein
Fresian vs. Belgian Blue (Leroy, 2004) domestic livestock species (Genicot et al.,
2005), bovine in vitro culture conditions (Barceló-Fimbres and Seidel, 2008) or
visual color (dark vs. light) (Leroy et al., 2005).
Additional research is necessary to elucidate mechanisms contributing to
variation in cryotolerance associated with individual animal, breed, species and
nutrition (Seidel, 2006). Previous studies in the cow have demonstrated
nutrition-induced modification of follicular components, which may have
implications for oocyte fatty acid metabolism, oocyte lipid composition and
embryo cryotolerance. Trans-10, cis-12 CLA influences mRNA expression of
genes involved in lipid metabolism in the bovine mammary gland, as well as in
bovine embryos after culture with CLA. Supplementation of cows with CLA may
alter lipid composition of oocytes via modification of oocyte gene expression.
The response to CLA supplementation and/or oocyte lipid metabolism may be
different between Bos indicus and Bos taurus breeds of cattle. To the author’s
knowledge there are no current reports evaluating mRNA expression of genes
involved in lipid metabolism in oocytes and embryos collected from cows fed
CLA.
Therefore, objectives of this study were to evaluate effects of CLA
supplementation of Holstein and Brahman cows on (1) follicle, oocyte and
embryo production (2) mRNA expression of CPT1, FADS2 and PPARα in
cumulus-oocyte complexes (COC) and (3) lipid content of Brahman oocytes
using Nile Red stain.
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Materials and Methods
Experiment 4.1: Holstein Cows
Experimental procedures in this study were approved by the Louisiana
State University Animal Care and Use Committee and were conducted at the
Louisiana State University Agricultural Center Dairy Research Farm (Baton
Rouge, LA) from May through July 2012.
Animals and Experimental Diets
Nonlactating, nonpregnant Holstein cows (n = 12) aged 3 to 8 years were
randomly allotted to experimental diets after stratification by age and body weight
(BW). Cows were maintained on a 0.6 ha bermudagrass-based (Cynodon
dactylon) paddock with minimal forage availability. Cows had access to shade
structures and fresh water.
Cows were supplemented with a lipid-encapsulated supplement
containing trans-10, cis-12 and cis-9, trans-11 conjugated linoleic acids (Lutrell®,
BASF, Lampertheim, Germany) at 150 g per hd/d (High-CLA, n = 4 cows)
100 g per hd/d (Mod-CLA, n = 4 cows) or were not supplemented with fat
(Control, n = 4 cows). Cows were gathered daily and individually fed in a locking
headgate feeding system (Picture in Appendix E). Each cow was offered 1 kg
per hd/d dry distillers grains (DDG) containing 150 g of CLA, 100 g of CLA or no
CLA (DDG only). An open space between cows in the locking headgate system
ensured cows only had access to the supplement intended for each animal.
Calculated inclusion of trans-10, cis-12 and cis-9, trans-11 CLA was 15 g per
hd/d (High-CLA) and 10 g per hd/d (Mod-CLA).
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Supplement refusal was recorded, but generally all cows consumed the
supplements immediately after it was offered. After supplements were
consumed, cows were individually fed a total mixed ration (TMR) including corn
silage and DDG (4.0 and 1.7 kg DM per hd/d for corn silage and DDG,
respectively). The TMR and free-choice grass hay were fed in order to meet or
exceed nutritional requirements. The headgate system was rinsed with a highpressure water hose after each feeding to ensure no supplement carryover to the
next day. Body weight of cows was recorded at 30 d intervals.
Synchronization for Oocyte Collection
An outline of the TUGA schedule is presented in Figure 4.1 and the
ovarian stimulation schedule is presented in Figure 4.2. A dominant follicle
removal (DFR) procedure was performed on each cow to synchronize the
follicular wave 4 d before each TUGA session. Three injections (im) of FSH
(Folltropin®-V, Bioniche Animal Health, Athens, GA) were administered at 12 h
intervals beginning 36 h after the DFR. A descending-dose FSH schedule was
used with injections of 3.5, 3.0 and 2.5 ml (20 mg/ml) equating to 70, 60 and 50
mg FSH for each of the three injections, respectively. Cumulus-oocyte
complexes were collected 36 h after the final FSH injection (4 d after DFR).
Oocyte Collection
Oocytes were collected by TUGA in a similar manner as experiments in
Chapter III and equipment and materials used for TUGA are presented in
Appendix A. Oocytes were collected 11 d before the start of dietary
supplementation and at 14, 28 and 42 d of dietary supplementation.
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Figure 4.1 Schedule and procedures for trans-vaginal ultrasound-guided oocyte aspiration (TUGA) in Holstein cows
(Experiment 4.1). DFR is dominant follicle removal; FSH is Folltropin®-V, follicle stimulating hormone.
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Figure 4.2 Ovarian stimulation schedule and procedures before transvaginal ultrasound-guided oocyte aspiration (TUGA)
session in Holstein cows (Experiment 4.1). DFR is dominant follicle removal; FSH is Folltropin®-V, follicle stimulating
hormone (20 mg/ml) administered in descending-dose schedule (injections of 3.5, 3.0 and 2.5 ml).
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Contents from follicles approximately ≥4 mm were collected into the filter
containing 10 ml collection medium. The number of follicles targeted was
recorded for each cow, in each TUGA session. Oocyte collection medium (OCM)
was Dulbecco’s phosphate-buffered saline (PBS) with calcium and magnesium
containing 1% calf serum and heparin (10 IU/ml). Immediately following
collection, aspirate from each cow was transferred to a gridded dish containing
OCM and searched for COC with a dissecting microscope. Recovered COC
were graded according a four point scale similar to the procedures reported by
Leibfried and First (1979). Grade I and Grade II COC were placed in 1.5 ml
microtubules (2 COC/tube) in minimal volume (1 to 2 µl) of PBS containing 0.1%
polyvinyl alcohol (PVA) and stored at -80°C for later RNA isolation.
Synchronization and Ovarian Stimulation for Embryo Collection
Cows were subjected to ovarian stimulation and synchronization of estrus
prior to in vivo embryo collection on d 69 of dietary supplementation (Figure 4.3).
A DFR procedure was performed on each cow 14 d before embryo collection
(d 55 of supplementation) and a controlled internal drug release device (CIDR)
was inserted intra-vaginally. Eight injections (im) of FSH (Folltropin®-V, Bioniche
Animal Health, Athens, GA) were administered at 12 h intervals beginning 36 h
after the DFR. A descending-dose FSH schedule was used with injections of 3,
2.5, 2.5, 2, 2 1.5, 1.5 and 1 ml (20 mg/ml), equating to a total of 320 mg of FSH.
Cows were administered (im) prostaglandin F2α (Lutalyse®, 5ml, 25 mg) at the
time of the 7th and 8th FSH injection and CIDR were removed at the 8th FSH
injection. Estrus of cows was detected and cows were inseminated with high
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quality semen from the same Brangus sire at 12 ± 3 h (two 0.5 ml straws) and
24 ± 3 h (one 0.5 ml straw) after initiation of standing estrus.
Embryo Collection
Embryos were recovered via nonsurgical gravity flow embryo collection on
d 69 of dietary supplementation by a single technician. Briefly, cows were
restrained in a manual squeeze chute and given local anesthesia via a caudal
epidural injection of 5 ml of lidocaine (2%, Reproduction Resources, Walworth,
WI). The number of CL present was recorded for each cow. A Foley catheter
(18 or 20 Fr, Allegro Medical, Bolingbrook, IL) was passed through the cervix into
the uterine body and was connected to a 1 L bag of lactate ringer (containing 1%
bovine calf serum as a surfactant) via Y-junction tubing (Reproduction
Resources, Walworth, WI). The opposite end of the Y-tubing was connected to
an E-Z Way filter (Reproduction Resources, Walworth, WI). Immediately
following collection, filters were searched for ova with a dissecting microscope.
The number of recovered ova, degenerate/unfertilized ova, embryos and
transferable quality embryos (TQE, Quality Grades 1 and 2) were recorded for
each cow. Stage and Grade of embryos were assigned according to
International Embryo Transfor Society (IETS) guidelines. All TQE were placed in
1.5 ml microtubules (2 embryos/tube) in minimal volume (1 to 2 µl) of PBS
containing 0.1% polyvinyl alcohol (PVA) and stored at -80°C for later RNA
isolation or mass spectrometry analyses.
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Figure 4.3 Synchronization schedule and procedures for ovarian stimulation before in vivo embryo collection in Holstein
and Brahman cows (Experiment 4.1 and Experiment 4.2). DFR is dominant follicle removal; FSH is follicle stimulating
hormone administered in desending-dose injections (Folltropin®-V in Experiment 4.1; Pluset® Original and Pluset® Flex H
in Experiment 4.2). CIDR is controlled internal drug release device; PG is prostaglandin F2α (Lutalyse®, 5 ml, 25 mg, im).
AI is artificial insemination at 12 h and 24 ± 3 h after standing estrus.
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Experiment 4.2: Brahman Cows
Experimental procedures in this study were approved by the Louisiana
State University Animal Care and Use Committee and were conducted at the
Louisiana State University Agricultural Center Reproductive Biology Center (St.
Gabriel, LA) from January through June 2013.
Animals and Experimental Diets
Nonlactating, nonpregnant Brahman cows (n = 17) aged 4 to 14 years
were randomly allotted to experimental diets after stratification by age body
weight (BW) and body condition (BCS). Cows were maintained on an 8 ha
paddock consisting primarily of bermudagrass (Cynodon dactylon), blue grass
(Poa pratensis) and white clover (Trifolium repens). Cows had access to a
permanent shade structure, fresh water and free choice mineral supplement.
Cows were gathered daily, sorted into individual stalls in a barn and fed a
lipid-encapsulated supplement containing trans-10, cis-12 and cis-9, trans-11
conjugated linoleic acids (CLA, Lutrell®, BASF, Lampertheim, Germany) or were
not supplemented with fat (Control). Supplements were fed individually in rubber
hook-over style feed pans (Little Giant® by Miller Manufacturing Co., Eagan, MN).
The CLA (150 g per hd/d) was fed after incorporation with a pelleted soybean hull
supplement (1 kg/hd) or the soybean hull supplement only was fed (Control).
Cows were trained to eat out of feed pans for ~14 d before the start of the trial.
Supplement refusal was recorded, but generally all cows consumed the
supplements immediately after it was offered. Calculated CLA inclusion was
15 g per hd/d each of trans-10, cis-12 and cis-9, trans-11 CLA.
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After supplements were consumed, cows were individually fed an
additional 2 kg per hd/d soybean hull pellets from the start of the trial until d 36 of
supplementation and 1 kg per hd/d soybean hulls from d 37 through d 74 of
supplementation in order to meet or exceed nutritional requirements until
adequate forage growth occurred. Cows were also offered free-choice grass hay
from the start of the trial until d 36 of supplementation. Body weight and BCS of
cows was recorded monthly.
Synchronization for Oocyte Collection
An outline of the TUGA schedule is presented in Figure 4.4. A dominant
follicle removal (DFR) procedure was performed on each cow to synchronize the
follicular wave 4 d before each TUGA session. Ovaries were not stimulated with
FSH in Experiment 4.2.
Oocyte Collection
Procedures for oocyte collection were similar to those used in Experiment
4.1 and a list of equipment and materials used for TUGA is available in Appendix
A. Oocytes were collected via TUGA 23 d before the start of supplementation
and at 19, 40 and 106 d of dietary supplementation. The number of follicles
targeted was recorded for each cow, in each TUGA session. Grade I and Grade
II COC from the first three oocyte collections (d 19, d 40 and d 106 of
supplementation) were placed in 1.5 ml microtubules (2 COC/tube) in minimal
volume (1 to 2 µl) of PBS containing 0.1% polyvinyl alcohol (PVA) and stored at
-80°C for later RNA isolation. Grade I, and II COC from the final oocyte
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Figure 4.4 Schedule and procedures for trans-vaginal ultrasound-guided oocyte aspiration (TUGA) in Brahman cows
(Experiment 4.2). DFR is dominant follicle removal. FSH was not used for ovarian stimulation befroe TUGA in
Experiment 4.2.
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collection (d 106 of supplementation) were washed in fresh OCM and cumulus
cells were removed by high speed vortex 3 to 4 min in a 15 ml conical tube
containing 1 ml of HEPES Talp medium with 1 mg/ml hyaluronidase. Completely
denuded oocytes were placed in a single well of a 4-well plate (Thermo Scientific,
Rochester, NY) containing fixative medium for Nile Red analysis.
Nile Red Stain
Denuded oocytes were incubated in 4-well petri dishes containing
gluteraldehyde/formaldehyde fixative medium (Appendix B) overnight (18 ± 2 h)
at 4°C. Fixed oocytes were washed 4 times with PBS before Nile Red staining.
Oocytes were stained in a single well of a 4-well plate containing Nile Red (1
µg/ml) working solution (Appendix C) at room temperature (~24°C) in complete
darkness for 24 h. After incubation, oocytes were washed 3 times in PBS and
suspended in 10 µl droplets of ProLong® Gold antifade reagent (Invitrogen
Corporation, Carlsbad, CA) on a 25 x 55 mm glass slide. Slides were prepared
with three droplets per slide containing 5 to 15 stained oocytes per droplet.
Cover slips were carefully placed over the droplet of ProLong® Gold, lightly
pressed down on all four corners and sealed with nail polish. Oocytes from each
donor cow remained separated throughout fixing, staining and slide preparation.
Oocytes stained with Nile Red were evaluated with a Nikon Labophot
microscope equipped with epifluorscent illumination and a FITC dichroic filter
cube with long pass filter (excitation: 400-500 nm and emission: 515 nm).
Images of each oocyte were captured with fluorescence microscopy at 20x
objective (0.4 NA) using a QImaging Micropublisher 3.3 camera with QCapture
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Pro software and stored on a PC for analysis. After established, camera settings
remained identical to capture each image. ImageJ software
(imagej.nih.gov/ij/index.html) was used to evaluate mean florescence intensity of
Nile Red stained oocytes in each image. Five samples from similar areas of
each oocyte were measured to calculate mean florescence intensity. A total of
49 oocytes collected from CLA-fed cows (n = 9 cows) and 46 oocytes from
Control-fed cows (n = 6 cows) were stained and evaluated with Nile Red.
Synchronization and Ovarian Stimulation for Embryo Collection
Cows were subjected to ovarian stimulation and synchronization of estrus
prior to in vivo embryo collection on d 74 of dietary supplementation (Figure 4.3)
and procedures used in Experiment 4.2 were similar to those in 4.2. A DFR
procedure was performed on each cow 14 d before embryo collection (d 60 of
supplementation) and a controlled internal drug release device (CIDR) was
inserted intra-vaginally. Eight injections (im) of FSH (Pluset® Original and
Pluset® Flex H, Minitube of America, Inc., Verona WI) were administered in a
descending-dose at 12 h intervals beginning 36 h after the DFR. A total of 6.5 ml
of Pluset® Flex H (FSH:LH = 3:1) and 6.25 ml of Pluset® Original (FSH:LH = 1:1)
was injected per cow, delivering a total of 560 IU of FSH and 333 IU of LH based
on labeled concentrations. Cows were administered (im) prostaglandin F2α
(Lutalyse®, 5ml, 25 mg) at the time of the 7th and 8th FSH injection and CIDR
were removed at the 8th FSH injection. Estrus of cows was detected and cows
were inseminated with semen from a single fertile Brangus sire at 12 ± 3 h (two
0.5 ml straws) and 24 ± 3 h (one 0.5 ml straw) after initiation of estrus.
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Embryo collection
Procedures for embryo collection were similar to those used in Experiment
4.1. The number of CL present and total recovered ova, degenerate/unfertilized
ova, embryos and transferable quality embryos (TQE, Quality Grades 1 and 2)
were recorded for each cow. Stage and Grade of embryos were assigned
according to International Embryo Transfor Society (IETS) guidelines. All TQE
were placed in 1.5 ml microtubules (2 embryos/tube) in minimal volume (1 to 2
µl) of PBS containing 0.1% polyvinyl alcohol (PVA) and stored at -80°C for later
RNA isolation and or mass spectrometry analyses.
mRNA Isolation and Reverse Transcription
Messenger RNA was isolated from COC (2 COC/sample) using RNeasy®
Plus Micro Kit (Qiagen® Inc., Valencia, CA) (Appendix F). A total of 16 samples
were isolated in Experiment 4.1 (Holstein cows) from COC collected on d 42 of
supplementation and 28 samples were isolated in Experiment 4.2 (Brahman
cows) from COC collected on d 40 of dietary treatment. The lysate buffer (Buffer
RLT Plus) was added directly to the microtubules containing COC while at -80°C.
Each sample mRNA was eluted in 17 µl nuclease-free water and directly
converted into cDNA using an iScript™ cDNA Synthesis Kit (Bio-Rad
Laboratories, Inc., Hercules, CA). The iScript™ kit transforms mRNA into more
stable cDNA using reverse transcriptase. The iScript reaction mix contained 4 µl
of iScript reaction mix, 1 µl of reverse transcriptase and 15 µl of mRNA elution
(from Micro Kit). Reactions were placed into a thermocycler for 5 min at 25°C, 30
min at 42°C and 5 min at 85°C. The resulting cDNA transcribed from each
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sample was diluted with nuclease-free water and stored at -20°C until gene
expression analysis.
Primer Validation and Calibrator Development
Primers were designed from bovine gene sequences using the BLAST
function of GenBank (Table 4.1) and were purchased from Invitrogen ™ (Carlsbad,
CA). Bovine liver tissue was used as template cDNA for primer validation and
calibrator development. Messenger RNA was isolated from bovine liver tissue
using the Dynabeads® mRNA Direct Kit™ (Invitrogen, Carlsbad, CA) (Appendix
G) and was immediately converted to cDNA using the iScript™ cDNA Synthesis
Kit (Bio-Rad) (Appendix H).
Basic PCR reactions (Appendix I) were conducted using the JumpStart™
REDTaq® ReadyMix™ Reaction Mix (Sigma-Aldrich Inc., St. Louis, MO) to obtain
an amplicon for each gene of interest, which were evaluated by gel
electrophoresis using 2% agarose gel containing ethidium bromide. Gels were
evaluated under UV light using a BIO-RAD Universal Hood II. Bands were
compared with a 100 bp ladder to verify primer accuracy.
A calibrator was developed as a positive control for quantitative PCR
(qPCR) using bovine liver mRNA converted to cDNA similar to above. The
calibrator contained the cDNA from liver tissue and purified PCR product
(QIAquick® PCR Purification Kit, Qiagen® Inc., Valencia, CA) encoding genes of
interest (CPT1, FADS2 and PPARα) and internal reference genes (Poly A and
GAPDH). Calculated concentrations of PCR products in the calibrator were
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Table 4.1 PCR Primers

Primer1

GeneBank Accession
Number

Product
size (bp)

CPT-1

NM_001034349.2

F 5’ -CGACCCAAACAAGTACCCCA- 3’
R 5’ -CGCTGGGCATTTGTCTCTGA- 3’

156

FADS2

NM_001083444.1

F 5’ -CCGACAAGTGGCTGGTCAT- 3’
R 5’ -GTGATCTGGGAATTCTTGCCG- 3’

232

PPARα

NM_001034036.1

F 5’ -TGGACGAATGCCAAGATCTGA- 3’
R 5’ -ATGACGAAAGGCGGGTTGTT- 3’

204

Poly A

X63436

F 5’ -AAGCAACTCCATCAACTACTG- 3’
R 5’ -ACGGACTGGTCTTCATAGC- 3’

169

GAPDH

U85042

F 5’ -CCTTCATTGACCTTCACTACATGGTCTA- 3’
R 5’ -TGGAAGATGGTGATGGCCTTTCCAT- 3’

127

Sequence

1

Bos taurus poly(A) polymerase (Poly A) (reference gene), Bos taurus glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (reference gene), Bos taurus carnitine palmitoyltransferase 1 (CPT-1), Bos taurus fatty acid desaturase 2
(FADS2), Bos taurus peroxisome proliferator-activated receptor α (PPARα).
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2 pg/µl for each gene of interest and 0.2 pg/µl for each reference gene. PCR
was optimized for each gene using 10-fold dilutions of the calibrator to develop a
standard curve using qPCR. Melt curves for each gene were evaluated to
confirm only a single product was amplified. Results from PCR optimization and
calibrator evaluates for each gene are presented in Appendix J. The first dilution
of the calibrator for each genes was selected as the positive control for qPCR.
Quantitative PCR
Quantitative PCR was used to evaluate relative gene expression in COC
collected from cows fed CLA or a Control supplement in both Experiment 4.1 and
Experiment 4.2. Quantitative PCR was performed using SsoFast™ EvaGreen®
Supermix (Bio-Rad Laboratories, Inc., Hercules, CA, USA) in 20 µl reactions
using 96-well plates and a Bio-Rad MyiQ thermocycler (Bio-Rad Laboratories,
Inc., Hercules, CA) (Appendix K). Each reaction consisted of 10 μl of SsoFast, 4
μl of sample cDNA, 4 μl water, and 2 μl of forward and reverse primer pairs (10
pmol/μl) for each gene (Table 4.1). Measurements were conducted in triplicate
(20 µl per reaction into designated wells of the 96-well plate) and each plate
included a negative control (no template cDNA). The thermocycler procedure
consisted of enzyme activation at 95°C for 1 min and 40 cycles of denaturing at
95°C for 5 s and annealing at 61°C for 30 s. A melt curve was conducted by
increasing the temperature 0.5°C every 10 s from 61°C to 95°C (68 repeats).
Amplification, standard curves and gene expression efficiency were normalized
against internal reference genes PAP and GAPDH.
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Statistical Analyses
Cow was considered the experimental unit in both experiments as dietary
supplements were fed individually. Cow BW and BCS and all embryo responses
(CL present, number of recovered ova, degenerate/unfertilized ova, embryos and
TQE) were analyzed using the GLM procedure of SAS (SAS Institute Inc., Cary,
NC) with dietary treatment in the model. Follicle and COC responses (number of
follicles targeted, total COC and Quality COC recovered) were analyzed with the
Mixed procedure of SAS. Main effects included dietary treatment, collection and
the interaction. Nile Red florescence intensity was analyzed with the Mixed
procedure of SAS. The model included dietary treatment with cow as a repeated
measurement. Nonsignificant (P > 0.07) higher order interactions were excluded
from the model. When effects were significant (P ≤ 0.05), least squares means
(LSM) were compared using LSD (pdiff) of SAS. Recovery rate of COC and total
ova were analyzed with Chi Square using the Frequency procedure of SAS.
Relative gene expression was evaluated in COC collected from cows fed
CLA (150 g per hd/d) or a Control supplements using the REST 2009 Software
(Pfaffl et al., 2002). This software uses a mathematic model that accounts for
different PCR efficiencies of the genes of interest (GOI) and reference genes and
allows normalization of GOI against multiple references genes. The REST
software calculated expression (relative to internal reference genes PAP and
GAPDH) for each GOI in each sample and a geometric mean for each treatment
group was calculated. Estimates of concentrations used the equation c = A*eCT
(where A*e is the PCR efficiency) to allow exponential variation. The REST
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software provided 95% confidence intervals for expression rations and calculated
a P-value to identify up-regulation or down-regulation for GIO between dietary
treatment groups within experiments (Experiment 4.1 and 4.2).
Results
Experiment 4.1: Holstein Cows
Body weight of cows was not influenced (P ≥ 0.94) by treatment at any
time period throughout the trial. Cows weighted 695 ± 25 kg at the start of
supplementation and 657 ± 18 kg at the end of the trial.
Follicle, Oocyte and Embryo Responses
A total of 394 oocytes were collected from 12 Holstein cows after a total of
48 TUGA sessions (n = 105 CLA-High, n = 199 CLA-Mod and n = 114 Control).
Follicle and oocyte responses of Holstein cows are presented in Table 4.2.
There were no collection (P ≥ 0.19) or treatment by collection interactions
(P ≥ 0.10) for follicle and COC responses, therefore collection was removed from
the model. Cows fed Mod-CLA had more follicles targeted (P = 0.003), COC
(P < 0.001) and Quality COC (P = 0.005) recovered than cows fed High-CLA or
Control supplements, respectively. However, Mod-CLA cows had more follicles
present (P = 0.02) at the TUGA session before initiation of dietary treatments,
indicating the differences in follicle and oocyte responses are likely not
associated with dietary treatment. Cows fed High-CLA, Mod-CLA and Control
supplements produced 12.4, 18.2 and 10.5 ± 1.5 follicles and 6.6, 13.3 and 7.6 ±
1.2 COC per cow per TUGA session, respectively. Oocyte recovery rate from
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Table 4.2 Follicle and oocyte responses of Holstein cows fed CLA or no lipid
supplement1
Dietary supplement2
Item

SE

P value

10.5a

1.5

0.003

13.3b

7.6a

1.2

<0.001

6.1a

10.3b

6.1a

1.0

0.005

52.5a

72.9b

72.2b

High-CLA

Mod-CLA

Control

4

4

4

Follicles targeted

12.4a

18.2b

COC recovered

6.6a

Quality COC recovered3
Recovery rate4 (%)

Cows (n)

<0.001

1

No collection or treatment by collection interactions were detected so mean
response per cow per collection was reported. Oocytes were collected 11 d
before the start of feeding and at 14, 28 and 42 d of feeding (four collections).
2
Nonlactating Holstein cows were supplemented with either a lipid-encapsulated
supplement containing trans-10, cis-12 and cis-9, trans-11 conjugated linoleic
acids at 150 g per hd/d (High-CLA) 100 g per hd/d (Mod-CLA) or were not
supplemented with fat (Control).
3
Qualtiy Grade I and Grade II oocytes according to a four-point scale.
4
Number COC recovered/number follicles targeted.
a,b
Means within row without a common superscript were different (P ≤ 0.05).

cows fed High-CLA (52.5%) was reduced (P<0.001) compared with recovery
rates from Mod-CLA (72.9%) and Control (72.2%) fed cows.
In vivo embryo responses of Holstein cows are reported in Table 4.3. A
total of 52 embryos (Grade I or Grade II) were collected from 11 cows (4.6
embryos/cow). One High-CLA fed cow was not collected because of poor
ovarian stimulation and the presence of unovulated follicles at collection. Dietary
treatment did not influence any of the embryo responses measured (P ≥ 0.30).
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Table 4.3 Embryo responses of Holstein cows fed CLA or no lipid supplement 1
Dietary supplement2
SE

P value

6.3

1.9

0.48

6.5

4.8

2.3

0.68

1.5

2.5

4.0

2.0

0.69

Embryos5

6.7

5.3

2.8

1.7

0.30

Recovery rate6 (%)

67.7

70.3

73.1

Item

High-CLA

Mod-CLA

Control

3

4

4

CL4

9.5

8.8

Total ova

7.7

Degenerate/unfertilized

Cows3 (n)

0.90

1

In vivo embryos were collected on d 69 of supplementation
Nonlactating Holstein cows were supplemented with either a lipid-encapsulated
supplement containing trans-10, cis-12 and cis-9, trans-11 conjugated linoleic
acids at 150 g per hd/d (High-CLA) 100 g per hd/d (Mod-CLA) or were not
supplemented with fat (Control).
3
One cow in the High-CLA group was not collected because of poor ovarian
stimulation and/or multiple unovulated follicles.
4
Number corpora lutea present at the time of embryo recovery
5
Quality Grade 1 and Grade 2 embryos collected (according to the International
Embryo Transfer Society (IETS) guidelines.
6
Number ova recovered/number of CL present.
2

Gene Expression
A total of 14 samples (n = 7 each from CLA-High and Control groups)
consisting of 2 COC/sample collected on d 42 of feeding were used for gene
expression analyses in Experiment 4.1. Dietary supplementation of Holstein
cows did not influence the expression of CPT1 (P = 0.95), FADS2 (P = 0.41) or
PPARα (P = 0.55) in COC. Box plots representing the expression of each gene
of interest evaluated in Experiment 4.1 are available in Figures 4.5, 4.6 and 4.7.
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Figure 4.5 Expression ratio of CPT1 in cumulus-oocyte complexes collected from
Holstein cows (Experiment 4.1) fed CLA or no lipid supplement. Boxes represent
the interquartile range (middle 50%). Dashed line within box is the median.
Whiskers are minimum and maximum.

Figure 4.6 Expression ratio of FADS2 in cumulus-oocyte complexes collected
from Holstein cows (Experiment 4.1) fed CLA or no lipid supplement. Boxes
represent the interquartile range (middle 50%). Dashed line within box is the
median. Whiskers are minimum and maximum.
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Figure 4.7 Expression ratio of PPARα in cumulus-oocyte complexes collected
from Holstein cows (Experiment 4.1) fed CLA or no lipid supplement. Boxes
represent the interquartile range (middle 50%). Dashed line within box is the
median. Whiskers are minimum and maximum.

Experiment 4.2: Brahman Cows
Dietary treatment did not influence body weight (P ≥ 0.79) or BCS (P ≥
0.78) of cows at any time period throughout the trial. Cows weighted 605 ± 14 kg
with at the start of supplementation and 670 ± 16 kg at the end of the trial. Cow
BCS was 5.2 ± 0.2 at the start of the trial and 5.6 ± 0.2 at the end of the trial.
Follicle, Oocyte and Embryo Responses
A total of 774 oocytes were collected from 17 Brahman cows after a total
of 51 TUGA sessions (n = 406 for CLA and n = 368 for Control). Follicle and
oocyte responses of Brahman cows are presented in Table 4.4.
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Table 4.4 Follicle and oocyte responses of Brahman cows fed CLA or no lipid
supplement1
Dietary supplement2
SE

P value

17.0

1.7

0.90

15.6

15.3

2.4

0.93

Quality COC recovered3

10.7

10.6

1.5

0.99

Recovery rate4 (%)

91.0

90.0

Item

CLA

Control

9

8

Follicles targeted

17.3

COC recovered

Cows (n)

0.63

1

No collection or treatment by collection interactions were. Oocytes were
collected 23 d before the start of dietary supplementation and at 19 and 40 d of
dietary supplementation (three collections).
2
Nonlactating Brahman cows were supplemented with either a lipid-encapsulated
supplement containing trans-10, cis-12 and cis-9, trans-11 conjugated linoleic
acids at 150 g per hd/d (CLA) or were not supplemented with fat (Control).
3
Qualtiy Grade I and Grade II oocytes according to a four-point scale.
4
Number COC recovered/number follicles targeted.
There were no collection (P ≥ 0.30) or treatment by collection interactions
(P ≥ 0.68) for follicle and COC responses, therefore collection was removed from
the model. Dietary CLA supplementation did not influence the number of follicles
targeted (P = 0.90) COC recovered (P = 0.93) or number of Quality COC
recovered (P = 0.99). Responses for CLA compared with Control-supplemented
cows were 17.3 vs. 17.0 ± 1.7 follicles targeted, 15.6 vs. 15.3 ± 2.4 COC
recovered and 10.7 vs. 10.6 ± 1.5 Quality COC recovered. Rate of COC
recovery was similar (P = 0.63) between dietary treatments and total COC
recovery rate across treatments was 90.5%.
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In vivo embryo responses of Brahman cows are reported in Table 4.5. A
total of 63 embryos (Grade I and Grade II) were collected from 12 cows (5.3
embryos/cow). One CLA fed cow and two Control fed cows were not collected
because of poor response to ovarian stimulation and/or the presence of multiple

Table 4.5 Embryo responses of Brahman cows fed CLA or no lipid
supplement1
Dietary supplement2
SE

P value

14.5

2.1

0.20

4.1

7.5

1.9

0.27

Degenerate/unfertilized6

4.0

4.7

0.9

0.62

Embryos7

3.0

5.3

2.1

0.48

Recovery rate8 (%)

39.3

51.7

Item

CLA

Control

8

4

CL4

10.5

Total ova5

Cows3 (n)

1

0.14

In vivo embryos were collected on d 74 of dietary supplementation, responses
are presented per cow.
2
Nonlactating Brahman cows were supplemented with either a lipid-encapsulated
supplement containing trans-10, cis-12 and cis-9, trans-11 conjugated linoleic
acids at 150 g per hd/d (CLA) or were not supplemented with fat (Control).
3
One CLA cow and two Control cows were not collected because of poor ovarian
stimulation and/or multiple unovulated follicles and one Control cow had
endometritis at the time of collection and was not collected.
4
Number corpora lutea present at the time of embryo recovery.
5
Total ova included fertilized embryos, degenerate and unfertilized ova
6
Unfertilized and degenerate embryos were classified based on International
Embryo Transfer Society (IETS) guidelines
7
Quality Grade 1 and Grade 2 embryos collected (IETS) guidelines.
8
Number ova recovered/number of CL present.
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unovulated follicles at the time of collection. Additionally, one Controlsupplemented cow had endometritis at the time of collection and was not
collected. Dietary treatment did not influence any of the embryo responses
measured (P ≥ 0.20).
Nile Red
A total of 49 oocytes collected from CLA-fed cows (n = 9 cows) and 46
oocytes from Control-fed cows (n = 6 cows) were stained with Nile Red in
Experiment 4.2. Mean Nile Red intensity was not influenced (P = 0.79) by dietary
treatment (Figure 4.8). Representative images of Nile Red stained oocytes are
available in Appendix D.
CLA

Control

20

Nile Red Intensity (units)

18
16
14
12
10
8

n = 49
oocytes

n = 46
oocytes

6
4
2

P = 0.79
0

Figure 4.8 Mean Nile Red intensity of oocytes collected from Brahman cows
supplemented with CLA ( n = 9 cows) or no fat supplement (Control) (n = 12
cows). Oocytes were collected on d 109 of dietary supplementation.
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Gene Expression
A total of 28 samples (n = 14 each from CLA and Control groups)
consisting of 2 COC/sample collected on d 40 of dietary supplementation were
used for gene expression analyses in Experiment 4.2. Feeding Brahman cows
CLA compared with Control supplements did not influence the expression of
CPT1 (P = 0.32), FADS2 (P = 0.27) or PPARα (P = 0.63) in COC. Box plots
representing the expression of each gene of interest evaluated in Experiment 4.2
are presented in Figures 4.9, 4.10 and 4.11.

Figure 4.9 Expression ration of CPT1 in cumulus-oocyte complexes collected
from Brahman cows (Experiment 4.2) fed CLA or no lipid supplement. Boxes
represent the interquartile range (middle 50%). Dashed line within box is the
median. Whiskers are minimum and maximum.
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Figure 4.10 Expression ration of FADS2 in cumulus-oocyte complexes collected
from Brahman cows (Experiment 4.2) fed CLA or no lipid supplement. Boxes
represent the interquartile range (middle 50%). Dashed line within box is the
median. Whiskers are minimum and maximum.

Figure 4.11 Expression ration of PPARα in cumulus-oocyte complexes collected
from Brahman cows (Experiment 4.2) fed CLA or no lipid supplement. Boxes
represent the interquartile range (middle 50%). Dashed line within box is the
median. Whiskers are minimum and maximum.
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Discussion

Body weight of Holstein cows in Experiment 4.1 was not influenced by 70
d of CLA supplementation and body weight and BCS of Brahman cows in
Experiment 4.2 was not influenced by 107 d of CLA supplementation. Results
indicate that the small amount of energy supplied from the CLA supplement likely
did not significantly alter net energy intake of cows. The CLA (80% fat) fed at
150 g per hd/d results in supplementation of 120 g of fat per hd/d. This
contributed <4% of the metabolizable energy required for maintenance for
nonlactating, nongestating cows of similar breed, BW, BCS and age to the cows
used in the current study (NRC 1996, Level 1 Model).
Holstein cows fed Mod-CLA had greater follicles targeted (P = 0.003),
COC and Quality COC recovered than cows fed High-CLA or Control
supplements, respectively However, Mod-CLA cows had more follicles present
at the first TUGA session (before initiation of dietary treatments), indicating the
differences in follicle and oocyte responses are likely not associated with dietary
treatment. Mean follicle and oocyte responses are likely easily influenced by one
or two cows with increased follicle counts as there were only four cows per
treatment group. Cows were not stratified by follicle count before the experiment.
Dietary CLA did not influence follicle and oocyte responses compared with
controls in Brahman cows in Experiment 4.2.
Differences in oocyte recovery rate found in Experiment 4.1 could have
been due to difficulty in collection of one cow in the High-CLA group.
Inexperience or inconsistent technique by the technician(s) performing TUGA or
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searching and processing oocytes may have also contributed to differences in
oocyte recovery rate in Experiment 4.1. Oocyte recovery rate was not different
between dietary treatment groups in Brahman cows in Experiment 4.2.
Höffmann et al. (2008) reported increased follicles present per collection
when lactating Holsteins were fed CLA (Lutrell at 100 g/d) compered
unsupplemented cows. Ewes fed fish oil (high in PUFA) had increased follicle
and oocyte production compared with unsupplemented ewes (Zeron et al.,
2002a). Follicle responses after CLA supplementation may depend on
physiological stage of production (lactation vs. nonlactating) in cows. Highly
productive lactating Holsteins, like those in the study by Höffmann et al. (2008),
likely repartitioned energy from milk fat depression into increased follicle
production. Nonlactating cows in the current study may not experience the
benneficial effects of CLA supplementation because they are not deficient in
energy like high producing Holstein cows during early lactation. However,
supplementation with ≤10 g/d of each trans-10, cis-12 and cis-9, trans-11 CLA
appears to benefit reproduction in lactating Holstein cows even without significant
changes in energy balance (Bernal-Santos et al., 2003; Castañeda-Gutiérrez et
al., 2005).
Nile Red intensity was not influenced by dietary treatment of Brahman
cows in Experiment 4.2. This indicates that concentration of intracytoplasmic
neutral lipids did not differ in oocytes collected from cows fed CLA or Control
supplements in the current study. Nile Red intensity of oocytes from lactating
Holstein cows was not influenced by CLA supplementation in the study
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presented in Chapter III of this dissertation. Nile Red staining allows evaluation
of lipid content for relative comparison of individual oocytes from different donors
or culture conditions. However, this method does not permit qualitative
composition of lipids, such as identification of fatty acids or different lipid
fractions, nor does it allow absolute quantitative analysis.
Embryos co-cultured with trans-10, cis-12 CLA in vitro contained less
lipids and post-thaw viability was improved compared with control cultured
embryos (Pereira et al., 2007). There are currently no reports using Nile Red to
evaluate lipid content of oocytes from cows fed CLA. More dynamic quantitative
lipid analysis techniques may have been beneficial to evaluate possible
differences between dietary treatments.
Dietary supplementation of Brahman and Holstien cows with CLA
compared with control supplementation did not influence COC expression of
genes involved in lipid metabolism (CPT1, FADS2 and PPARα). In vitro culture
of embryos altered mRNA expression of genes coding for fatty acid utilization
and synthesis (Algriany et al., 2007). Al Darwich et al. (2010) reported that
PUFA were involved in the control of adipogenesis and events that alter gene
expression of multiple enzymes involved in lipid metabolism of bovine embryos.
Additionally, dietary CLA-induced milk fat depression in dairy cows resulted in the
coordinated down regulation of mRNA expression for genes involved in
mammary lipid synthesis (Piperova et al., 2000; Peterson et al., 2003).
Expression of CPT1 was up-regulated in liver and adipose by dietary
PUFA supplementation in rats (Ikeda et al., 1998). During bovine oocyte
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maturation, CPT1 mRNA increases indicating an increase in β oxidation during
this stage (Algriany et al., 2007). The CPT1 enzyme catalyzes a rate-limiting
step in the transfer of long-chain fatty acyl-CoA from the cytosol to mitochondria
for oxidation (Abu-Elheiga et al., 2000; Kerner and Hoppel, 2000).
The FADS2 gene is a member of the fatty acid desaturase gene family.
Enzymes resulting from FADS2 regulate unsaturation of fatty acids through the
addition of double bonds. In vitro embryos cultured with 100 µM of trans-10, cis12 CLA had reduced FADS2 transcript level compared with control cultured
embryos (Al Darwich et al., 2010). This result likely modified the
saturated/unsaturated fatty acid balance in embryos and could influence
membrane fluidity (Al Darwich et al., 2010). However, post-thaw in vitro embryo
survival was not improved after co-culture with 100 µM of trans-10, cis-12 CLA
(Al Darwich et al., 2010).
Peroxisome proliferator-activated receptor alpha (PPARα) is a member of
the PPAR family of ligand-dependent transcription factors (Rosen et al., 1999).
Expression of PPARα is greater in tissues that have high rates of fatty acid
oxidation, and is the primary subtype that facilitates lipid-induced activation of
fatty acid oxidation associated genes (Braissant et al., 1996). Dietary
unsaturated fatty acids have been reported to alter gene expression through
PPAR, leading to altered metabolism, growth and cell differentiation in different
tissues of rats (Ide, 2000; Jump, 2004). Polyunsaturated fatty acids were
described as a natural ligand or activator of PPAR, although PUFA mediate
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genes involved in lipid metabolism through both PPAR dependent and nonPPAR pathways (Ren et al., 1997).
Differences in fatty acid composition between follicular fluid, granulosa
cells and COC after dietary fatty acid supplementation suggest a selective uptake
of specific fatty acids in different ovarian compartments (Zeron et al., 2002;
Adamiak et al., 2006; Fouladi-Nashta et al., 2009; Zachut et al., 2010; Aardema
et al., 2012). Aardema et al. (2012) concluded that cumulus cells protect oocytes
against elevated follicular fluid fatty acid concentrations by accumulation of these
fatty acids. Uptake of fatty acids by the follicle and oocyte is likely highly
selective as a protective mechanism to ensure fatty acid composition of oocytes
remains safe or optimum (Bilby et al., 2006; Santos et al., 2008a; Fouladi-Nashta
et al., 2009; Sturmey et al., 2009). The highly regulated mechanisms involved in
fatty acid uptake by bovine ovarian components may help explain why gene
expression of COC and lipid content of oocytes (measured by Nile Red intensity)
were not influenced by CLA supplementation in the current study.
Oocytes were collected on d 42 (Experiment 4.1) and d 40 (Experiment
4.1) of dietary supplementation. This may not have been sufficient time for
supplemental CLA to modify the follicular environment in a way that altered
metabolic gene expression of COC. The origin of lipids and the timing of lipid
deposition in bovine oocytes are not fully understood. It appears that oocytes
acquire and/or deposit lipids between the time of primordial follicle activation and
the antral follicle stage (Fair et al., 1997). Although it is difficult estimate, the
course of follicular growth takes a long time relative to the reproductive cycle of
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the animal; several weeks in rodents, and perhaps several months in larger
animals (Hirshfield, 1991; Fortune, 2003).
Summary
Dietary supplementation of Brahman and Holstien cows with trans-10, cis12 CLA compared with control supplementation did not influence COC
expression of genes involved in lipid metabolism (CPT1, FADS2 and PPARα). It
appears that ovarian lipid metabolism was either not altered by CLA
supplementation or that slight modifications were not enough to influence
expression of the metabolic genes analyzed. Additionally, lipid content of
oocytes measured by Nile Red was not influenced by CLA supplementation. The
highly regulated mechanisms involved in fatty acid uptake by ovarian
components may help explain why lipid content of oocytes and gene expression
of COC was not influenced by CLA supplementation in the current study.
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CHAPTER V
CRYOSURVIVAL OF IN VITRO-PRODUCED BOVINE EMBRYOS AFTER
COLLECTION OF OOCYTES FROM COWS FED TRANS-10, CIS-12
AND CIS-9, TRANS-11 CONJUGATED LINOLEIC ACIDS

Introduction
Cryotolerance and cryosurvival are terms used in the Scientific Literature
that describe the ability of cells to survive a cryopreservation procedure.
Variation in cryotolerance exists between embryos from different breed, species
and management conditions. Reduced tolerance to chilling and cryotolerance of
oocytes and embryos has been associated with greater cytoplasmic lipids (Kim et
al., 2001; Abe et al., 2002; Seidel, 2006). Nagashima et al. (1994) previously
reported improved post-thaw survival of porcine embryos after centrifugation and
removal of lipids at the 1-cell stage. Cooling causes lateral phase separation of
membrane lipids in artificial and bacterial membranes (Petit and Edidin, 1974)
and ram spermatozoa (Holt and North, 1986). When porcine embryos were held
at 15°C, structural changes within lipid droplets caused droplets to coalesce and
form larger droplets (Edidin and Petit., 1977). The resulting loss or decrease in
cytoplasmic organization of organelles may irreversibly damage bovine embryos
(Mohr and Trounson, 1981).
Although cryopreservation of in vivo-produced bovine embryos is common
place, in vitro-produced embryos are more sensitive to chilling and
cryopreservation than in vivo-produced embryos (Leibo and Loskutoff, 1993;
Pollard and Leibo, 1993; Farin et al., 1999). Non-physiological culture conditions
alter in vitro embryo lipid metabolism resulting in increased embryo lipids, which
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likely contributes to reduced cryotolerance of in vitro compared with in vivo
bovine embryos (Dorland et al., 1994; Crosier et al., 2001b; Abe et al., 2002).
Research has closed the gap in cryosurvival between in vivo and in vitro bovine
embryos, yet there remains opportunity for improvement before the widespread
adoption of in vitro embryo cryopreservation (Seidel, 2006).
The concentration and type of fat included in ruminant diets may influence
the composition of oocytes and embryos, and therefore, their cryotolerance.
Inclusion of calcium salts of palm oil in ewe diets altered phospholipid fatty acid
composition of follicular components (Wonnacott et al., 2010). Oocytes from
ewes fed fish oil had a lower temperature of lipid phase transition, leading to
superior membrane integrity after chilling (Zeron et al., 2002a). Fatty acid
composition of follicular fluid in dairy cows is sensitive to dietary supply of
polyunsaturated fatty acids (PUFA) using soybean oil (Batista et al., 2010).
Feeding dairy cows an encapsulated flaxseed oil altered the fatty acid
composition of milk, plasma, follicular fluid, cumulus-oocyte complexes (COC)
and granulosa cells (Zachut et al., 2010). In vivo-produced embryos from Nellore
heifers were more sensitive to cryopreservation when diets included rumenprotected PUFA (Guardieiro, 2010; Guardieiro et al., 2014). The previous
mentioned studies have demonstrated the potential means for modification of
follicular fluid and oocyte composition in vivo, which may have implications for
embryo cryosurvival.
Another interesting area of study has identified specific conjugated linoleic
acids (CLA) that inhibit milk fat synthesis in dairy cows (Loor and Herbein, 1998;
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Chouinard et al., 1999a; Chouinard et al., 1999b). The trans-10, cis-12 CLA
isomer was identified as a potent inhibitor of milk fat synthesis in lactating cows
(Baumgard et al., 2000; Baumgard et al., 2001; Peterson et al., 2002). A rumenprotected CLA supplement has been developed (Lutrell®, BASF) containing CLA
isomers known to suppress milk fat. Lipid encapsulated CLA suppressed milk fat
when fed to lactating sheep and goats (Lock et al., 2006; Lock et al., 2008) and
cows (Perfield et al., 2004; Castañeda-Gutiérrez et al., 2007b; Pappritz et al.,
2011).
Inclusion of trans-10, cis-12 CLA in bovine embryo culture medium
improved post-thaw embryo survival compared with control embryos without
influencing overall blastocyst production (Pereira et al., 2007; Pereira et al.,
2008; Ruiz et al., 2013). This improvement in cryosurvival may be due to
reduced accumulation of lipids in trans-10, cis-12 CLA cultured embryos,
evaluated by Nomarski microscopy analysis. In addition, these results may be
explained by increased membrane fluidity due to incorporation of trans-10, cis-12
CLA into bovine embryo membranes (Pereira et al., 2007). The author is
unaware of any published data involving the effects of dietary CLA
supplementation of cows on cryosurvival of embryos.
In vitro survival assays have been used to evaluate post-thaw survival of
embryos in a number of published studies involving in vitro culture conditions
and/or cryopreservation techniques for bovine (Pugh et al., 1998; Enright et al.,
2000; Abe et al., 2002; Lopatářová et al., 2002; Rizos, 2003; Pereira et al., 2007;
Pereira et al., 2008; Al Darwich et al., 2010; Ruiz et al., 2013) and porcine
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embryos (Men et al., 2006). Generally, these researchers evaluated embryo
survival or re-expansion based on a defined set of criteria at the time of thawing
and again at 12 h or 24 h intervals through 24 h to 72 h of in vitro culture. The
number and percentage of embryos hatching were also reported in a number of
these studies.
A number of research groups have transferred d-7 or d-8 in vitro-produced
bovine embryos and recovered them on d 14 to d 16 to evaluate embryonic
survival, development and/or gene expression. These assays have been used to
compare survival and/or gene expression between in vivo- and in vitro-produced
bovine embryos (Bertolini et al., 2002; Angulo-Campos, 2010), in vitro and
somatic cell nuclear transfer embryos (Alexopoulos and French, 2009) and to
compare different in vitro culture conditions (Block et al., 2007). Day-14 bovine
embryos are spherical, ovoid or elongated (Alexopoulos and French, 2009) and
this stage immediately precedes important embryonic events such as maternal
recognition of pregnancy and the formation of extra-embryonic membranes and
the embryo proper (Bertolini et al., 2002). Transfer of d-8 embryos and their
recovery at d 14 may be a useful assay to evaluate early embryonic survival and
development of cryopreserved embryos. The number of embryos recovered at
d 14 and their morphology may allow comparison of cryosurvival between
experimental treatments.
Research is necessary to elucidate mechanisms contributing to variation
in cryotolerance associated with individual animal, breed, species and nutrition
(Seidel, 2006). Better understanding of mechanisms contributing to variation in
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cryotolerance of embryos will continue to improve success of embryo
cryopreservation. Previous studies in the cow have demonstrated nutritioninduced modification of follicular fluid and oocyte fatty acid composition, which
may have implications for embryo cryotolerance. Furthermore, addition of trans10, cis-12 CLA to bovine embryo culture media has improved cryotolerance of
embryos (Pereira et al., 2007; Pereira et al., 2008; Ruiz et al., 2013).
Further research is warranted to determine if supplementing cows with trans-10,
cis-12 CLA could influence the fatty acid composition of oocytes in vivo, and to
determine potential influence on subsequent cryosurvivial of in vitro-produced
embryos. Therefore, objectives of this study were to evaluate effects of CLAsupplementation of crossbred cows on (1) follicle and oocyte production and in
vitro embryo production after TUGA and (2) cryosurvival of in vitro-produced
embryos using post-thaw in vitro and in vivo survival assays.
Materials and Methods
Animals and Experimental Diets
Experimental procedures in this study were approved by the Louisiana
State University Animal Care and Use Committee, and were conducted at the
Louisiana State University Agricultural Center Reproductive Biology Center (St.
Gabriel, LA) from March through August, 2013. Crossbred (Angus x Red Angus
and Angus x Brangus) cows (≤1/4 Brahman) (n = 28) aged 4 to 7 years were
randomly allotted to a 2 X 2 factorial experimental design after stratification by
body weight and body condition score (BCS) (1 to 9). Cows were maintained on
5 ha paddocks of blue grass (Poa pratensis), bermudagrass (Cynodon dactylon)
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and white clover (Trifolium repens). Groups of cows (n = 4 groups of 7 cows
each) were randomly assigned to paddocks and were rotated every 14 d to
reduce confounding paddock effects. Cows had access to clean water, mineral
supplement and portable shade structures and/or shade trees in each paddock.
Cows were fed either a lipid-encapsulated supplement containing trans10, cis-12 and cis-9, trans-11 conjugated linoleic acids (CLA, Lutrell®, BASF,
Lampertheim, Germany) or were not supplemented with fat (Control). All cows
were group fed 1 kg per hd/d of a pelleted soybean hull supplement fed in feed
bunks. The CLA was top-dressed (150 g per hd/d) or the soybean hull
supplement only was fed (Control). Supplement refusal was noted but generally
all cows consumed the supplements immediately after it was offered. Calculated
CLA inclusion was 15 g per hd/d each of trans-10, cis-12 and cis-9, trans-11
CLA. Body weight (BW) and body condition score BCS of cows was recorded
monthly.
Synchronization for Oocyte Collection
Oocytes were collected using transvaginal ultrasound-guided oocyte
aspiration (TUGA) on d 129 (Collection 1) and d 143 (Collection 2) of feed
supplementation. An outline of the synchronization and collection procedures is
presented in Figure 5.1. A dominant follicle removal (DFR) procedure was
performed on each female to synchronize the follicular wave at d 125 of
supplementation (4 d before TUGA). Three injections (im) of FSH (Pluset®
Original and Pluset® Flex H, Minitube of America, Inc., Verona WI) were
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Figure 5.1 Synchronization schedule and procedures for trans-vaginal ultrasound-guided oocyte aspiration (TUGA) in
crossbred beef cows. DFR is dominant follicle removal; FSH is Pluset® Original and Pluset® Flex H, follicle stimulating
hormone, administered im. FSH was used in advance of the first TUGA (Collection 1, d 129) but not before the second
TUGA (Collection 2, d 143).
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administered in a descending dose at 12-h intervals beginning 36 h after the
DFR. Based on labeled concentrations, injections delivered 87.5, 70 and 35 IU
of FSH and 52.5, 70 and 35 IU of LH for the three injections, respectively.
Oocytes were collected 36 h after the final FSH injection (4 d after DFR) on d 129
of feeding. A DFR was performed on each female 9 d following TUGA to
synchronize the follicular wave for a second oocyte collection. Cows were not
stimulated with FSH for Collection 2 and TUGA was preformed 5 d after the DFR
at d 143 of feeding. This resulted in a 14-d interval between oocyte collections.
Oocyte Collection Procedure
Ooctyes were collected by TUGA on d 129 (Collection 1) and d 143 of
feed supplementation using similar procedures as experiments in Chapter III and
Chapter IV and a list of equipment and materials used for TUGA is presented in
Appendix A. Follicular content from all visible follicles were collected into the
filter containing 10 ml collection medium. The number of follicles targeted and
CL present were recorded for each cow, in each TUGA session. Oocyte
collection medium (OCM) was Dulbecco’s phosphate-buffered saline (PBS) with
calcium and magnesium containing 1% calf serum and heparin (10 IU/ml).
Immediately following collection, aspirate from each cow was transferred
to a gridded dish containing OCM and searched for COC with a dissecting
microscope. Recovered COC were graded according a four point scale (I
through IV) similar to procedures reported by Leibfried and First (1979).
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In Vitro Production and Cryopreservation of Embryos
All COC of Grade III or better were washed in fresh OCM, moved through
3 drops of oocyte maturation medium and placed in microtubules containing
maturation medium. The COC were matured by treatment group in microtubules
(~50 COC/tube) in a battery powered shipment incubator maintained at 38.5°C.
While maturing, COC were shipped overnight to Trans Ova Genetics (Centerville,
TX). Maturation media was prepared by Trans Ova and shipped overnight on
icepacks the day before oocyte collections. Oocytes were processed for in vitro
fertilization (IVF) 20 ± 2 h after being placed in maturation medium. Semen from
a single bull of known IVF success (laboratory standard) was used to fertilize
oocytes.
Trans Ova conducted IVF and in vitro culture procedures according to
standard operating procedures and all oocytes across treatment groups were
handled the same with similar culture media and environments. After 7 d of
culture, embryos produced were assigned a developmental stage and grade
according to International Embryo Transfer Society (IETS) guidelines. All
embryos of Grade 1 and Grade 2 were cryopreserved in individual 0.25 ml plastic
straws containing 1.5 M ethylene glycol using a slow-cooled, controlled-rate
embryo freezing system. A total of 198 (n = 94 CLA and 104 Control)
transferable quality embryos (TQE)(Quality Grades I and II) were cryopreserved
and shipped in liquid nitrogen to the LSU Reproductive Biology Center for
analysis.
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Post-thaw In Vitro Survival of Embryos
Embryos were thawed in groups according to treatment (n = 4), d of
freezing (n = 2) and embryo stage and grade. Straws containing embryos were
held in air at room temperature for 5 s and placed into a 37°C water bath for 30 s.
After thawing, embryos were expelled into a dish and rinsed 3 times in HEPES
Talp medium (Appendix L). Cryopreserved In vivo-produced bovine (Angus)
embryos (n = 61) were used as a control for the in vitro survival assay. In vivo
embryos were collected on the same ranch in Florida and were cryopreserved by
a single IETS freeze code using a slow-cooled method in 1.5 M ethylene glycol.
The initial cryosurvival evaluation (8 ± 2 min post-thaw) was recorded and
embryos were washed in modified synthetic oviductal fluid (mSOF) and placed in
a single well of 4-well plates containing mSOF with 5% FBS (Appendix M) for
culture. Embryos were cultured in groups (n = 7 to 12 embryos) in an incubator
at 39°C under 5% CO2 in air for 24 h. Cryosurvival was defined as an embryo
with an intact zona pellucida and an expanded or re-expanding blastocoel cavity.
Embryos were recorded as either survived or did not survive. Survival of
embryos was evaluated at the time of thawing and at 12 h and 24 h ± 0.5 h postthaw by a single technician.
Post-thaw In Vivo Survival of Embryos
After 24 h or culture embryos were rinsed in Hepes Talp medium and
loaded according to treatment group and d of freezing into 0.25 ml straws
containing Syngro® Holding Medium (Bioniche Animal Health, Belleville, ON;
distributed by Reproduction Resources, Walworth, WI). Embryos were
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transferred into synchronous (8 d after the onset of standing estrus) recipient
cows (n = 10) into the uterine horn ipsilateral to a palpable corpus luteum (CL).
Embryos were transferred by treatment group into a single recipient cow (n = 10
recipients for the 4 dietary treatment pens on each of 2 freeze days and 2 in vivo
control groups). A total of 231 embryos (n = 85, 92 and 54 for CLA, Control and
in vivo, respectively) were transferred into 10 cows (n = 17 to 38 embryos/cow).
Embryos were collected from cows 6 d after transfer (d 14) via nonsurgical
gravity flow embryo collection by a single experienced embryo transfer
technician. Large Foley catheters (24 to 20 Fr, Allegro Medical, Bolingbrook, IL)
were used to collect potentially large and/or elongated embryos. Recovered
embryos that were the appropriate size/stage with a distinguishable inner cell
mass (ICM) were considered viable. Embryos not recovered or those that did not
advance in development were considered dead or dying. All recovered embryos
were placed into Syngro® Holding Media until photos were captured.
Statistical Analyses
Cow BW and BCS were analyzed using the GLM procedure of SAS (SAS
Institute Inc., Cary, NC) and the model included dietary treatment (CLA and
Control) and pen was the experimental unit. Follicle, COC (number of follicles
targeted and COC recovered) and embryo (number transferable quality embryos
produced) responses were analyzed with the Mixed procedure of SAS. Main
effects included dietary treatment, collection (1 and 2) and the interaction and the
experimental unit was pen. Any nonsignificant effects (P > 0.07) were excluded
from the model. When effects were significant (P ≤ 0.05), least squares means
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(LSM) were compared using LSD (pdiff) of SAS. Recovery rate of COC, embryo
production rate (transferable quality embryos produced in vitro), post-thaw in vitro
survival and hatching and in vivo survival of embryos were analyzed using Chi
Square analyses with the frequency procedure of SAS. When Chi Square
resulted in P ≤ 0.07 for post-thaw and in vitro embryo survival analyses, a Tukey
multiple comparisons of proportions test was used to determine differences
among the three groups of embryos thawed (in vitro embryos from CLA and
Control-supplemented oocyte donors and in vivo control embryos).
Results
Body Weight and Body Condition of Cows
Body weight of cows was not influenced (P ≥ 0.87) by treatment at any
time period throughout the trial. Cows weighted 623 ± 10 kg at the start of
supplementation and 660 ± 9 at the end of the trial. Supplementation did not
affect BCS of cows (P ≥ 0.67) and was 5.6 ± 0.1 and 6.0 ± 0.1 at the start and
end of supplementation, respectively.
Follicle, Oocyte and Embryo Production
Follicle and oocyte responses are presented in Table 5.1. A total of 775
oocytes were collected from 28 cows over two collections (n = 357 CLA, n = 418
Control). There were no collection (P ≥ 0.82) or treatment by collection
interactions (P ≥ 0.38) for follicle and COC responses, therefore, means of
responses for the two collections combined were analyzed. Supplemental
treatment did not influence the number of follicles targeted (P ≥ 0.40) or COC
recovered (P = 0.39) per TUGA session.
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Table 5.1 Follicle, oocyte and in vitro embryo production of crossbred cows
fed CLA or no lipid supplement1
Dietary supplement2
Item

CLA

Control

SE

P value

Mean response per pen per collection3
Follicles targeted (per cow)4

106 (15.2)

122 (17.4)

19

0.59

COC recovered (per cow)5

89 (12.8)

105 (14.9)

18

0.58

85.7

84.0

Embryos produced (per cow)7

23.5 (3.4)

26 (3.7)

Embryo production rate8 (%)

26.3

24.9

COC Recovery rate6 (%)

1

0.52
2.6

0.54
0.68

Oocyte donors were crossbred Angus x Red Angus and Angus x Brangus (≤1/4
Brahman) cows (aged 4 to 7 years).
2
Oocyte donor cows were supplemented (150 g per had/d) with either a lipidencapsulated supplement containing trans-10, cis-12 and cis-9, trans-11
conjugated linoleic acids (CLA) or were not supplemented with fat (Control).
3
There were 7 cows/pen, 2 pens/trt (2 X 2 factorial arrangement) and oocytes
were collected from each cow on d 129 (Collection 1) and d 143 (Collection 2) of
supplementation.
4
There were no collection (P = 0.86) or treatment by collection interactions
(P = 0.38) for follicles targeted/pen, therefore collection (1 and 2) was eliminated
from the statistical model.
5
There were no collection (P = 0.82) or treatment by collection interactions
(P = 0.38) for COC recovered/pen, therefore collection (1 and 2) was eliminated
from the statistical model.
6
Number cumulus-oocyte complexes (COC) recovered/number follicles targeted.
7
There were no collection (P = 0.13) or treatment by collection interactions (P =
0.08) for TQE produced/pen, therefore collection (1 and 2) was eliminated from
the statistical model.
8
Number of embryos (Grade 1 and Grade 2) produced after 7 d of
culture/number of oocytes fertilized.
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Mean follicles targeted and COC recovered per pen across treatments for
Collection 1 and Collection 2 were 116.8 and 111.5 ± 19.3 follicles and 100.0 and
93.8 ± 17.9 COC, respectively. Rate of COC recovery was similar (P = 0.52)
between dietary treatments and total COC recovery rate across treatments was
84.9%. Means of responses for the two collections combined were analyzed
(Table 5.1). The number of TQE produced per pen were not different (P = 0.54)
between cows fed CLA (n = 47) compared with Control (n = 52) supplemented
cows (Table 5.1). The rate of TQE produced (number of TQE frozen/number of
oocytes fertilized) were not different between cows fed CLA or no lipid
supplement (P = 0.68) and TQE production rate was 25.6% across dietary
treatments (Table 5.1).
Quality grades of in vitro-produced embryos are presented by collection (1
and 2) and dietary treatment in Table 5.2. More Grade 1 embryos were
produced (P = 0.04) after Collection 1 (FSH stimulated) compared with Collection
2 (not stimulated) (21.5 vs. 13.8 ± 1.7 embryos/pen for collection 1 and 2,
respectively). There was a dietary treatment by collection interaction (P = 0.04)
for production of quality Grade 1 embryos (Table 5.2). Supplementation of CLA
did not influence the number of Grade 1 (P = 0.77) or Grade 2 (P = 0.09)
embryos frozen (n = 72 vs. 69 Grade 1 embryos and n = 22 vs. 35 Grade 2
embryos produced after collection of oocytes from cows fed CLA and Control,
respectively).

127

Table 5.2 Quality grade of in vitro embryos produced after collection of oocytes from cows fed CLA or no lipid
supplement1
Collection 12

Collection 2

SE

P value

CLA

Control

Mean4

CLA

Control

Mean

Dietary
Trt5

Collect.
Mean6

Trt

Collect.

Trt*
Collection

Grade 1

19

24

21.5a

17

10.5

13.8b

2.4

1.7

0.77

0.04

0.16

Grade 2

2bc

11.5a

6.8

9ad

6bcd

7.5

1.4

1.0

0.09

0.63

0.04

Total

21

35.5

28.3

26

16.5

21.3

3.7

2.6

0.54

0.13

0.08

Item
Embryos/pen3

1

Quality grades of embryos were assigned by experienced technicians according to International Embryo Transfer Society
(IETS) guidelines. Oocytes for in vitro embryo production were collected from cows (Angus x Red Angus and Angus x
Brangus) (≤1/4 Brahman) fed conjugated linoleic acids (CLA) or no fat (Control).
2
Oocytes were collected on d 129 (Collection 1) and d 143 (Collection 2) of supplementation. Three injections of FSH
(Pluset, im) were administered in a descending dose before Collection 1, while no FSH was used before Collection 2.
3
There were 7 cows/pen, 2 pens/trt (2 X 2 factorial arrangement).
4
Mean embryos per pen per collection (including both dietary treatments) were included to depict collection effects as
there were no statistical dietary effects.
5
Standard error for CLA and Control groups for each collection.
6
Standard error for collection means (included both dietary treatments).
a,b,c,d
Means within row without a common superscript were different (P ≤ 0.05).
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In Vitro Culture and Cryosurvival of Embryos
Embryos evaluated for post-thaw survival is listed by quality grade and
developmental stage in Table 5.3. Post-thaw in vitro survival and hatching rates
of in vitro embryos produced after collection of oocytes from donor cows fed CLA
or no lipid supplement and in vivo control embryos are presented in Table 5.4.
Supplemental treatment of oocyte donors did not influence post-thaw survival of
embryos at the time of thaw (P = 0.31) or at 12 h (P = 0.83) or 24 h (P = 0.55)
post-thaw. However, cryopreserved in vivo-produced control embryos had
greater post-thaw survival compared with both in vitro embryo groups (CLA and
Control) at the time of thaw (P = 0.03). The three groups did not differ in percent
embryo survival at 12 h (P = 0.36) or 24 h (P = 0.17) post thaw. The percentage
of embryos hatching after 24 h of in vitro culture did not differ (P = 0.95) between
CLA (23.3%) and Control (22.8%) supplemented oocyte donor groups. However,
in vitro embryos had a greater (P = 0.005) hatching rate compared with in vivo
control embryos (3.6%).
Post-thaw survival and hatching rates are displayed by embryo quality
grade (Grade 1 and Grade 2) in Table 5.5. Quality Grade 1 in vivo control
embryos had greater post-thaw survival at the time of thaw (P = 0.02) and tended
to be greater (P = 0.07) at 24 h post-thaw compared with in vitro embryos
produced from oocyte donors fed CLA, while survival of in vitro embryos from
Control-supplemented donors was intermediate at the time of thaw and at 24 h
post-thaw.
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Table 5.3 Stage and grade of embryos evaluated for post-thaw in vitro and in
vivo survival1

Embryo source2
CLA

Control

In vivo
control3

Grade 1

72

69

41

Grade 2

22

35

20

Compact morula (4)

1

3

37

Early blastocyst (5)

19

12

24

Blastocyst (6)

22

23

0

Expanded blastocyst (7)

52

69

0

Item
Totals embryos

Embryo Stage (IETS stage code)

1

Stage and grade of embryos were assigned by experienced technicians
according to International Embryo Transfer Society (IETS) guidelines.
2
Oocytes for in vitro embryo production were collected from cows (Angus x Red
Angus and Angus x Brangus) (≤1/4 Brahman) fed conjugated linoleic acids (CLA)
or no fat (Control).
3
Cryopreserved in vivo embryos were used as a control for in vitro and in vivo
survival assays.
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Table 5.4 Post-thaw in vitro survival and hatching of in vitro embryos produced
after collection of oocytes from cows fed CLA or no lipid supplement1
Embryo source1
CLA

Control

In vivo
control2

P value

Collection 14

87.5

93.7

96.4

0.34

Collection 2

81.3a

80.0a

100b

0.048

Total

84.1a

89.3ab

98.2b

0.029

Collection 1

89.5

87.3

96.4

0.41

Collection 2

83.3

80.0

88.9

0.65

Total

86.1

85.0

92.7

0.36

Collection 1

89.5

87.3

96.4

0.41

Collection 2

75.0

79.3

88.9

0.35

Total

81.4

84.8

92.7

0.17

Collection 1

26.3

17.5

7.1

0.13

Collection 2

20.8ab

34.5a

0.0b

0.004

Total

23.3a

22.8a

3.6b

0.005

Item
Post-thaw survival3 (%)

Survival after 12 h culture (%)

Survival after 24 h culture (%)

Hatching rate (%)

1

Oocytes for in vitro embryo production were collected from cows (Angus x Red
Angus and Angus x Brangus) (≤1/4 Brahman) fed conjugated linoleic acids (CLA)
or no fat (Control).
2
Cryopreserved in vivo embryos were used as a control for in vitro survival assay.
3
Embryos with an intact zona pellucida and expanded or re-expanding blastocoel
cavity at evaluation were considered to have survived cryopreservation.
4
There were 7 cows/pen, 2 pens/trt and 2 oocyte collections
a,b,c
Means within row without a common superscript are different (P ≤ 0.05).
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Table 5.5 Post-thaw in vitro survival and hatching rate of Grade 1 and Grade 2
in vitro embryos produced after collection of oocytes from cows fed CLA or no
lipid supplement1
Embryo source2
CLA

Control

In vivo
control3

P value

Post-thaw

80.6a

90.0ab

100.0b

0.02

12 h culture

83.9

83.3

97.1

0.13

24 h culture

80.7a

86.4ab

97.1b

0.07

Hatching rate

17.7a

18.6a

2.9b

0.07

Post-thaw

92.3

87.9

95.2

0.63

12 h culture

91.6

87.9

90.5

0.89

24 h culture

83.3

81.8

90.5

0.67

Hatching rate

37.5a

30.3a

4.8b

0.03

Item
Grade 1 embryo survival4 (%)

Grade 2 embryo survival (%)

1

Quality grade of embryos were assigned by experienced technicians according
to International Embryo Transfer Society (IETS) guidelines.
2
Oocytes for in vitro embryo production were collected from cows (Angus x Red
Angus and Angus x Brangus) (≤1/4 Brahman) fed conjugated linoleic acids (CLA)
or no fat (Control).
3
Cryopreserved in vivo embryos were used as a control for in vitro survival assay.
4
Embryos with an intact zona pellucida and expanded or re-expanding blastocoel
cavity at the evaluation were considered to have survived cryopreservation.

132

There was no difference in survival of Grade 1 embryos between the three
groups (CLA, Control and in vivo control) at 12 h post-thaw. Hatching rate of in
vitro-produced Grade 1 embryos were not different (P = 0.90) between
supplemental treatments (17.7% CLA vs. 18.6% for Control). However, hatching
rates of in vitro-produced embryos (across supplemental treatment groups)
tended to be greater (P = 0.07) than the hatching rate of in vivo control embryos
(2.9% hatching rate).
There were no differences in survival of quality Grade 2 embryos between
the three groups of embryos evaluated. Similar to Grade 1 embryos, hatching
rates of Grade 2 in vitro embryos were similar between supplemental treatments
(P = 0.57), but were significantly greater (P = 0.03) than in vivo control embryos
(4.8%).
There were no dietary treatment effects for post-thaw survival or hatching
of in vitro-produced embryos at any point, therefore data for the two in vitro
embryo groups (CLA and Control-supplemented oocyte donors) were combined
to evaluate the effect of embryo quality grade on post-thaw survival and hatching
of in vitro embryos (Table 5.6). There were no significant differences (P ≥ 0.30)
in survival between Grade 1 and Grade 2 embryos at the time of thaw or at 12 h
or 24 h post-thaw. A greater percentage (P = 0.025) of Grade 2 embryos
(33.3%) hatched after 24 h of post-thaw in vitro culture compared with Grade 1
embryos (18.2%).
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Table 5.6 Post-thaw in vitro survival of Grade 1 and Grade 2 in vitro-produced
embryos1
In vitro embryos2
Grade 1

Grade 2

P value

Post-thaw

85.3

89.8

0.73

12 h culture

83.6

89.5

0.30

24 h culture

83.5

82.5

0.87

Hatching rate

18.2

33.3

0.025

Item
Survival, %

1

Quality grades of embryos were assigned by experienced technicians according
to International Embryo Transfer Society (IETS) guidelines.
2
Oocytes for in vitro embryo production were collected from cows (Angus x Red
Angus and Angus x Brangus) (≤1/4 Brahman) fed conjugated linoleic acids (CLA)
or no fat (Control); there were no dietary treatment effects for survival or hatching
at any point, therefore data was combined to evaluate the effect of embryo
quality grade on survival and hatching.

In Vivo Survival of Embryos
Only 17 embryos were recovered at d 14 after 6 d in utero (total recovery
was 7.4% of embryos transferred at d 8). Recovery of expanded or elongated d
14 embryos produced from donor cows fed CLA (12.9%) was greater (P = 0.03)
compared with in vivo control embryos (1.8%), while recovery of embryos
produced from Control fed donor cows (5.4%) was intermediate and did not differ
from CLA-supplemented group (Table 5.7). Pictures of representative d-14
embryos are presented in Appendix N.
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Table 5.7 In vivo survival of in vitro embryos produced after collection of
oocytes from cows fed CLA or no lipid supplement1
Embryo source2
CLA

Control

In vivo
embryos3

Embryos transferred, n

85

92

55

Embryos recovered, n

11

5

1

12.9a

5.4ab

1.8b

Item

Recovery/Survival rate, %

P value

0.03

1

Embryos (d 8) were transferred into synchronous cows by treatment group and
collected 6 d later on d 14; recovered embryos that were the appropriate
size/stage with a distinguishable inner cell mass were considered to have
survived.
2
Oocytes for in vitro embryo production were collected from cows (Angus x Red
Angus and Angus x Brangus) (≤1/4 Brahman) fed conjugated linoleic acids (CLA)
or no fat (Control).
3
Cryopreserved in vivo embryos were used as a control for in vivo survival assay.

Discussion
Body weight and BCS of cows was not influenced by 143 d of CLA
supplementation, indicating that the small amount of energy supplied from the
CLA supplement likely did not significantly alter net energy intake of cows. The
CLA (80% fat) was supplemented at 150 g per hd/d, equating to 120 g of fat per
hd/d. This contributes <4% of the metabolizable energy required for
maintenance for nonlactating, nongestating crossbred beef cows of similar breed,
BW, BCS and age to the cows used in the current trial (NRC 1996, Level 1
Model).
Dietary treatment did not influence the number of follicles targeted or COC
recovered per TUGA session in the current study. Höffmann et al. (2008)
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reported increased follicles present per collection when lactating Holsteins were
fed CLA (Lutrell at 100 g/d) compered unsupplemented cows. Ewes fed fish oil
(high in PUFA) had increased follicle and oocyte production compared with
unsupplemented ewes (Zeron et al., 2002a). Follicle responses after CLA
supplementation depend on physiological stage of production (lactation vs.
nonlactating) of cows. Highly productive lactating Holsteins, like those in the
study by Höffmann et al. (2008), likely repartitioned energy from milk fat
depression into increased follicle production. Nonlactating beef cows may not
see the same benneficial effects of CLA supplementation because they are not
deficient in energy like high prooducing Holstein cows during early lactation.
However, supplementation with ≤10 g/d of each trans-10, cis-12 and cis-9, trans11 CLA appears to benefit reproduction in lactating Holstein cows even without
significant changes in energy balance (Bernal-Santos et al., 2003; CastañedaGutiérrez et al., 2005). Ewes fed fish oil (high in PUFA) had increased follicle
and oocyte production (Zeron et al., 2002a).
The number of follicles present and COC recovered per collection was
similar between Collection 1 (FSH stimulated) and Collection 2 (no FSH).
Folltropin®-V (Bioniche Animal Health) is the most widely FSH product in the
industry for bovine ovarian stimulation, which according to literature provided by
Bioniche, has a very low LH:FSH ratio. The use of Pluset and Pluset Flex H for
ovarian stimulation in the current study likely supplied more LH and less FSH
than is typically used in ovarian stimulation protocols before TUGA, which may
have contributed to similar oocyte and follicle production between collections.
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A variety of ovarian stimulation protocols and FSH dosages increased the
number of follicles present and COC recovered per TUGA session in problem
(donors unsuccessful with conventional embryo collection) beef and dairy cows
(Looney et al., 1994), Holstein Friesion heifers (Bungartz et al., 1995), Friesian x
beef cows (Goodhand et al., 2000) and Angus-cross cows (Chaubal et al., 2006).
In contrast, no increases in follicle and COC production per TUGA session were
reported in Angus cows (Gibbons et al., 1994), Holstein cows (Stubbings and
Walton, 1995) or Simmental heifers (Goodhand et al., 1999). It is difficult to
compare results of the FSH ovarian stimulation studies due to variation in FSH
composition between and within product brands and the use of a wide variety of
ovarian stimulation protocols; the influence of biological factors such as breed,
age, physiological stage of production and nutrition further complicate
comparisons between studies (Chaubal et al., 2006).
Dietary treatment did not influence the number of Quality Grade 1, Grade
2 or total TQE produced in this experiment. The number of Quality Grade 1
embryos produced was almost identical between CLA (n = 72) and Control (n =
69) supplement groups. There was no difference (P = 0.09) in the number of
Grade 2 embryos between cows supplemented CLA (n = 35 embryos) compared
with Control-supplemented cows (n = 22 embryos). There was a dietary
treatment by collection interaction for production of Quality Grade 2 embryos
(Table 2). This outcome is likely a result of the small number of Grade 2
embryos produced in this trial, especially in the CLA group at Collection 1.
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Supplementation of lactating dairy cows with 100 g of lipid-encapsulated
CLA per hd/d improved cleavage rates and d-8 blastocyst rates in vitro
(Höffmann et al., 2008). Lactating dairy cows fed CA salts of palm oil at a high
inclusion rate (800 g/d) produced more blastocysts in vitro after TUGA compared
with a low (200 g/d) Ca salts inclusion (Fouladi-Nashta et al., 2007). However,
Bilby et al. (2006) reported no improvement in embryo production in vitro after
TUGA from PUFA supplemented lactating Holstein cows. Although embryo
production was not directly measured, Castañeda-Gutiérrez et al. (2007b)
concluded that CLA supplementation of lactating dairy cows improved ovarian
follicular steroidogenesis, supporting ovarian follicle development. Inclusion of
trans-10, cis-12 CLA into bovine oocyte maturation medium increased the rate of
high quality embryos on d 8 in vitro, but did not influence oocyte maturation or
embryo cleavage or blastocyst production (Lapa et al., 2011). However,
inclusion of trans-10, cis-12 CLA into embryo culture medium did not influence
blastocyst production (Pereira et al., 2007; Pereira et al., 2008; Ruiz et al., 2013).
More Grade 1 embryos were produced after FSH-treatment (Collection 1)
compared with no FSH stimulation (Collection 2) across dietary treatment
groups. Stimulating cows with FSH before TUGA increased the number of high
quality oocytes recovered per TUGA session (Goodhand et al., 1999; Goodhand
et al., 2000) and increased the number of in vitro embryos produced per TUGA
session (Looney et al., 1994; Goodhand et al., 1999; Chaubal et al., 2006).
Although total embryo production was not influenced by donor FSH treatment,
Gibbons et al. (1994) reported significantly more Grade 1 in vitro embryos
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produced after FSH treatment of Angus cows. The use of DFR and a
follicle/oocyte coasting period was similar between Collection 1 and Collection 2
in the current study. Stimulation with increased dosages of LH (Pluset Flex H) in
the second and third injections may have facilitated follicular growth and COC
maturation before Collection 1 as ovarian follicles transitioned from FSH to LH
dependence after the follicle recruitment phase.
In the present study, cryopreserved in vivo-produced control embryos had
greater post-thaw survival at the time of thaw compared with in vitro-produced
embryos from CLA and Control-supplemented oocyte donors. However, embryo
survival did not differ between in vitro-produced embryos from CLA and Controlsupplemented oocyte donors and in vivo-produced control embryos at 12 h or
24 h post-thaw, indicating comparable cryosurvival of in vitro and in vivo embryos
after post-thaw culture in this study. In vitro-produced embryos are more
sensitive to chilling and cryopreservation than in vivo-produced embryos (Leibo
and Loskutoff, 1993; Pollard and Leibo, 1993; Farin et al., 1999). Research has
closed the gap in cryosurvival between in vivo and in vitro bovine embryos, yet
there remains opportunity for improvement before the widespread adoption of in
vitro embryo cryopreservation (Seidel, 2006).
It is interesting to note that the percentage of embryos hatching after 24 h
of culture in the current study was greater for in vitro-produced embryos
compared with in vivo control embryos (22.8% vs. 3.6% for in vitro and in vivo
embryos, respectively). This was likely attributed to the difference in embryo
maturity between in vitro embryos and in vivo control embryos (Table 3). In the
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current study, 83.8% of in vitro embryos were blastocyst or expanded blastocyst
stage with fewer compact morula and early blastocysts. The in vivo control
embryos were all compact morula and early blastocysts with no blastocyst or
expanded blastocyst stage embryos.
Dietary supplementation of CLA before TUGA in the current study did not
influence post-thaw survival of in vitro-produced embryos at the time of thaw or at
12 h or 24 h post-thaw compared with Control-supplemented cows. The
percentage of embryos hatching after 24 h of culture was also not influenced by
dietary treatment of oocyte donor cows. When quality Grade 1 and Grade 2
embryos were analyzed separately by dietary treatment, embryo survival and
hatching followed similar trends. Ewe diets supplemented with calcium salts of
fish oil (high PUFA) altered phospholipid fatty acid composition of follicular
components and improved chilling resistance of oocytes (Zeron et al., 2002a).
Conversely, cryotolerance of in vivo-produced embryos decreased when Nellore
heifer diets were supplemented with calcium salts of palm oil, a rumen-protected
fat high in PUFA (Guardieiro, 2010; Guardieiro et al., 2014).
Inclusion of trans-10, cis-12 conjugated linoleic acid in bovine embryo
culture media improved post-thaw embryo survival compared with controls,
without influencing blastocyst production (Pereira et al., 2007; Pereira et al.,
2008; Ruiz et al., 2013). In contrast, post-thaw in vitro embryo survival was not
improved after co-culture with 100 µM of trans-10, cis-12 CLA (Al Darwich et al.,
2010). Improvements in cryosurvival after inclusion of trans-10, cis-12 CLA into
embryo culture medium does not appear to correlate to cryosurvival of in vitro
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embryos after dietary supplementation of trans-10, cis-12 CLA oocyte donors.
However, the current study is the first known trial involving direct measurement of
embryo cryosurvival after trans-10, cis-12 CLA supplementation in cows.
Fatty acid composition of follicular fluid and oocytes was not evaluated in
the current study. However, it appears that follicular fluid and oocyte composition
were either not altered by CLA supplementation or that slight modifications were
not enough to influence cryotolerance of in vitro embryos. Castañeda-Gutiérrez
et al. (2007a) reported very few alterations in follicular fluid fatty acid composition
after CLA supplementation in cows. However, fatty acid composition of bovine
follicular fluid was sensitive to changes in dietary supplementation of PUFA using
soybean oil (Batista et al., 2010) and fish oil (Childs et al., 2008). Feeding dairy
cows a rumen-protected flaxseed oil altered the fatty acid composition of plasma,
follicular fluid, COC and granulosa cells (Zachut et al., 2010).
The fatty acid composition of granulosa cells and COC are quite different
than that found in plasma and follicular fluid (Zachut et al., 2010). Differences in
fatty acid composition between follicular fluid, granulosa cells and COC after
dietary fatty acid supplementation suggest a selective uptake of specific fatty
acids in different ovarian compartments (Zeron et al., 2002; Adamiak et al., 2006;
Fouladi-Nashta et al., 2009; Zachut et al., 2010; Aardema et al., 2012). Lapa et
al. (2011) reported minimal changes in fatty acid concentration of oocytes after in
vitro maturation with trans-10, cis-12 CLA, concluding that oocytes accumulated
very small amounts of trans-10, cis-12 in a selective manner but maintained
relatively consistent fatty acid concentration to ensure cell integrity. Aardema et
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al. (2012) concluded that cumulus cells protect oocytes against elevated follicular
fluid fatty acid concentrations by accumulation of these fatty acids. Uptake of
fatty acids by the follicle/oocyte is likely highly selective as a protective
mechanism to ensure fatty acid composition of oocytes remains safe or optimum
(Bilby et al., 2006; Santos et al., 2008a; Fouladi-Nashta et al., 2009; Sturmey et
al., 2009). The highly regulated mechanisms involved in fatty acid uptake by
ovarian components may help explain why cryotolerance of in vitro embryos was
not influenced by CLA supplementation in the current study.
A lack of improvement in cryotolerance of embryos from CLAsupplemented cows in the current study may be a result of inconsistent or
incomplete protection of the CLA supplement from rumen biohydrogenation.
Inconsistency in reproductive responses to fatty acid supplementation is likely a
result of supply of specific unsaturated FA for absorption in the small intestine
(Santos et al., 2008b), which is influenced by the efficacy of methods used to
protect the supplement from biohydrogenation in the rumen. Using duodenal
fistulated cows, Pappritz et al. (2011) evaluated postruminal bioavailability of a
lipid-encapsulated CLA supplement similar to the one used in the current study
(Lutrell®, BASF Ludwigshafen, Germany) and results indicated a relatively low
rate of ruminal protection (5%).
There were no significant differences in survival between quality Grade 1
and Grade 2 in vitro-produced embryos across dietary treatments at any time
point in the current trial. However, a significantly greater percentage of Grade 2
in vitro-produced embryos hatched after 24 h post-thaw culture compared with
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Grade 1 embryos (33.3% vs. 18.2% for Grade 2 and Grade 1 embryos,
respectively). This result is difficult to explain and may not be indicative of
differences in embryo quality and/or predict differences in pregnancy success
between embryo quality grades. Hatching rates provide inference on the survival
of embryos and progression towards a viable pregnancy, but improved hatching
rates do not necessarily result in more pregnancies after transfer. Recent reports
evaluating both experimental (Spell et al., 2001) and commercial embryo transfer
data sets indicate no difference in pregnancy rates after embryo transfer between
quality Grade 1 and Grade 2 bovine embryos.
Embryo recovery rate at d 14 after 6 d in utero was extremely low and
inconsistent in the current trial. Only 17 embryos were recovered from 10
recipient cows after transfer of 232 viable embryos on d 8 (recovery rate = 7.4%).
Recovery rates at d 14 to d 16 after embryo transfer on d 7 ranged from 20 to
70% (Bertolini et al., 2002; Block et al., 2007; Alexopoulos and French, 2009). In
the current study, recovery rate of d-14 embryos produced from oocytes
collected from CLA-supplemented cows was greater than in vivo control
embryos, while Control-supplemented group was intermediate. However, based
on very poor recovery of embryos from all groups, it’s difficult to make any strong
conclusions regarding embryo survival based on these data. The number of
embryos recovered on d 14 was 11, 5 and 1 for CLA, Control and in vivo control
groups, respectively.
Recipient cows in the current study were in excellent body condition (BCS
= 6) and nutrition. All recipients had an observed estrus and had a palpable and
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ultrasound verified CL at the time of embryo transfer on d 8. Embryo recovery
was performed by a single experienced embryo transfer professional. Large
Foley catheters (24 to 20 Fr) were used for collections to accommodate the
recovery of expanded/or elongated d-14 embryos. The technician used the
largest catheter that would pass through the cervix for each cow.
Collection of large expanded d-14 embryos may require alternative
recovery methods such as uterine horn flushing with the syringe method or
modification of typical Foley Catheters by enlarging the ports to allow embryos to
enter the catheter. The embryo transfer technician noted that the uterus of the
d-14 recipient cows in the current study were flaccid and very difficult to
manipulate compared with d 7 cows, likely contributing to poor recovery rates.
Summary
Dietary supplementation of cows with trans-10, cis-12 CLA before oocyte
collection did not influence cryotolerance of in vitro-produced embryos. Although
not directly measured, it appears that follicular fluid and oocyte composition were
either not altered by CLA supplementation or that slight modifications were not
enough to influence cryotolerance of in vitro embryos. The highly regulated
mechanisms involved in fatty acid uptake by ovarian components may help
explain why cryotolerance of in vitro embryos was not influenced by CLA
supplementation in the current study. The current study is the first known trial
involving direct measurement of embryo cryosurvival after dietary
supplementation of trans-10, cis-12 CLA in cows.
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CHAPTER VI
SUMMARY AND CONCLUSIONS

Cryopreservation of embryos is an important tool used in the bovine
embryo transfer industry to preserve superior genetics. Although
cryopreservation of in vivo-produced bovine embryos has become widely
adapted, variation in cryotolerance exists between embryos from different
species, breeds and management conditions. In addition, there remains
opportunity to improve the success of embryo cryopreservation of in vitroproduced bovine embryos and embryos from Bos indicus breeds of cattle. To
the author’s knowledge this is the first report evaluating effects of CLA
supplementation in cattle on oocytes fatty acid metabolism, oocyte composition
and embryo cryotolerance.
In Chapter III of the current study, milk fat was depressed by 10.1% and
milk production increased 7.3% in lactation Holstein cows fed CLA. This study
supported other published results regarding dietary CLA-induced milk fat
depression in dairy cows. Results from Chapter III lead to a series of
experiments to determine effects of CLA supplementation on oocyte lipid
metabolism, lipid composition and embryo cryotolerance.
Supplementation with CLA did not influence follicle or oocyte production or
the number of quality oocytes or embryos produced in any of the trials in this
dissertation. Dietary supplementation of crossbred beef cows with trans-10, cis12 CLA before oocyte collection did not influence cryotolerance of in vitroproduced embryos (Chapter V). Dietary supplementation of Brahman and
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Holstien cows with trans-10, cis-12 CLA did not alter expression of genes in
cumulus-oocyte complexs (COC) involved in lipid metabolism (Chapter IV). Lipid
content of oocytes measured by Nile Red florescence in this study was not
influenced by CLA supplementation in Holstein (Chapter III) or Brahman cows
(Chapter IV).
Previous studies in the cow demonstrated nutrition-induced modification of
follicular components (Childs et al., 2008; Batista et al., 2010; Zachut et al.,
2010). However, results from the current research indicate that ovarian lipid
metabolism and oocyte composition was either not altered by CLA
supplementation or that slight modifications were not enough to alter expression
of the metabolic genes analyzed and resulted in no improvement in cryotolerance
of in vitro-produced embryos.
Differences in fatty acid composition between follicular fluid, granulosa
cells and COC after dietary fatty acid supplementation suggest a selective uptake
of specific fatty acids in different ovarian compartments (Zeron et al., 2002;
Adamiak et al., 2006; Fouladi-Nashta et al., 2009; Zachut et al., 2010; Aardema
et al., 2012). Uptake of fatty acids by the follicle/oocyte is likely highly selective
as a protective mechanism to ensure fatty acid composition of oocytes remains
safe or optimum (Bilby et al., 2006; Santos et al., 2008a; Fouladi-Nashta et al.,
2009; Sturmey et al., 2009). The highly regulated mechanisms involved in fatty
acid uptake by ovarian components may help explain why lipid content of
oocytes, gene expression of COC and cryotolerance of in vitro embryos was not
influenced by dietary CLA supplementation in the current study. In addition, the
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lack of response in the current study may be a result of inconsistent or
incomplete protection of the CLA supplement from rumen biohydrogenation.
The duration of CLA supplementation relative to oocyte collections in the
current study may not have been sufficient for supplemental CLA to modify the
follicular environment in a way that altered metabolic gene expression of COC.
The origin of lipids and the timing of lipid deposition in bovine oocytes are not
fully understood. It appears that oocytes acquire and/or deposit lipids between
the time of primordial follicle activation and the antral follicle stage (Fair et al.,
1997). Although it is difficult to estimate, the course of follicular growth takes a
long time relative to the reproductive cycle of the animal; several weeks in
rodents, and perhaps several months in larger animals (Hirshfield, 1991; Fortune,
2003). Dietary CLA could potentially influence ovarian lipid metabolism and
composition of bovine oocytes if the duration of supplementation before oocyte or
embryo collection were extended beyond the schedule used in the current trial.
Oocytes were collected after ~40 d of supplementation for gene express analysis
(Chapter IV) and ~140 d for in vitro embryo production and cryotolerance
evaluations (Chapter V).
Recently, considerable research has focused on the follicular microenvironment and oocyte quality and fertility in lactating dairy cows, as reviewed
by Leroy et al. (2012). Investigation in this area will likely continue to improve our
understanding of lipid metabolism and lipid uptake by the oocyte during follicular
development. Research designed to better understand factors influencing the
composition of oocytes may lead to practices that produce embryos better suited
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to survive cryopreservation. Although it appears difficult to alter bovine oocyte
lipid composition in vivo, further research is necessary to better understand
effects of both dietary CLA supplementation and in vitro culture CLA
supplementation on bovine oocyte and embryo lipid metabolism, lipid
composition and embryo cryotolerance.
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APPENDIX
PROTOCOLS AND MATERIALS

Appendix A. Equipment and supplies for transvaginal ultrasound-guided
oocyte aspiration (TUGA)


SonoSite® MicroMaxx® ultrasound system



8.5 MHz curved array transducer (model C11e, SonoSite®)



Hard plastic probe handle equipped with accessories to utilize short
needle systems (Boland Vet Sales; Keller, Texas,
www.bolandvetsales.com)



Plastic probe covers are used to protect the transducer and probe during
the procedure (distributed by Reproductive Resources, Walworth, WI;
product # 273028-3436)



Sterilized non-spermicidal lubricating jelly (Priority Care®, Vet One)



Non-radiopaque polyethylene tubing (inner diameter x outer diameter =
1.67 x 2.42 mm, 7.3 French; Intramedic®, Clay Adams® Brand, Becton
Dickinson and Co., Sparks MD)



Ureteral catheter connectors (Part # 050010, Cook Urological®)



EmCon® filters (Reproductive Resources, Walworth, WI)



Epidural needles (18 ga X 3.8 cm, Reproductive Resources or Vet One)



Lidocaine (2%, Reproductive Resources or Vet One)



Collection needles (18 ga x 7.6 cm, Lot # 100107, Air-Tite Products Co.,
Inc., Virginia Beach, VA)



Regulated vacuum pumps manufactured by Cook Veterinary Products
(Bloomington, IN; VMAR-5000) and Watanabe Tecnologia Aplicada
(Brazil; Pressure Max, BV-003)
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Plastic probe (Boland Vet Sales; Keller, Texas) designed for 8.5 MHz curved array
SonoSite® transducer, pictured with short disposable needle system (Bailey, 2011).

e

a

c
d

b

Short disposable needle system with needle guide (a), transducer (b), needle (c),
Metal connector (d) and plastic manipulation tool (e) (Bailey, 2011).
172

d
c

b

a

Short disposable needle (a) to metal connector (b), connected to plastic
collection tubing (c) connector is threaded into manipulation tool (d) (Bailey, 2011).

Figure 8. Ureteral catheter connector (Cook Urological) fixed to the lid of EmCon®
173

filter using epoxy glue, with collection tubing passing though connector (Bailey, 2011).
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a

c
b

a

b
d

EmCon® filter placed inside a Ziploc® quart plastic bag to ensure consistent suction
during TUGA; plastic oocyte collection tubing (a), ureteral catheter connector (b), tubing
connected to vacuum pump (c), attached to a ring stand during aspirations (d) (Bailey, 2011).

d

a
c
b

a

c
b

Regulated vacuum pumps manufactured by Cook Veterinary Products (left; Bloomington,
IN; VMAR-5000) and Watanabe Tecnologia Aplicada (right; Brazil; Pressure Max,
BV-003); pumps equipped with air filter (a), vacuum tubing that attaches to top of oocyte
filter (b), control pedal (c), and media tube warmer (Watanabe pump only) (d) (Bailey, 2011).
175

Oocyte collection at the LSU AgCenter Reproductive Biology Center, St. Gabriel, Louisiana.
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Oocyte collection using transvaginal ultrasound guided oocyte aspiration (TUGA)
at the LSU AgCenter Reproductive Biology Center, St. Gabriel, Louisiana.
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Appendix B. Nile Red Fixative Medium

Fixative Medium
1. 216 µl Formaldehyde (16%)
2. 500 µl Glutaraldehyde (50%)
3. 3,284 µl Dulbecco’s PBS

Medium needs to be made on the day of fixing samples and stored at 4°C

Appendix C. Nile Red Stain
Nile Red Stock:
1. 10 mg Nile Red
2. 10 ml DMSO

Nile Red Working Solution:
1. 5 µl Nile Red Stock
2. 4,995 µl NaCl (0.9%)
3. 5 mg Polyvinyl-Pyrrolidine (PVP)

Preparing Nile Red Working Solution:
1. Prepare in 15 ml conical tube wrapped in tin foil as solution is light
sensitive
2. Centrifuge at 2,500g for 10 min than filter solution using a 0.25 µm filter
attached to a 25 ml embryo friendly (Norm-Ject) syringe
3. Oocytes incubated in a single well of a 4-well plate at room temperature
for 24 h in complete darkness.
4. Place sterile H20 (500-1,000µL) in middle of 4-well dish (between wells) to
ensure Nile Red stain does not evaporate
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A

B

C

D

E

F

50 µm

Appendix D. Images of bovine oocytes stained with Nile Red dye (20x objective). These oocytes were stained for a
course project (Bailey, 2010) and images were captured in the same manner as those presented in this dissertation.
Images were adjusted for brightness and contrast to enhance differences in morphology and distribution of lipid
droplets within the cytoplasm (these images not meant to compare intensity). Oocytes A and B have a relatively
homogeneous distribution, C and D have areas of more localized lipids and oocytes E and F both have fewer, larger
lipid dropplets distributed throughout the cytoplasm.
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Appendix E. The locking headgate feeding system used to feed Holstein cows in Experiment 4.1
(cows being trained with corn silage) at the LSU AgCenter Dairy Research Farm, Baton Rouge.
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Appendix F. mRNA Isolation of Cumulus-oocyte complexes (COC)
RNeasy® Plus Micro Kit
Catalog number 74034 (QIAGEN® Inc., Valencia, CA)

1. Add 350 µl Buffer RTL Plus directly to microtubules containing COC while
still at -80°C (add buffer while tube is still in freezer).
2. Vortex for 2 min at maximum speed.
3. Transfer lysate to a gDNA Eliminator spin column placed in a 2 ml
collection tube. Centrifuge for 30 s at 9,000 x g, discard the column and
save the flow-through.
4. Transfer the sample to an RNeasy MinElute spin column placed in a 2 ml
collection tube. Close the lid and centrifuge for 15 s at 9,000 x g. Discard
the flow-through.
5. Add 700 µl Buffer RW1 to the RNeasy MinElute spin column. Close the
lid, centrifuge for 15 s at 9,000 x g and discard flow-through.
6. Add 500 µl Buffer RPE to the RNeasy MinElute spin column. Close the
lid, centrifuge for 15 s at 9,000 x g and discard flow-through.
7. Add 500 µl of 80% ethanol to the RNeasy MinElute spin column. Close
the lid, centrifuge for 2 min at 9,000 x g to wash the spin colmn
membrane. Discard the collection tube with the flow through.
8. Place the RNeasy MinElute spin column in a new 2 ml collection tube.
Open the lid of the spin column and centrifuge at max speed for 5 min to
dry the membrane. Discard the collection tube with the flow-through.
9. Place the RNeasy MinElute spin column in a new 1.5 ml collection tube
and add 17 µl RNase-free water directly to the center of the spin column
membrane. Close the lid gently and centrifuge for 1 minute at max speed
to elute the RNA.
10. RNA from COC was directly converted into cDNA using an iScript™ cDNA
Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, CA).
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Appendix G. mRNA Isolation of Bovine Liver Tissue
Dynabeads® mRNA Direct Kit™
Catalog number 61011/61012 (Invitrogen, Carlsbad, CA)
Procedures for “standard” version of manufacturer’s instructions
1. Add Liver sample (~20 mg sample) from -80°C into a 10 ml round bottom
tube.
2. Add 1250 µl lysis/binding buffer directly to the tube containing the frozen
liver sample while the sample is still in the -80°C freezer.
a. RNA is very sensitive, must add buffer in freezer and work quickly
to prevent mRNA degredation.
3. Use sonication grinding tool to mince/homozenize liver tissue within the
buffer inside the 10 ml tube.
a. Sonicate tissue for 1 to 2 min or until tissue is completely
homogenized into the buffer.
b. There will be considerable bubbles and foam production so ensure
the tube is large enough to contain everything while mixing.
4. Force lysate through a 20 or 21 gauge needle 3 to 5 times using a 2 ml
syringe to shear DNA (as described by manufacturer’s instructions).
5. Prepare 250 µl Dynabeads Oligo (dT)25 per manufacturer instruction.
6. Add sample lysate to pre-washed Dynabeads (washed in lysis/binding
buffer) in 1.5 µl microtubule.
7. Resuspend beads completely into sample lysate and incubate with
continuous mixing (roller mixer) for 10 min at room temperature to
hybridize polyA to beads.
8. Place tubule on magnet for 2 min and remove supernatant. If solution is
noticeably viscous, increase the time to ~10 min if necessary.
9. Wash beads/mRNA complex twice in 1250 µl Washing Buffer A at room
temperature and place tubule on magnet to separate the beads from the
solution between each washing step.
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10. Wash beads/mRNA complex twice in 1 ml Washing Buffer B at room
temberature. Place tubule in the magnet to separate the beads from the
solution.
11. Elute mRNA from the beads by adding 27 µl nuclease-free water, incubate
at 70°C for 2 min and immediately place tubule on the magnet. Pipette
supernatant containing mRNA to a new RNASE-free tubule.
12. RNA from Liver was directly converted into cDNA using an iScript™ cDNA
Synthesis Kit (Bio-Rad Laboratories, Inc., Hercules, CA).

Appendix H. cDNA Synthesis Protocol
iSCRIPT cDNA Synthesis Kit
Catalog number 170-8890 (Bio-Rad Laboratories, Inc., Hercules, CA, USA)

1. 20 µl reactions were carried out in PCR tubes (Bio-Rad).
2. Add 4 µl of iScript reaction mix and 1 µl of reverse transcriptase to a 15 µl
RNA sample (bovine liver samples isolated by Dynabeads, bovine COC
isolated by RNeasy® Plus Micro Kit.
a. If using less than 15 µl RNA sample add nuclease-free water to a
final volume of 20 µl for each reaction.
3. Place PCR tubes into thermocycler and run cDNA protocol.
a. 5 min. at 25°C, 30 min. at 42°C and 5 min. at 85°C (hold at 4°C).
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Appendix I. Quantitative PCR Protocol
SsoFast™ EvaGreen® Supermix
Catalog number 172-5200 through 172-5205 (Sigma-Aldrich Inc., St. Louis, MO)

1. Quantitative PCR was used to evaluate relative gene expression in COC
collected from cows fed CLA or a Control supplement in both Experiment
4.1 and Experiment 4.2 using 20 µl reactions in 96-well plates.
2. Plate templates were set-up on the computer controlling the thermocycler.
3. One gene per plate per experiment was run (14 unknowns in Experiment
4.1 and 28 unknowns in Experiment 4.2).
4. Each reaction consisted of 10 μl of SsoFast, 4 μl of sample cDNA
(isolated from COC using RNeasy® Plus Micro Kit), 4 μl water, and 1 μl of
forward primer (10 pmol/μl) and 1 μl of reverse primer (10 pmol/μl).
a. Master mixes were prepared to avoid pipetting error and reduced
contamination.
5. Added 20 µl of each reaction into designated well of a 96-well plate
(samples run in triplicate), cover plate securely with sealing tape.
6. Placed 96-well plate into thermocycler with the following program:

Item

Temperature

Time

Enzyme activation

95°C

1 min

Denaturation

95°C

5s

Annealing/extension

61°C

30 s

61°C-95°C

10 s/step

40 cycles:

Melt curve (68 steps)

Annealing temperature is specific to primers used.
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Appendix J. Primer Validation and Calibrator Evaluations

PCR Primers

Primer1

GeneBank Accession
Number

Product
size (bp)

CPT-1

NM_001034349.2

F 5’ -CGACCCAAACAAGTACCCCA- 3’
R 5’ -CGCTGGGCATTTGTCTCTGA- 3’

156

FADS2

NM_001083444.1

F 5’ -CCGACAAGTGGCTGGTCAT- 3’
R 5’ -GTGATCTGGGAATTCTTGCCG- 3’

232

PPARα

NM_001034036.1

F 5’ -TGGACGAATGCCAAGATCTGA- 3’
R 5’ -ATGACGAAAGGCGGGTTGTT- 3’

204

Poly A

X63436

F 5’ -AAGCAACTCCATCAACTACTG- 3’
R 5’ -ACGGACTGGTCTTCATAGC- 3’

169

GAPDH

U85042

F 5’ -CCTTCATTGACCTTCACTACATGGTCTA- 3’
R 5’ -TGGAAGATGGTGATGGCCTTTCCAT- 3’

127

Sequence

1

Bos taurus poly(A) polymerase (Poly A) (reference gene), Bos taurus glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (reference gene), Bos taurus carnitine palmitoyltransferase 1 (CPT-1), Bos taurus fatty acid desaturase 2
(FADS2), Bos taurus peroxisome proliferator-activated receptor α (PPARα).
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Amp/Cycle (top), Standard Curve (middle) and melting curve (bottom) for Poly A.
186

Amp/Cycle (top), Standard Curve (middle) and melting curve (bottom) for
GAPDH.
187

Amp/Cycle (top), Standard Curve (middle) and melting curve (bottom) for CPT1.
188

Amp/Cycle (top), Standard Curve (middle) and melting curve (bottom) for
FADS2.
189

Amp/Cycle (top), Standard Curve (middle) and melting curve (bottom) for PPAR.
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Appendix K. PCR Protocol
JumpStart™ REDTaq® ReadyMix™ Reaction Mix
Catalog number P0982 (Sigma-Aldrich Inc., St. Louis, MO)

1. Basic PCR reactions were conducted to validate each primer and for
calibrator development using 50 µl reactions carried out in PCR tubes.
2. Each reaction consisted of 25 µl of JumpStart™ REDTaq® ReadyMix™, 2 µl
of forward primer (10 mM), 2 µl of reverse primer (10 mM), 16 µl of water
and 5 µl of sample cDNA (mRNA isolated from bovine liver).
a. Prepare master mixes when possible to avoid repeated pipetting
and/or contamination.
3. Placed tubes into thermocycler with the following program:

Item

Temperature

Time

Hotstart

94°C

2 min

Denaturation

94°C

30 s

Annealing

61°C

30 s

Extension

72°C

1 minute

Final extension

72°C

5 min

Hold

4°C

indefinitely

35 cycles:

a. Annealing temperature is specific to primers used.
4. Remove tubes from thermocycler and add 15 µ of each PCR product to a
2 % agarose gel containing ethidium bromide.
5. Gels were evaluated under UV light using a BIO-RAD Universal Hood II.
Bands for were compared with a 100 bp ladder to verify primer accuracy.
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Appendix L. HEPES Talp Medium
Item

Product ID

Company

HEPES-TL
BSA, Fraction V

40 ml
A-4503

Sigma

Na pyruvate (20 mM stock)
Pen/Strep

Amount

120 mg
400 µl

15140-122

Gibco

200 µl

Appendix M. mSOF Medium
Item

Product ID

Company

Amount

SOF

IVL05-100ML

Caisson Labs

35.2 ml

FBS (5%)

2 ml

BME (essential a.acids)

800 µl

MEM (nonessential a. acids)

400 µl

Pen/Strep

15140-122

Gibco

400 µl

Glucose stock (50 µM)

G-7021

Sigma

1200 µl

192

1000 µm

Appendix N. Images of d-14 bovine embryos from in vivo survival assay in Chapter V (4X objective).
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Brahman cow from Experiment 4.2 (Chapter IV) at the LSU AgCenter Reproductive Biology
Center, St Gabriel, Louisiana.
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Brahman cows from Experiment 4.2 (Chapter IV) heading toward the barn for their
daily supplementation at the LSU AgCenter Reproductive Biology Center, St Gabriel, Louisiana.
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